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ABSTRACT OF DISSERTATION

MECHANISM AND KINETICS OF COVALENT AMIDE-LINKED
ADDUCT FORMATION IN SOLUTION AND SOLID-PEPTIDE FORMULATIONS
Peptides and proteins are prone to chemical and physical degradation in solutions
and solids. One of the most common chemical degradation pathways involves
deamidation of asparagine residues through a reactive succinimide intermediate resulting
in the formation of aspartyl and isoaspartyl degradation products.
In this work, kinetic studies in aqueous solutions demonstrated that the
succinimide intermediate is susceptible to attack by nucleophiles other than water. This
may lead to a variety of alternative degradants. In solutions containing high
concentrations of ammonia, the succinimide generated in the deamidation of the model
peptides Phe-Asn-Gly and Phe-isoAsn-Gly underwent back-reaction with ammonia
leading to peptide isomerization. Intramolecular cyclization involving the N-terminus of
Phe-Asn-Gly to form a cyclic diketopiperazine was also observed. Experiments
employing the succinimide as the starting reactant and kinetic models confirmed that the
above pathways proceed exclusively through an imide intermediate.
To maximize their stability, proteins and peptides are formulated as lyophilized
solids. However, succinimide-mediated deamidation remains important in solidTstate
degradation. Accelerated stability studies of the model peptide Gly-Phe-Asn-Gly in the
presence of excess Gly-Val in amorphous lyophiles revealed the formation of four
deamidation products from the reaction of the succinimide intermediate with water as
well as four covalent amide-linked adducts. The amide-linked adducts were identified as
diastereomers formed by nucleophilic attack of the Gly-Val N-terminus at either the ■
alpha or beta-carbonyl of the succinimide. A comprehensive kinetic model confirmed
that the formation of all four hydrolysis products and the four covalent-adducts proceed
exclusively through the succinimide.
The relative ratio of formation of hydrolysis products to covalent-adducts reflects
a competition between water and the N-terminus of neighboring peptides for reaction
with the succinimide intermediate. This ratio varies with formulation. The sensitivity of
the individual reaction steps involved in deamidation and covalent adduct formation to
formulation changes (e.g., variation in water content and dilution of reactants by
increasing excipient content) were explored. Increasing water content accelerated adduct

and hydrolysis degradant formation while increases in concentration of a polymeric
excipient (HPMC) appeared to haye no significant effect.
The novel mechanism described offers an alternative pathway for peptide and
protein aggregation, particularly in amorphous solid formulations.
KEYWORDS: Asparagine deamidation, aggregation, covalent adduct, amorphous
lyophiles, reaction kinetics
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CHAPTER 1 - STATEMENT OF THE PROBLEM AND HYPOTHESES
The number of therapeutic macromolecules (e.g., peptides, proteins) has increased
over the years and will continue to increase over time. This poses a problem to the
formulation scientist as these macro molecules are inherently unstable. Degradation, both
chemical and physical, can occur at any point in the lifetime of a therapeutic protein from
synthesis to dosing. The longest time interval for a commercial drug product is the
storage of the final product that must have a two year shelf-life as established by the
FDA. In order to achieve the required stability, and minimize the degradation, proteins
and peptides are formulated as lyophilized (generally amorphous) solids. Degradation in
lyophilized powders is influenced by several formulation parameters including water
content, nucleophile concentration, and the glass transition temperature (Tg) of the
formulation.
Reactivity in amorphous solids has historically been correlated to the molecular
mobility of the system which is correlated to Tg. Amorphous lyophiles exist as a glass
When stored below the Tg. In the glassy region, translation mobility is highly restricted
and reactivity may favor pathways that require minimal mobility. In contrast, lyophiles
are in the rubbery region when stored above the Tg. The rubbery region allows for more
translational mobility which accelerates the rate of degradation. More recently, research
has shown that reactivity may not be correlated to Tg. Consequently, chemical and
physical reactivity may be significant even at storage temperatures well below the Tg.
One of the most common chemical degradat ion pathways for proteins and
peptides is deamidation of asparagine residues. Deamidation of asparagines is of interest
because it is a spontaneously occurring major route of degradation that proceeds through

a reactive intermediate. As such, deamidation, both in solutions and amorphous solids,
will be the model chemical pathway for this study. Deamidation is a multi-step process.
The first step is an intramolecular cyclization involving attack by the backbone amide
nitrogen of an asparagine residue on the side-chain amide of asparagine to form a
succinimide intermediate. The second step is the intermolecular attack of water at one of
the carbonyl groups of the imide intermediate resulting in hydrolysis products. Only
recently has it been proposed in the current literature that the succinimide intermediate
can react with other nucleophiles such as primary amines of adjacent proteins/peptides to
form covalent adducts. One of the two major goals of this thesis is to prove that reactions
of the succinimide intermediate with other nucleophiles are important, leading to a
potentially vast array of degradants.
The multistep nature of the deamidation reaction pathway is ideal to study how
various formulation conditions (e.g., water content and dilution effects) affect the
individual reaction pathway. As the first step is intramolecular, it may be independent of
various formulation conditions such as excipient concentration (dilution) and water
content (plasticization). In contrast, bimolecular reactions involved in the breakdown of
the succinimide may be highly dependent on these same variables. The second major
goal of this thesis is to examine the effects of formulation variables on the various
reaction steps leading to the formation of either hydrolysis products or other covalent
adducts from the succinimide intermediate.

The research in this thesis was guided by the following hypotheses;

1. The succinimide intermediate that forms from asparagine may be susceptible to
attack by nucleophiles other than water (e.g., free amines) in aqueous solutions.
Experiment: Determine the degradation products when ammonia is added to
aqueous solutions. Additionally, the structure of the model compound, Phe-AsnGly, allows for nucleophilic attack of the N-terminus, presenting another
competing pathway of degradation for the imide intermediate.

2. In amorphous solids, where bulk water has been removed, the same succinimide
intermediate observed in aqueous solutions may be susceptible to nucleophilic
attack resulting in covalent, amide-linked adducts.
Experiment: Degradation of a model peptide, Gly-Phe-Asn-Gly, in lyophilized
solids containing excess Gly-Val may form covalent amide-linked adducts via a
succinimide intermediate. Use analytical techniques such as mass spec to identify
and characterize adducts.

3. The kinetics of formation of both hydrolysis products and covalent amide-linked
adducts can be rationalized using a kinetic model based on a reaetion mechanism
that assumes a central role for the succinimide intermediate.
Experiment: A comprehensive kinetic model was developed to fit the
eoncentration profiles for the disappearance of the starting reactant and hydrolysis
and covalent adduct degradants in amorphous solids. Simultaneously fitting data
from an asparagine containing peptide and its reactive succinimide intermediate
will confirm that degradants proceed exclusively through the imide intermediate.

4. The multi-step reaction pathways involved in deamidation may be sensitive to
various formulation conditions in amorphous lyophiles. Specifically,
intramolecular cyclization to form succinimide formation may be insensitive to
the formulation conditions (e.g., water content, peptide concentration, nucleophile
dilution by excipient addition) while the bimolecular breakdown of the
succinimide may be highly dependent on the same parameters.
Experiment: Water content and dilution of the nucleophile by the addition of a
polymer excipient were varied. The effects of the various formulation conditions
on the individual reaction pathways were assessed using a kinetic model.

Copyright © Michael P. DeHart 2011

CHAPTER 2 - BACKGROUND AND LITERATURE REVIEW
Introduction
The use of peptides and proteins (large molecules) as therapeutic drug entities has
increased over the years. This dramatic increase is due in part to the mapping of the
human genome project which was completed in 2003. It is estimated that the total market
value of therapeutic peptides was approximately $2 billion in 2010. The estimated
market value for proteins is even higher with a predicted market value of $160.1 billion
in 2013‘. Obtaining a piece ofthe huge market share of therapeutic large molecules
comes at a cost though as peptides and proteins present several obstaeles in formulating a
therapeutic dosage form.
The bioavailability of large molecules is poor when administered as an oral
dosage form. The low bioavailability is due, in part, to the inherent physical
characteristics of the large molecules. The size of large molecules does not allow for
passive diffusion across intestinal membranes. Proteins are highly polar molecules with
charged side-chains on certain amino acid residues (e.g., aspartic acid, glutamic acid, and
lysine) leading to preferential partitioning of peptides and proteins into the aqueous
solution of the stomach and intestines, thereby reducing transport across the intestinal

membrane. Research is consistently examining new ways of promoting the oral delivery
of large molecules including lipid-based delivery systems^, conjugation with
polyethylene glycols (peglyation)^, microspheres'', and therapies in conjunction with
membrane penetrating peptides^. The inherent nature of the stomach also contributes to
the reduced bioavailability of orally delivered peptides and proteins. The stomach has an
extremely low pH and enzymes that catalyze the breakdown of proteins. Considering the

low bioavailability of large molecules and the ability of the stomach to breakdown
proteins, oral dosage forms for such molecules are generally impractical. Therefore,
alternative routes of administration are required. Generally this route of administration is
through an intravenous (IV) solution.

Protein Stability
Administration of a therapeutic large molecule as an IV solution eliminates the
problems of poor oral bioavailability. However, peptides and proteins are inherently
unstable in aqueous formulations. Such instability may be classified as either chemical or
physical degradation, though these pathways are not mutually exclusive.
Chemical degradation often involves a specific amino acid residue and alters the
primary sequence of the protein. Methionine is prone to oxidation to form methionine
sulfoxide and can oxidize even further to methionine sulfone. Amino acids containing
aromatic ring structures (e.g., tryptophan, tyrosine, histidine) are also prone to oxidation
when exposed to ultraviolet light or metal ions^'*. Cysteine residues oxidize in the
presence of strong oxidizers^, often leading to formation of disulfide linkage^.
Asparagine and glutamine amino acid residues undergo deamidation in aqueous solutions
via an imide intermediate. The imide intermediate is rapidly hydrolyzed to form peptides
containing isomers of aspartic or glutamic acid. Deamidation of asparagine and
glutamine is non-enzymatic (i.e., spontaneous) with asparagine deamidation occurring at
a much faster rate due to formation of a more favorable five-membered imide
intermediate as opposed to a six-membered imide in glutamine'®. In addition to chemical
degradation, proteins can undergo physical degradation.

Physical degradation refers to any process where the protein undergoes a change
without an alteration in chemical composition. Examples of physical instability include
denaturing and unfolding, surface adsorption, and aggregation. Aggregation is of
particular concern because it not only results in a lower therapeutic concentration due to
precipitation" and reduction in bioavailability'^ '^, but could induce an immunological
response when dosedProteins can aggregate through various mechanisms and
protein aggregation has been the topic of several reviews ' . Even though protein
unfolding is considered a thermodynamically reversible process, specific regions may
become exposed and self-associate and form irreversible aggregates. Surface to surface
interactions, along with ionic interactions between two proteins, are classified as noncovalent aggregation. Proteins may also undergo covalent aggregation involving crosslinking of oxidized cysteine residues’^ or rearrangement of existing sulfide bridges^^.
Other examples of covalent aggregation include the cross-linking of lysine and
dehydroalanine formed by a P-elimination reaction in cysteine or serine residues ,
oxidation of tyrosine to form a bityrosine linkage^^'^"*, and amide-linked aggregate
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formation'

Deamidation Review
Asparagine deamidation has been the subject of significant amounts of research.
The research is so vast that there are books completely dedicated to the topic^^'^*. Based
on the available research, a website has been developed that can help predict asparagine
deamidation rates for any protein (www.deamidation.org~). Several different factors that
influence deamidation in solutions have been studied such as types of buffers and
solvents , ionic strength , and dielectric constants . However, the understanding of the

effects of these parameters obtained from solution studies may not be readily applicable
to solid state deamidation. Below is a review of the various mechanisms of deamidation
and how pH and primary sequence influences the overall rate in aqueous solutions and
lyophilized solids.

Deamidation Mechanism
Peptides and proteins containing asparagines can degrade through several
different mechanisms, some of which involve reactive intermediates. Direct hydrolysis
of the side-chain amide in asparagine resulting in the formation of aspartic acid occurs in
acidic conditions. Direct attack of the N-terminus amino on the side-chain amide of an
asparagine residue located next to the N-terminus results in a cyclic diketopiperazine.
Generally, asparagine deamidation predominantly proceeds through a reactive
intermediate. Asparagine residues located at the C-terminus of a peptide or protein
deamidate through an anhydride intermediate under acidic conditions'^ resulting in the
formation of a C-terminal apartyl peptide as the only degradant. Isoasparagine
degradants have been reported when fragmentation occurs at asparagine residues through
an imide intermediate^^. Peptide fragmentation at asparagine residues is facilitated when
the next amino acid in the sequence is proline^^. Each of the previously mentioned
deamidation mechanisms are specific to certain primary sequences or solution conditions
and are limited in scope. The most common route of asparagine deamidation is one that
proceeds through a succinimide intermediate resulting in the formation of aspartatyl and
isoaspartatyl residues without peptide fragmentation (Figure 2-1).

pH Effects
Deamidation of asparagine residues in peptides exhibit a relative minimum in the
pH rate profile in a pH range of 4-6 with increases in rate as pH is increased or decreased.
At neutral to basic pH, the mechanism of deamidation proceeds through an imide
intermediate^'*. The formation of the imide intermediate is base catalyzed by the
deprotonation of the asparaginyl amide nitrogen in the peptide backbone. The negatively
charged nitrogen attacks the asparaginyl side-chain amide forming a tetrahedral
intermediate followed by the expulsion of ammonia. The subsequent breakdown of the
imide into hydrolysis products is also base catalyzed. The types of degradants that are
generated during asparagine deamidation is also pH dependent. The ratio of isoaspartate
to aspartate is approximately 3:1 and favors isoaspartate as pH increases.
Under acidic conditions, the mechanism of deamidation changes fi’om one
involving a succinimide intermediate to a direct, general acid catalyzed hydrolysis of the
asparaginyl side-chain amide functional group^^. This results in the formation of peptide
degradants containing only aspartatyl residues. At pH values below the pKa of the
aspartate side-chain carboxyl, aspartates form relatively stable imide intermediates that
can be isolated. Hydrolysis of the imide does occur, but at a much slower rate.
Aspartates have several different pathways of degradation in acidic conditions including
imide formation^^, anhydride formation and peptide fi-agmentation^^. Therefore, the
formation of isoaspartate residues during asparagine deamidation at acidic pH values is a
degradant of a degradant and not considered part of the deamidation pathway.
A change in the rate limiting step of deamidation is observed at pH 6.5-7.0. At
acidic pH values, the rate limiting step is the formation of the succinimide intermediate^^.

As pH increases into the basic region, the rate limiting step in the formation of the
succinimide intermediate becomes ammonia removal around pH 6.5-7.0^’. In addition to
these mechanistic effects of pH, the molecular species of the peptide influences the rate
of deamidation. Several instances have been reported in which the rates of deamidation
are influenced by ionizable groups at the N-terminus, or C-terminus, an imidazole group,
or the ionization of the hydroxyl group of tyrosine ’ .
By definition, pH is a measure of the activity of hydronium ion in aqueous
solutions. In the solid-state, pH is not well defined. However, correlations between the
pH of a reconstituted sarnple and chemical degradation in the solid-state have been
reported. Song et al. tried to compare the effects of apparent pH (“pH”) effects in
amorphous solids on deamidation rates with those in solution. A summary of their results
is described. The authors discovered that the “pH” profile of asparagine deamidation in
amorphous solids of PVP mirrors that in solution with a relative minimum in the slightly
acidic region with evidence of general acid and base catalysis^^. In the strongly basic
region, “pH” independence was observed for deamidation in solution and amorphous
solids. In addition to the noticeable catalytic effects “pH” has on the rate of deamidation
in amorphous solids, the authors also noted that “pH” also affects the mechanism in
acidic conditions. Asparaginyl peptides deamidate via an imide intermediate in acidic
amorphous solids compared to direct hydrolysis in solution^^. As the true pH of a solid is
difficult to determine, the authors suggest that the measured pH differs from that of the
true pH of the polymeric solid. The authors also reported a “pH” independent region in
the basic region. They attribute this plateau in rate of deamidation to a change in the rate
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limiting step from deprotonation of the peptide nitrogen to the expulsion of the leaving
group (ammonia).

Primary Sequence Effects
Asparagine deamidation in peptides is influenced by the amino acid residues
positioned before and after the asparagine. Rates of asparagine deamidation
demonstrated a threefold variability with variation in the amino acid residue in the N-1
position'**’. A change in the amino acid residue in the N+1 position from glycine to valine
resulted in an order of magnitude decrease in deamidation rate . The lack of a side-chain
on glycine allows greater flexibility of the peptide backbone which may facilitate imide
formation. A simple summary of the effects of the N+1 amino acid is that steric
hindrance reduces the rate of deamidation (i.e. larger, branched amino acids hinder
deamidation).
However, steric hindrance is only one of several influences that the N+1 amino
acid has on deamidation. Serine, cysteine, and histidine facilitate deamidation by
stabilizing anionic transition state intermediates during the formation of the succinimide
intermediate^**. Proline changes the mechanism of deamidation via an imide intermediate
to peptide backbone cleavage at the Asn-Pro bond^^ '*'. The shift in mechanism occurs
because when proline is in the N+1 position there is not a proton on the nitrogen in the
peptide backbone that can be removed. Instead, the side-chain amide nitrogen of
asparagine attacks the peptide backbone carbonyl resulting in two peptide fragments.
Lysine alters the ratio of aspartate to isoaspartate by inductive effects that influence the
breakdown of the imide intermediate'*^. In acidic solutions, rates of deamidation were
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independent of the N+1 amino acid, confirming a lake of dependence on primary
sequence in imide formation in acidic solutions. Using primary sequence as a predictor
for asparagine deamidation does not extrapolate well for proteins with higher order
structure. Tertiary structures place distant amino acids based on primary sequence in
close proximity to labile asparagines and may have greater influence on the rate of
deamidation than the N+1 amino acid'^^. A website that combines research on
deamidation rates based on primary sequences of model peptides with crystalline
structures of proteins has been developed to predict deamidation rates of asparaginyl
peptides and proteins (www.deamidation.org).
Very little research has been performed examining the influence of primary
sequence on deamidation in the solid state. The labs of Topp and Borchardt have
examined the effects of amino acids in the N-1, N-2, and N+1 position. They discovered
that ionized, acidic amino acids in the N+1 position increase local hydration creating a
“solution-like” environment due to the ionized functional groups'’"'. This local hydration
resulted in an increase in deamidation rates. Deamidation rates showed an inverse
relationship to amino acid hydrophobicity and size in the N-1 and N-2 positions'*^.

Asparagine Involvement in Alternate Degradant Formation
Generally asparagine deamidation is studied under conditions where the
nucleophile is water resulting in aspartyl- and isoaspartyl-containing peptides. However,
asparagines have been implicated in the formation of alternative degradants some of
which involve a reactive succinimide intermediate generated during asparagine
deamidation. Lura and Schirch proposed that the N-terminus can attack the side-chain
amide of an asparaginyl residue to form a seven-membered ring structure"’^. The
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proposed structure was supported by NMR analysis and its formation was completely
eliminated when the N-terminus was acylated. Jomvall proposed that a six-membered
ring can, form by direct attack of the N-terminus on the isoaspartate formed by
deamidation through an imide intermediate'*^. The mechanism proposed by Jomvall is a
secondary degradation pathway and doesn’t directly involve the asparagine residue.
However, in a similar pathway, Schon and Kisfauldy observed that during peptide
synthesis an imide intermediate formed when specific protecting groups were used in
peptide synthesis involving aspartate residues'**. The protecting group on the aspartate
side-chain is removed in acidic conditions, but the Fmoc protecting group on the Nterminus is also removed. The result of deprotecting both functional groups results in the
N-terminus attacking the a-carbonyl on the imide intermediate to form a six-membered
diketopiperazine. Peptide synthesis is carried out in non-aqueous systems and may not be
representative of pharmaceutically relevant conditions. The non-naturally occurring
amino acid isoasparagine was observed when the protein concanavalin A fragments
during deamidation*^. Fragmentation occurs when the amide side-chain nitrogen of the
asparagine residue attacks the peptide backbone carbonyl resulting in a C-terminal
succinimide. The rapid hydrolysis of the imide intermediate results in the formation of
C-terminal asparaginyl and isoasparaginyl peptides. Clearly degradants other than
hydrolysis products (aspartate and isoaspartate) can occur either directly from asparagine
or its degradants (e.g., succinimide intermediate or aspartates).
Based on the research presented above, the first goal of this project was to
confirm that the succinimide intermediate can react with amine nucleophiles in aqueous
solutions and to explore the conditions in which these reactions compete effectively with
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hydrolysis. The tripeptide, Phe-Asn-Gly, was formulated in aqueous solutions containing
various concentrations of ammoinia and at varying pH values. If the succinimide is
susceptible to attack by ammonia, the reaction should generate asparaginyl- and
isoasparaginyl-containing peptides. This mechanism parallels that when water attacks
either carbonyl on the succinimide intermediate. Based on the structure of the peptide,
the succinimide intermediate may also be susceptible to nucleophilic attack by the Nterminus amino group resulting in the formation of a diketopiperazine. In the
formulations explored, all three nucleophiles (ammonia, water, and N-terminus) could
compete for reactions at the succinimide carbonyls. Changes in the storage conditions
such as nucleophile concentration and pH may affect the relative amounts of each
degradant.

Succinimide Involvement in Aggreeation
Due to their instability in aqueous solutions, peptides and proteins are stored as
lyophilized solids to maximize their stability"*^. The lyophilized dosage form is then
reconstituted prior to administration. Even though long term stability may be achieved in
lyophilized solid formulations, degradation still occurs. In many cases, deamidation and
aggregation are occurring simultaneously as in lyophilized dosage forms of human
growth hormone^^, insulin^antibodies^^, and recombinant human deoxyribonuclease
I^"*. Only recently has a correlation between the imide intermediate formation and
covalent aggregation been observed. Severs and Froland formulated PACAP peptide in
DMSO with the intent of preventing deamidation in aqueous solutions^^. Instead, they
observed succinimide intermediates along with dimers and multimers. The authors
speculated that covalent dimers formed when nucleophiles on another peptide (e.g.,
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lysine, serine, N-terminus) attacked a carbonyl on the succinimide intermediate. This
hypothesis is reasonable because water is no longer present to react with the succinimide
to form hydrolysis degradants. Desfougeres et al. observed a linear relationship between
the amount of covalent linked dimers and the percent of succinimide in the degradants in
hen egg-white lysozyme^^. They discovered that in addition to succinimide formation via
an asparagine residue, aspartates contributed to the overall number of succinimides when
lyophilized powders from pH 3.5 solutions were heated. They proposed nucleophilic
attack of an amine (i.e., lysine, N-terminus) in one molecule occurred on either of the two
carbonyls on a succinimide intermediate. Similar to the observations in DMSO, in the
absence of water, the succinimide intermediate still forms and appears to be susceptible
to nucleophilic attack by other nucleophiles.
The second goal of this project was to demonstrate that the same succinimide
intermediate generated during asparagine deamidation can form covalent amide-linked
adducts with an adjacent peptide. It has been demonstrated that freeze drying proteins
does not prevent the intramolecular cyclization of asparagines to form succinimide
intermediates which are relatively stable in some formulations^^. In lyophilized
formulations where the bulk water has been removed, the effective concentration of other
nucleophiles (e.g., N-terminus of a peptide) becomes much larger. This shift in
nucleophile concentration may facilitate the formation of covalent adducts via a
succinimide intermediate. To examine this potential pathway, a model peptide, Gly-PheAsn-Gly, and its succinimide intermediate were lyophilized in the presence of excess
Gly-Val. Degradation profiles were monitored for the presence of covalent adducts
consistent with the reaction between Gly-Val and the succinimide intermediate.
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Glass Transition Temperature
As previously stated, to increase the stability of protein formulations they are
lyophilized. The result of this process in most cases is an amorphous solid. Drugs
formulated for oral delivery as an amorphous solid are advantageous over crystal dosage
forms in that they may overcome poor aqueous solubility and slow dissolution rates^^.
However, unlike their crystalline counterparts, amorphous solids are more sensitive to
physical and chemical degradation^* though isolated instances where the crystal is more
unstable have been reported^^.
Historically, reactivity in amorphous solids has been correlated to molecular
mobility of the system as defined by the glass transition temperature (Tg). Briefly, Tg is a
specific physical parameter associated with amorphous solids which differ from the
melting point of a crystal. Applying heat to a crystal at a constant rate results in an
increase in the temperature up to the melting point. At the melting point, applying more
heat to the system does not increase the temperature. Instead, the heat applied to the
system is used to melt the solid. Once the crystal has completely melted, the temperature
of the melt will begin to rise again. Compare this to a truly amorphous system. Applying
heat to amorphous solids result in a continuous increase in temperature up to the Tg. At
the Tg, the amorphous solid continues to increase in temperature at a different rate due to
a change in heat capacity. Amorphous solids at temperatures below the Tg exist in the
glassy region, whereas storage above the Tg results in a supercooled liquid or rubbery
phase.
Figure 2-2 is a pictorial representation of the difference between the melting point
of a crystal and the glass transition temperature of amorphous solids. In this scenario,
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changes in volume, or coefficient of thermal expansion, are monitored over a temperature
range using thermo-mechanical analysis. However, a common method of determining
the Tg measures changes in heat capacity using a differential scanning calorimeter.
Describine Reaction Kinetics in Amorphous Solids
Significant research has been performed examining the correlation between Tg
and reactivity^®"^^, but a growing body of work suggests that reactivity may not be
correlated to global mobility^^'^’. Kinetics reactions in amorphous lyophiles stored below
the Tg, where local mobilities are dominant, can sometimes be explained by simple
Arrhenius equation due to relatively small energies of activation^*'^^. In contrast
relaxations in the rubbery state require a more complicated model such as the empirical
Williams-Landell-Ferry (WLF) equation which has been applied to reactivity in
amorphous solids to explain reaction kinetics (Equation 1)™'^'.

iog^= c,(r-7-.)
k
q+ct-t;)

Equation 1

'

where k' is the observed rate constant at the experimental temperature,

is the observed

rate constant at a reference temperature, 7$, Ci and C? are constants derived from
experimental data. The complex nature of reactioin kinetics in solids led to several
different mathematical models to fit solid-state kinetic data. The Avrami equation has
been developed to explain rates of crystallization (Equation

The general

assumption in the equation is that random nucleation occurs from which crystal growth
occurs in three dimensions and consumes other nuclei as the crystals expand.

Equation 2

«=

or

a = \-e-'^‘"
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In Equation 2, a is the fractional extent of crystallization; k is the overall rate constant for
both nucleation and crystal growth (K = k"); n is the Avrami exponent, a parameter
determined by the mechanism of crystallization that provides qualitative information on
the nature of the nucleation and the crystal growth processes.
The Kohlrausch-Williams-Watts (KWW) equation was first derived to describe
relaxation in amorphous formulations (Equation 3).

Equation 3

0(t) = exp[-(t/T)'^

In Equation 3, (f) (t) is a relaxation time function, t is the average relaxation time, and (3 is
a measure of the distribution of relaxation times. Yoshioka et al. found that the non
exponential aggregation processes in lyophilized bovine serum y-globulin (BGG)^'* and pgalactosidase^^ could be explained using the KWW equation. Luo and Anderson found
that the KWW equation was applicable to the dimerization of cysteine beyond the initial
rate region^^.
The third goal of this project was to take the mechanistic understanding of
deamidation obtained from solution studies and develop a quantitative understanding of
deamidation and degradant formation from the succinimide intermediate in lyophilized
solids. Kinetic models were developed based on the individual steps along the
deamidation pathway such as succinimide formation and its subsequent breakdown by
attack of a nucleophile. Monitoring the individual degradants, including the hydrolysis
and adduct degradants isomers, provide an opportunity to quantitatively evaluate
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mechanism-based kinetic models that assign a central role to the succinimide
intermediate for these amorphous solid state reactions.

Factors Influencing Reactivity in Amorphous Solids
A review of the effects of storage with respect to the Tg on chemical reactivity
was discussed in the previous section. However, chemical reactivity in amorphous solids
is also dependent on several other factors including pH, water content, reactant
concentrations and physical state of the formulation.

Apparent pH
In solutions, pH is a common parameter that is important in determining
reactivity. By definition, pH is the negative log of hydronium activity in solution; it is
difficult to measure the pH in lyophilized solids. Several different analytical techniques
have been developed to examine the pH in solids including Fourier transform infrared
(FTIR)^^, indicator dyes^*, and nuclear magnetic resonance spectroscopy^^. One
convention that has been used previously is to measure the pH of a reconstituted sample,
prior to or post freeze drying (defined as the apparent/effective pH or “pH”) ’ . The
major pitfall of all of these methods of analyzing “pH” is that they are an indirect
measurement regardless of the technique (e.g., using an indicator or the pH of a
reconstituted sample).
As previously mentioned, the pH of a solution can affect the degradation
pathways and relative rates of deamidation in solutions. In amorphous solids. Song et al.
also discovered a change in the rate determining step from the “pH” dependent
deprotonation of the amide backbone to the “pH” independent expulsion of the ammonia
19

group^^. Apparent pH effects have been also reported for methionine oxidation*',
81
aspartate isomerization*^, and human growth hormone aggregation*^.

Water content
A common way changing the molecular mobility of an amorphous solid is to
introduce water into the system. Water sufficiently plasticizes amorphous solids allowing
experiments to examine chemical reactivity above and below the Tg at constant
temperature. Even in lyophilized solids where the bulk water is removed, there is enough
g-j

residual water to facilitate chemical and physical degradation . Linear relationships
between water content and reactivity have been reported in amorphous solids for the
degradation of an aspartyl-containing hexapeptide*^, insulin^', and the aggregation of
bovine serum albumin (BSA) , y-globulin , and insulin . However, the relationship
between water content and reactivity cannot be defined by an established equation. Bellshaped curves have been reported in the case of Maillard reaction*^ **. Increasing water
content facilitates reactivity by increasing the mobility of the system to a relative
maximum. Any additional water added to the system acts as a diluent between the two
reactants (sugar and peptide) reducing the reaction rate. Therefore, water may have
multiple effects on amorphous solids by acting as a plasticizer to reduce the Tg thereby
increasing molecular mobility, as a direct reactant in hydrolysis reactions, or as a solvent
that may enhance the stability of the transition state of reactive intermediates . Lai et al.
examined the different roles of water in polymeric lyophiles containing
poly(vinylpyrrolidone.^°. To examine the deamidation rates based on changes in Tg,
glycerol was used as a plasticizer instead of water. They found that the overall rate of
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deamidation correlated with a reduction in Tg at constant water content. Similar results
were observed by Strickley and Anderson where increasing water content facilitated the
formation of covalent adducts of insulin instead of hydrolysis products in lyophiles of
trehalose**^.
The different roles of water in solid state reactions make it difficult to discern the exact
effect water has on chemical reactivity in specific formulations.

Concentration/Dilution Effects
Crystallization and second-order reactions, such as dimerization, may be reduced
in lyophilized solids by decreasing the effective concentration of the reactants. Generally
reactants are diluted by adding sugars (sucrose, trehalose) or polymers (PVP, HPMC) as
bulking agents in lyophilized formulations. Konno and Taylor found that adding polymer
to an amorphous dispersion of felodipine reduced the extent of crystallization of the drug
compared to the drug alone^’. Surprisingly they discovered that adding polymer
increased the water content which in turn reduced the Tg. This increased global mobility
failed to accelerate crystallization due to the diluting effects of the polymer. Strickley
and Anderson also showed a direct correlation between insulin concentration and dimer
fraction**^. Luo and Anderson also showed that cysteine oxidation to form disulfide
linkage was consistent with second-order kinetics in the initial rate region . General
dilution effects decreasing the rate of aggregation of bovine serum albumin in lyophiles
containing carboxymethyl-cellulose, dextran, DEAE-dextran, or polyethyleneglycol^^.

Phase Separation
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Unlike the crystalline drugs where the molecule exists in a uniform ordered three
dimensional lattice, amorphous drugs may exist as a non-homogeneous mixture including
regions of partial crystallinity. Phase separation can be detected by modulated
temperature DSC^^, atomic force microscopy, and scanning electron microscopy^'*.
During the lyophilization process, buffer salts, bulking agents and various other
excipients may crystallize and form a separate phase in the formulation^^. Mannitol is a
common lyophilization excipient that recrystallizes in lyophiles due to its low transition
temperature. The recrystallization of mannitol results in a mixture of crystalline and
amorphous regions^^. Mannitol crystallization can be prevented by adding additional
excipients to the formulation effectively diluting the mannitol. Heterogenous regions of
crystalline and amorphous regions were also observed in ternary mixtures of itraconazole,
PEG 6000, and HPMC 2910 E5^^. At the desired ratio of itraconazole/PEG 6000/HPMC,
a completely amorphous dispersion provided optimal dissolution rates by avoiding
recrystallization of the drug which decreased the rate of dissolution. While phase
separation may lead to a physical change such as crystallization, it may also prevent
stabilization of the active ingredient. For example, lactate dehydrogenase was found to
lose its activity during the freeze drying process. Analysis of dried samples showed that
the excipient, PEG 8000, recrystallized resulting in degradation of the enzyme in the
freezing and drying steps during lyophilization^^. A heterogeneous mixture containing
two different reactive species was hypothesized to explain the observed biphasic reaction
kinetics for disulfide formation from cysteine in amorphous PVP lyophiles^^. Evidently,
phase separation is a common occurrence in amorphous solids and can account for
various unusual observations.
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The fourth goal of this project was to examine how formulation variables affect
the overall rates of deamidation and degradant formation using the same model
formulations as those described above (lyophiles containing Gly-Phe-Asn-Gly and the
nucleophile Gly-Val). The two step process of deamidation involves an intramolecular
cyclization to form a reactive intermediate followed by the bimolecular breakdown of the
succinimide. The individual steps of deamidation may be sensitive to various
formulation parameters. For example, succinimide formation involved an intramolecular
reaction and may be insensitive to any changes in the formulation that alter molecular
mobility or nucleophile concentrations. On the contrary, bimolecular degradation
pathways may be sensitive to these same variables. Plasticization accompanying the
introduction of water into the formulation may enhance the mobility of larger molecules,
enabling them to come into closer proximity to the succinimide. Adding additional
excipient to the formulation dilutes the effective concentration of the nucleophile, GlyVal, and may shift the degradant profile fi-om adducts to hydrolysis products.
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Figure 2-1. Reaction pathway illustrating the base catalyzed formation of the
succinimide intermediate during deamidation followed by nucleophilic attack of water at
either carbonyl resulting in the formation of aspartyl- and isoaspartyl-containing peptides.
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Figure 2-2. Pictorial representation of how different cooling rates result in two
different amorphous solids with distinct glass transition temperatures. The
melting point of a solid is highlighted by the sharp decrease in volume
compared to the continuous decrease for amorphous solids.
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CHAPTER 3 - THE ROLE OF THE CYCLIC IMIDE IN ALTERNATE
DEGRADATION PATHWAYS FOR ASPARAGINE-CONTAINING
PEPTIDES AND PROTEINS.

Introduction
The chemical instability of peptides and proteins can usually be attributed to
certain “hot spots” where reactivity is enhanced due to the presence of key amino acids or
amino acid sequences at these locations. One of the most common examples is the
prevalence for deamidation, isomerization, and racemization reactions to occur at
asparagine and glutamine residues in proteins.

The predominant pathway for

asparagine modification under physiological conditions and in pharmaceutical
formulations involves the nucleophilic attack of the amide side-chain by the adjacent
peptide bond nitrogen on the C-terminal side in the backbone resulting in the liberation of
ammonia and the formation of a reactive five-membered succinimide ring
intermediate.The imide intermediate is then hydrolyzed to give aspartate and
isoaspartate mutations, typically in an approximate 3:1 ratio favoring isoaspartate.'* The
cyclic imide can also racemize due to the acidic hydrogen at the a-carbon leading to the

formation of peptides containing D-succinimide, D-aspartate, and D-isoaspartate. As a
secondary pathway of deamidation, direct hydrolysis of the functional group can occur in
acidic conditions. Glutamine deamidation also involves formation of a cyclic imide
intermediate, though its rate of formation is much slower compared to the rate of
generation of the five-membered ring fi-om asparagines.
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Imides can also form when the side chain amide nitrogen attacks the C-terminal
peptide bond in the peptide backbone, resulting in peptide bond hydrolysis and producing
a fragment containing a C-terminal asparagine or isoasparagine. This pathway of
deamidation occurs only when the adjacent (N+1) amide nitrogen contains no removable
hydrogen as in the case of proline and sarcosine."*’’^ Asparagine residues located at the Cterminus of proteins (e.g., at the A-21 position in insulin) have been shown to undergo
deamidation via an alternate mechanism under acidic conditions, involving the formation
of a cyclic anhydride intermediate, which is more reactive than the cyclic imide.'^'*'^
The rate of formation of the reactive cyclic imide intermediate, which is ratelimiting for the overall reaction, depends on various factors including pH,'^ temperature,'*
primary sequence,higher order structure,'* ’^ ionic strength,^** and buffer choice.' In
general, imide formation is accelerated in basic conditions and when the N+1 amino acid
is alanine, serine, histidine, or glycine. The major effect of the amino acid in the N+1
position is steric hindrance as demonstrated by glycine in the N+1 position which can
increase rates of deamidation by as much as 1 Ox. Various books, ’ reviews, ’ ' and a
website lwww.deamidation.org) are available to assist in attempts to predict deamidation
rates from protein structure and environmental conditions.
Though the variety of isomerized and racemized deamidation products known to
form via the cyclic imide intermediate is well documented, the list may not be exhaustive.
Studies of the deamidation of the A-21 asparagine residue in the insulin molecule
demonstrated that the reactive cyclic anhydride intermediate formed in this reaction could
also react with nucleophilic primary amine groups in neighboring insulin molecules
leading to covalent dimer formation.

The partitioning of the cyclic intermediate to
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form either deamidated products or covalent aggregates was also observed in solid-state
lyophilized formulations, where the predominant product was highly dependent on
formulation conditions such as protein concentration and water content.This
observation led us to consider the possibility that covalent amide-linked aggregate
-formation in therapeutic and endogenous peptides and proteins may also be mediated
through an imide intermediate.
Non-reducible covalent aggregates have been observed in a variety of proteins,
including commercial insulin preparations, ' ribonuclease,
alteplase,

bovine somatotropin,

and human growth hormone.^^ While insulin dimers were characterized to

be covalent amide-linked dimers, those in ribonuclease appear to involve lysinoalariine
cross-links. None of these examples implicated the cyclic imide in covalent aggregate
formation, however.
Recently, cyclic imide, isoaspartate, and/or racemized aspartate degradation
products forming at asparagine or aspartate residues in amyloid-P (AP) peptides have
been examined with respect to their roles in the deposition of amyloid fibrils in the brain
and their implications in Alzheimer’s disease.Nilsson examined the amyloid
aggregation of the sequence SNNFPAILSS and found that trace impurities derived Iforn
deamidation drove aggregation.^’ Shimizu et al.^^ suggested that spontaneous
isomerization at Asp23 in Ap induces a conformational change that plays a role in the
deposition of Ap peptides. Orpiszewski et al.^'‘ hypothesized that transient succinimide
formation induces a non-native conformation in soluble AP that renders it amyloidogenic
and neurotoxic. Whatever the mechanism(s), similar processes may be involved in other
amyloid diseases including Parkinson’s disease, type II diabetes,
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prion disease,

and

perhaps Huntington’s disease where glutamine rich proteins aggregate."*® While cyclic
imide formation may parallel the formation of insoluble protein deposits, we are unaware
of any studies establishing a causative role for imide-mediated covalent aggregates in
these processes.
Peptide sequences that have asparagine at the penultimate position also appear to
exhibit enhanced reactivity, resulting in the formation of a diketopiperazine.'*''^^
However, Lura and Schirch"*^ attributed diketopiperazine formation to the direct
nucleophilic attack of the amino-terminus on the side-chain Asn amide to form a sevenmembered ring. As a note of nomenclature, penultimate generally refers to the second to
last amino acid at the C-terminal end. However, penultimate in this manuscript refers to
the amino acid in the second position in relation to the N-terminus. This is done to
remain consistent with previous literature.
In this paper we consider the potential central role of the cyclic imide
intermediate in the formation of additional degradation products formed by the attack of
nucleophiles other than water. We consider first the solution reaction of the succinimide
intermediate with ammonia as ammonia concentration and pH are varied in order to fully
characterize the reversible formation of cyclic imide. Second, we examine an alternative
pathway for diketopiperazine formation involving intramolecular attack of the amino
terminus on the cyelie imide intermediate formed during asparagine deamidation. The
results suggest that inter- and intramoleeular attack by nucleophilic amines at cyclic
imide intermediates generated during Asn deamidation and Asp isomerization may
produce a variety of heretofore unexplored reaction products.
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Materials and Methods

Chemicals and Reagents
The Fmoc protected L-amino acids - Fmoc-Asn-OH, Fmoc-Asp(OtBu)-OH,
Fmoc-isoAsn-OH, Fmoc-Phe-OH, and Fmoc-Gly-Wang Resin were purchased from
Fluka (Switzerland). Fmoc-Asp(OH)-OtBu and Fmoc-isoAsp were purchased from
AnaSpec (San Jose, CA). 1-Hydroxybenzotriazole (HOBt), 1,3-diisopropylcarbodiimide
(DIG), piperidine, and (2S-c/5)-(-)-5-Benzyl-3,6-dioxo-2-piperazineacetic acid were
purchased from Aldrich (St. Louis, MO). All other salts and organic solvents
(triflouroacetic acid (TFA), dimethylformamide (DMF), ethyl ether, methanol, and
acetonitrile) used for HPLC analysis and peptide synthesis were purchased from Fisher
Scientific (Springfield, NJ). All compounds were ACS grade or better and used as they
were received from the supplier. Deionized water was used throughout the experiments.

Peptide Synthesis
Approximately 0.2 mmol of the Fmoc-Gly-Wang resin was placed into a test tube
and washed twice with DMF. The Fmoc group was removed by mixing with ~3mL of
piperidine and DMF (50:50) for 30 minutes. The resin was then washed three times with
DMF, once with methanol, and three more times with DMF.
Two milliliters of a 0.25 M stock solution of Fmoc amino acid (Fmoc-AA) in
DMF were mixed with 0.5 mL of a 0.5 M stock solution of 1-hydroxybenzotriazole
(HOBt) in DMF and stored for 15 minutes at -20°C with occasional shaking. To this
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solution, 79 uL of diisopropylcarbodiimide was added and stored at -20°C for an
additional 15 minutes with occasional shaking.
This activated Fmoc-AA solution was then added to the test tube containing resin.
The coupling reaction was carried out at room temperature for 2 hours. After coupling,
the Fmoc group was removed fi-om the resin and the resin was washed as described
above. This procedure was repeated until the extension of the peptide sequence was
complete with the last step being the removal of the Fmoc group fi-om the terminal amino
acid.
The peptide was cleaved fi-om the resin by mixing the resin in neat TFA (4mL) at
room temperature for at least 2 hours. The solution containing the peptide was then
filtered through a glass wool filter using a syringe and washed (2x) with small amounts of
TFA. The solutions containing the peptide were then collected and placed under a stream
of nitrogen to remove excess TFA. The remaining peptide solution was then added to
ethyl ether (40mL) to precipitate the peptide. The precipitate was centrifuged and
washed with ether (3x) to yield the crude product.
The crude peptide was dissolved in water and the pH of the solution was adjusted
to the theoretical isoelectric point of each peptide. The compounds were then purified
using HPLC using an analytical column (Supelcosil ABZ+ column (25 cm x 4.6 mm, 5pm pore size), see HPLC Analyses for more details) and a mobile phase containing 99:1
water:acetonitrile (without buffer) at a flow rate of 0.8 mL/min. Collected fi-actions were
pooled and lyophilized (Labconco Freezone 4.5).
The lyophilized peptides were characterized by HPLC, UV, and mass
spectroscopy. HPLC peak purity was determined from the relative area of the peptide
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peak compared to the total area of all peaks. Apparent purity by UV analysis was
determined by comparing the absorbance of a 2 mM solution of the peptide at 257 nm to
the absorbance of phenylalanine standards at similar concentrations. Mass spectra were
generated using a MicroMass ZMD 4000 LC/MS detector. Dilute peptide solutions (100
ug/mL) in acetonitrile:water (50:50) were injected into the detector at a flow rate of 0.04
mL/min using a syringe. The source block temperature was 100°C, the desolvation
temperature was 300°C and the cone voltage was 40eV with a scanning range of 200-800
amu. The diketopiperazine was further characterized by 'H NMR using a Varian INOVA
400 MHz instrument with deuterium oxide as the solvent.
Phe-Asn-Gly (FNG) - HPLC purification was performed after adjusting the pH of
the aqueous solution to its theoretical isoelectric point of 6.03. Lyophilization of the
purified sample produced a white, fluffy solid. HPLC purity: 98% (13.5 min retention
time). UV at 257 nm (i.e., phenylalanine X,max): 93%. Mass spectrum: calculated m/z for
C,5H2oN405 (M+H)^ is 337; major peaks at 337 ((M+H)^, 38%), 359 ((M+Na)^, 100%),
375 ((M+K)^ 52%), and 696 ((M+H)^:(M+Na)^ dimer, 12%).
Phe-isoAsn-Gly (FisoNG) - HPLC purification was performed after adjusting the
pH of the aqueous solution to its theoretical isoelectric point of 6.03. Lyophilization of
the purified sample produced a white, fluffy solid. HPLC purity: 98% (15 min retention
time). UV at 257 nm (i.e., phenylalanine X.max): 96%. Mass spectrum: calculated m/z for
C15H20N4O5 (M+H)^ is 337; major peaks at 214 (35%), 337 ((M+H)^ 98%), 359
((M+Na)^, 100%), 375 ((M+K)^ 53%), 674 ((M+H)^ dimer, 16%), and 696
(M+H)^:(M+Na)^ dimer, 20%).
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Phe-Asp-Gly (FDG) - HPLC purification was performed after adjusting the pH of
the aqueous solution to its theoretical isoelectric point of 3.13. Lyophilization ofthe
purified sample produced a white, fluffy solid. HPLC purity: 98% (12 min retention
time). UV at 257 nm (i.e., phenylalanine >.,nax): 92%. Mass spectrum: calculated m/z for
C,5H,9N306 (M+H)^ is 338; major peaks at 209 (44%), 214 (49%), 230 (39%), 338
((M+H)^, 69%), 360 ((M+Na)^ 100%), and 376 ((M+K)^ 73%).
Phe-isoAsp-Gly (FisoDG) - HPLC purification was performed after adjusting the
pH of the aqueous solution to its theoretical isoelectric point of 2.17. Lyophilization of
the purified sample produced a white, fluffy solid. HPLC purity: 95% (10.75 min
retention time). UV at 257 nm (i.e., phenylalanine A-^ax): 92%. Mass spectrum:
calculated m/z for C15H19N3O6 (M+H)"^ is 338; major peaks at 209 (48%), 338 ((M+H)"^,
100%), 360 ((M+Na)^ 72%), and 376 ((M+K)^ 25%).
{[(2S-cis)-5-benzyl-3,6-dioxopiperazin-2-ylJacetylamino}-acetic acid (DKP) —
The reagent (25'-ci\y)-(-)-5-benzyl-3,6-dioxo-2-piperazineacetic acid was coupled to the
deprotected resin and the peptide was cleaved from the resin as stated above. HPLC
purification was performed without pH adjustment. Lyophilization of the purified sample
produced a white, fluffy solid. HPLC purity: 99% (45 min retention time). UV at 257
nm (i.e., phenylalanine Amax): 97%. 'H NMR (400MHz, D2O) 5 0.9 (dd (J= 10 Hz and
16 Hz), IH, Asn-p-CH(H)-), 2.14 (dd (J= 4 Hz and 16 Hz), IH, Asn-P-CH(H)-), 3.05
(dd (J = 5 Hz and 14 Hz), IH, Phe-P-CH(H)-), 3.29 (dd (J = 4 Hz and 14 Hz), IH, Phe-pCH(H)-), 3.78 (s, 2H, Gly-CH2-), 4.24 (dd (J = 4 Hz and 10 Hz), IH, Phe-a-CH-), 4.48 (t,
J = 4 Hz, IH, Asn-a-CH-), 7.25-7.50 (m, 5H, Phe-phenyl-). The calculated m/z for
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C,5H,7N303 (M+H)^ is 320; major peaks at 214 (81%), 241 (11%), 245 (71%), and 320
((M+H^ 100%), 342 ((M+Na)^, 29%), and 452 (7%).

Determination ofpKa Values for the Amino Terminus
Microtitrations were performed using a three-neck microvessel equipped with a
pH microelectrode, a water-saturated nitrogen gas line (polyethylene), and a titrant line
positioned at the top of the solution to be titrated and connected to a 10 pL gastight
syringe controlled by a microinjection pump (CMA/100, CMA/Microdialysis; Acton,
MA) (Hamilton Co., Reno, NV) as described previously."*^ Water-saturated nitrogen was
bubbled into the solution to provide mixing and maintain C02-free conditions without
loss of water volume. The temperature was maintained at 25 °C using a water-jacketed
container.
Dilute solutions of each peptide (2 pM for FNG, FisoNG and 3 pM for FDG and
FisoDG) and titrant solutions (0.13 and 0.27 M NaOH, respectively) were prepared in
deionized water. Aliquots of each peptide solution (200 pL) were transferred to the
microvessel and titrant solution was added in 0.4 pL increments and allowed to mix for
45 seconds before recording pH. Data for hydrogen ion concentration versus volume of
titrant added were fitted to comprehensive equations derived fi-om the relevant charge
balance equations coupled with expressions for the various mass balances, Ka values, and
Kw.

HPLC Analyses
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HPLC analyses were conducted on a Waters Alliance LC/MS system with a
Micromass ZMD 4000 detector when performing detenninations of unknown degradants
for the purpose of determining the mass and peak identity. Otherwise, separations were
performed on either an automated system consisting of a Waters 510 pump, Waters
717plus autosampler, and a Waters 2487 dual wavelength absorbance detector controlled
by PeakSimple chromatography data system (SRI Model 302) or a modular HPLC
system that consisting of a Rheodyne 7725 injector, a Beckman 1 lOB pump, a Waters
2487 dual wavelength detector, and a Spectra Physics SP4270 integrator. Isocratic
separations of the peptides and their degradants were accomplished using a Supelcosil
ABZ+ column (25 cm x 4.6 mm, 5-pm pore size) and a mobile phase containing 50 mM
ammonium acetate at pH 4.76 and acetonitrile in a ratio of 98:2 at 0.5 mL/min with UV
detection at 257 nm. Separation of the cis- and trans- isomers of the DKP was carried out
using the same HPLC column and buffer as above but with 6% acetonitrile.
Concentrations of the starting peptide and degradants formed were determined by
comparison of peak areas to those of reference standards, when available. For degradants
for which reference standards were not available (e.g., imide intermediates and
diketopiperazine isomers), peak areas were converted to concentrations by assuming that
response factors were the same as similarly eluting peptides because their absorbance at
257 nm could be attributed exclusively to the phenylalanine portion of each molecule.

Kinetic Studies
Kinetic studies were conducted at 25 °C using either FNG or FisoNG at an initial
concentration of 300 pg/mL in the following buffers: (1) pH 9.5 sodium carbonate
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buffer (0.2 M, 0.5 ionic strength adjusted with sodium chloride) to determine the reaction
kinetics and degradation products formed in the absence of ammonia; (2) ammonium
chloride buffers (0.5 M, 0.5 ionic strength adjusted with sodium chloride) varying in pH
from 8.5-10.5 to monitor the reversible reaction of the cyclic imide with ammonia and to
determine the pH dependence of various reaction steps in the presence of ammonia; and
(3) pH 10 ammonium chloride buffers varying in ammonia concentration from 0.2-2 M
to examine the dependence of various reaction pathways on ammonia concentration,
particularly the reactions of ammonia with cyclic imide to form FNG and FisoNG.
Aliquots of 200 pL were taken at predetermined time intervals and diluted with a
measured volume of glacial acetic acid (2-20 pL) required to match the sample and
mobile phase pH and quench the reaction. Samples were either immediately analyzed by
HPLC or stored in a -20°C freezer until analysis.
An additional study in carbonate buffer at pH 9.5 (0.2 M, 0.5 ionic strength
adjusted with sodium chloride) was conducted starting with the cyclic imide intermediate
prepared by incubating FisoDG (~20 mg/mL) at pH in formate buffer for three days.
Isolation of the imide peak was achieved by injecting 100 pL of the incubated FisoNG
and using the analytical methods as previously described. The peak was collected, freeze
dried and used for the carbonate buffer experiment at pH 9.60 and at 25 °C. At
predetermined time intervals, 200 pL aliquots of the formulation were removed, diluted
with 4 pL glacial acetic acid, and immediately analyzed by HPLC.
Based on the reactant and product concentration versus time profiles, pathways of
degradation or formation were proposed and differential equations were derived to fit the
concentration versus time profiles for the starting materials and all degradants. Fits were
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performed by non-linear least squares regression analysis using commercially available
computer software. (Scientist, Micromath Scientific Software, St. Louis, MO).

Results

HPLC Separation and Characterization of Degradants
Shown in Figure 3-1 are representative chromatograms obtained during the
reactions of FNG (panel A) and FisoNG (panel B) in pH 9.5 carbonate buffer at 25 °C.
Evident from comparing these chromatograms is that both peptides form the same
decomposition products. The identities of all degradants with the exception of the cyclic
imide were determined by comparison of retention times to those of synthetic standards
(see Figure 3-3). The peaks eluting at ~ 10 and 12 min, respectively, forming at a ratio of
~ 2.1:1 were identified as the deamidated peptides, FisoDG and FDG. The mass
spectrum of the peak eluting at ~28 min exhibited m/z of 320, consistent with the
calculated molecular weight of the cyclic succinimide intermediate (M+H)^ after loss of
ammonia. The concentration of the putative succinimide intermediate increased with
time at the initial stages of reaction then gradually disappeared, as is characteristic for a
reactive intermediate.
An additional degradant eluting at a retention time of ~45 min was shown to be a
diketopiperazine (DKP, Figure 3-3). The mass spectrum indicated a peak at m/z of 320
(M+H)^ consistent with the molecular weight for a DKP (C15H17N3O3). The cis-DKP,
{[(2S-cis)-5-benzyl-3,6-dioxopiperazin-2-yl]acetylamino}-acetic acid, was therefore
synthesized, and shown to exhibit the same mass spectrum and retention time as the
unknown degradant. NMR spectra obtained for both the synthesized DKP standard and
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pooled fractions of the DKP peak separated by HPLC are shown in Figure 3-2. The
NMR spectra of the synthesized compound and the degradant isolated from the reaction
mixtures matched well. Extra peaks observed in the collected DKP spectra could be
attributed to residual solvent impurities (e.g., acetic acid) from the HPLC separation. The .
long retention time for this compound is consistent with the loss of the ionizable amino
group at the N-terminus upon formation of a six-membered ring.
Though it is not clearly apparent in the chromatograms in Figure 3-1, the DKP
peak appeared to be slightly asymmetric under the chromatographic conditions employed .
for the kinetic studies in carbonate buffer at pH 9.5. When the mobile phase was
modified to contain 6% rather than 2% acetonitrile the peak eluting at ~ 45 min was
resolved into two separate peaks. The (cis)-DKP reference standard which was
synthesized produced a single peak at 19.7 min. The second peak at 21.8 min exhibited
the same mass spectrum {m/z of 320 (M+H)^), also consistent with the molecular weight
for a diketopiperazine and was designated as the trans-DKP.

Kinetics in the Presence and Absence ofAmmonia
Reactant and product concentrations (expressed as % of total molar cone.) versus
fime in carbonate buffer at pH 9.5 are shown in Figure 3-4, where panels A and B reflect'
the results when the initial reactant was either FisoNG or FNG. To determine which
products form directly from the succinimide intermediate, the HPLC fraction
representing the imide intermediate was collected and incubated in pH 9.45 carbonate
buffer. These results are shown in Figure 3-4C. An inspection of the three panels clearly
reveals that the three reaction products (i.e., the two deamidation products and the DKP
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(i.e., the combined isomers)) form in parallel and reach similar final concentrations
regardless of the initial reactant. At the completion of the reaction, the
DKP:FisoDG:FDG ratios were 3.8:2.3:1 (fi-om FisoNG), 3.3:2.3:1 (from FNG) and
3.0:3.3:1 (from the succinimide intermediate). The fact that each of these reaction
products form directly fi-om the cyclic imide with no apparent lag time, as illustrated in
Figure 3-4C, and that the product ratios are similar regardless of the initial reactant
provide strong evidence that all three degradants form via the cyclic imide intermediate.
In ammonium chloride buffers (pH 8.5-10.5) varying in ammonia concentration (0.2-2
M), an additional degradant was observed in both the FNG and FisoNG kinetic studies
which matched the retention time of the corresponding asparagine-containing isomer
(i.e., FNG formed FisoNG and vice versa. Figure 3-5). Such isomerization can occur
only from the reaction of the imide intermediate with ammonia in the same fashion that
aspartate and isoaspartate result from the nucleophilic attack by water or hydroxide at
either of the two imide carbonyls.
Based on the knowledge of the decomposition products generated and the kinetic
information in the presence and absence of ammonia, a comprehensive reaction scheme
(Figure 3-3) was developed. As illustrated in Figure 3-3, FNG and FisoNG can undergo
deamidation to form the succinimide intermediate at rates determined by the pseudo-first
order rate constants, ki and Iq, respectively. In the presence of ammonia, the formation of
the succinimide intermediate is reversible, with the back-reaction with ammonia leading
to either FNG or FisoNG depending on the relative values of the second order rate
constants, k.i and k4, respectively. The imide may also react with water to form FisoDG
(k2), FDG (k3), or undergo intramolecular attack by the amino terminus to form the cis-
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or trans-DKP (ks). Racemization also occurs via the succinimide'^ and therefore has been
included in Figure 3-3 though it was not directly monitored in these studies. Succinimide
racemization may account for the fact that both cis- and trans- isomers of DKP were
generated directly from the imide intermediate, as discussed below. Figure 3-4C
demonstrated that the DKP formed directly from the succinimide intermediate, as there is
no lag time evident in its formation. Using another mobile phase each suspected DKP
isomer could be separately monitored by HPLC. Under the conditions of this experiment,
the formation of the cis-isomer exceeded that of the trans-isomer (data not shown).
When the data in Figure 3-4C were combined with the data for formation of the
individual isomers, first-order rate constants of 6.6 x 10'^ and 0.85 x 10'^ min ' were
obtained for the formation of the cis- and trans-DKP isomers, respectively.
The synthesized DKP (cis-isomer) and a collected HPLC fraction of the putative
trans- isomer were also incubated in pH 9.45 carbonate buffer, resulting in their partial
interconversion to the corresponding isomer. Their interconversion provides further
support for the assignment of the unknown DKP isomer as the trans-form. Initial rate
data for the isomerization of DKP from cis to trans, and vice versa, in carbonate buffer at
pH 9.5 and 25 °C (not shown) yielded rate constants of 8.5 ± 1.1 xlO'^ min ' and 4.0 ± 0.
5 xlO'^ min ' for k-.

and k

-

respectively, indicating that the trans-form is

favored with an equilibrium constant (K«q =

cis^transJk.Irans-^cis )of2.1.

A complete set of differential equations based on Figure 3-3 and the above
experimental observations was used to fit simultaneously the kinetic data for reactant
disappearance and product appearance versus time for each set of solution conditions.
The reactant and product concentration versus time profiles (Figure 3-4A-C) were
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combined in a single regression analysis to generate self-consistent values of all rate
constants that could be determined. The solid lines in Figures 3-4A-C illustrate the
excellent fits of the model described in Figure 3-3 to the data obtained in carbonate buffer
at pH 9.5 in the absence of ammonia. The values of these rate constants are listed in
Table 3-1 (first column). Similar kinetics experiments were carried out at 25 °C in 0.5 M
ammonia buffer at various pH values (8.5 to 10.5) and constant ionic strength (0.5) and in
pH 10 ammonium chloride buffers varying in ammonia concentration fi'om 0.2-2 M.
Shown in Figure 3-5 are representative semi-logarithmic (left panels) and linear plots
(right panels) of the concentration versus time profiles for the loss of FisoNG (A) and
FNG (B) and the formation of decomposition products in 2 M ammonia at pH 10.00 and
25 °C. The curves shown are the results of non-linear least squares fits of the data to a
set of differential equations representing Figure 3-3. The values of all rate constants
obtained fi-om regression analysis of the reactant and product concentration vs. time
profiles generated in 0.5 M ammonia buffer at various pH values (8.5 to 10.5) and at
constant ionic strength (0.5) are listed in Table 3-1. An inspection of the values of these
rate constants at varying pH indicates that each reaction pathway is pH dependent,
although to different degrees.

pH and Ammonia Effects on the Various Reaction Steps Involved in Asn and isoAsn
Deamidation
Pseudo first-order rate constants in 0.5 M ammonium chloride buffers listed in
Table 3-1 representing the reversible formation of succinimide intermediate fi'om FNG
(i.e., ki,k.i) or FisoNG (i.e., k4, k.4) are plotted versus pH in Figure 3-6. The slopes of the
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plots of log ki, k.i, k4, and lt4 vs pH approach 1.0 at pH > 9 indicating that both the
formation of the succinimide and its reverse reaction with ammonia are hydroxide-ion
eatalyzed. To account for the nonlinearity in the profiles for ki and IC4 at lower pH, a
simple model that ineludes the possible effects of ionization of the amino terminus was
constructed (Eqn. 1).
k.' = ^

\[OH~]

k,={k

4[OW]

RNHy^

A:
)[OH~]i
l[0/T]
J

(1)

J

(2)

JpMN.* ^ '^Afnn-i
''RNH^
4[0«“

JRNH-,

where k^^^^ and k^^^^ are the second-order rate constants for cyclic imide formation
from FNG, and fRNH3+ and fRNH2 are the fi-actions of peptide or cyclic imide having a
protonated amino and neutral amino terminus, respeetively. An analogous equation (Eqn.
2) was applicable for k4 the corresponding pseudo first-order rate constant for formation
of cyclic imide from FisoNG. The solid lines in Figure 3-6 are based on these equations,
and the species-specific rate constants for the forward reactions are listed in Table 3-2.
These results indicate that the transition states for the reversible hydroxide-mediated
formation of cyclic imide fi'om FNG and FisoNG are significantly stabilized by
protonation of the amino terminus.
Displayed in Figure 3-7 are the first-order rate constants fi'om Table 3-1 for
isospartate (k2), aspartate (k3), and DKP (ks) formation versus pH over the pH range
explored (i.e., pH 8.4-10.4) in 0.5 M ammonia buffers. As is evident by the parallel lines
having slopes of 1.0, aspartate and isoaspartate form from the eyelie imide intermediate
via reactions which are first-order in hydroxide ion (Eqns. 3 & 4). Values for the
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bimolecular rate constants

and kf.\ obtained from least-squares regression

analyses of the data for FisoDG and FDG formation in Figure 3-7 (lines represent the
computer fits) are listed in Table 3-2. The ratio of isoaspartate to aspartate products
averaged 3.1 ± 0.4 and was independent of pH over this range.
k.=k

[OH~]
2[otrv-*

(3)

k.-k

[OH~]

(4)

2

Deamidation was found to predominate at pH 10.5 while at lower pH values, the
formation of DKP became increasingly dominant. DKP formation (ks) increased with pH
from pH 8.4 to pH 9.4, then reached a plateau, indicating that DKP formation involves
attack by the neutral phenylalanine amino terminus (Eqn. 5) where ks represents the
observed first-order rate constant for DKP formation at each pH and
the species-specific rate constant where

represents

is the ionization constant for the

phenylalanine N-terminus. pH-microtitrations yielded pKa values of 7.65 ±0.10, 7.87 ±
0.18, 7.82 ± 0.20, 8.06 ± 0.39 for the phenylalanine amino in FNG, FisoNG, FDG, and
FisoDG, respectively, while a kinetically determined pKa of 8.76 was obtained for the
amino terminus in the cyclic imide intermediate from the fit of ks using Eqn. 5. The rate
constants generated from the pH profiles for each reaction pathway are summarized in
Table 3-2.
5

5[OH~]

a

\

a

J

(5)

The rate equations governing the formation of FDG, FisoDG, and DKP, the
terminal degradation products in the deamidation of FNG or FisoNG, and the pH profiles
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in Figure 3-7 for these products, illustrate the dramatic influence that pH has on the
products generated. This is further illustrated in Figure 3-8, where the fractions of each
of these products produced at the completion of the reaction in 0.5 M ammonia buffers
are shown as a function of pH. Similar pH dependencies for the product ratios were
observed in the initial rates of product formation as a function of pH (not shown),
consistent with reactions involving competition for the same intermediate. Values at pH
7.5 were calculated from the rate constants in Table 3-2 and the rate equations for each
reaction.
The back-reactions of the cyclic imide in the presence of 0.5 M ammonium
chloride buffer to produce asparagine containing compounds could not be detected at the
lowest pH (8.4) but the apparent first-order rate constants for formation of FisoNG (k^)
and FNG (k.i) increased with pH. Thus, the reverse reaction depends on the
concentrations of neutral ammonia and hydroxide ion as depicted in Eqn. 6 for k.i where
k

is a third-order rate constant for based catalyzed reaction of the cyclic imide

with ammonia. According to the principle of microscopic reversibility, k.i and k.4 are
also expected to depend on the state of ionization of the phenylalanine amino terminus as
demonstrated for ki and k4 but insufficient data were available at lower pH to warrant
consideration of this possibility in the rate equation.
(6)

Solution experiments at varying concentrations of ammonia (0.2-2 M) and
constant pH (10.00) were performed to examine the effects of ammonia concentration on
various reaction steps. With increasing ammonia concentration, the rates of formation of
the corresponding asparagine-containing isomer (i.e., FisoNG from FNG or FNG from
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FisoNG) increased as well, as suggested by Eqn. 6. Figure 3-9 shows the values of these
rate constants normalized by the total concentration of ammonia (i.e., k.i/[NH3]T and k.
4/[NH3]t) vs. [NH3]t. As predicted by Eqn. 6, the quantity k.i/[NH3]T is constant
indicating that k.| is linearly dependent on ammonia concentration. However, a similar
plot showed an increase in k4/[NH3]j with the total concentration of ammonia, indicating
the presence of a pathway that is second order in ammonia concentration. The formation
of FisoNG from the reaction of ammonia with the cyclic imide therefore appears to be
eatalyzed by both hydroxide ion and ammonia, where ammonia is presumably acting as a
general base. These observations indicate that k^ should be described by Eqn. 7.
k ,,

where

(V)

-4[OH'

represents the specific base catalyzed reaction of the cyclic imide with

ammonia and

represents the rate constant for reaction of the cyclic imide with

ammonia catalyzed by ammonia acting as a general base. The rate constants reflecting
the other reaction pathways shown in Figure 3-3 did not exhibit statistically significant
increases with increasing ammonia concentration at pH 10.

Discussion

Although other pathways have been identified, the predominant route of
degradation of asparagine residues in peptides and proteins at neutral to basic conditions
is through the intramolecular attack of the backbone amide nitrogen on the asparagine
side-chain carbonyl, leading to the loss of ammonia and formation of a cyclic
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succinimide intermediate, as outlined in Figure 3-3.The imide then undergoes
rapid degradation via nucleophilic attack by water or hydroxide ion at the alpha- and
beta- carbonyl groups to produce isoaspartate and normal aspartate-containing
degradation products in an approximate ratio of 3:1 in solution."*
This study examines the potential for decomposition at Asn-containing residues in
peptides and proteins to generate a more diverse array of decomposition products due to
nucleophilic amine nucleophile attack on the cyclic imide intermediate The kinetics of
reaction of the model peptide Phe-Asn-Gly (FNG) and its isomer Phe-isoAsn-Gly
(FisoNG) were explored as a function of pH (8.5-10.5) in the presence and absence of
ammonia buffer (0.2-2 M) by HPLC to monitor reactant disappearance and product
formation. In addition to deamidation to form the isoAsp and Asp peptides in
approximately a 3:1 ratio, at least two additional types of reactions occurring via the
succinimide intermediate were observed. Back-reaction of the succinimide with
ammonia led to isoAsn formation via peptide backbone isomerization (same mechanism
as iso Asp formation) while intramolecular attack by the peptide amino terminus produced
cis- and trans-diketopiperazines. A kinetic model incorporating the central role for the
succinimide intermediate in all processes was derived to fit the concentration versus time
data, from which the pH and ammonia concentration dependence of each reaction step
could be determined.

Effect ofpH on cyclic imide formation
Previous studies have shown that the formation of cyclic imide is rate-limiting in
the deamidation of Asn residues."* Our results, as illustrated in Table 3-1 and Figures 3-3
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& 3-4, are consistent with this expectation. Deamidation of FNG (k|) and FisoNG (k4)
followed pseudo-first order kinetics at constant pH under all conditions explored. In both
carbonate buffer at pH 9.45 and ammonium chloride buffers varying in pH and ammonia
concentration, the cyclic imide could be quantified by HPLC but its concentration
remained low throughout the reaction, consistent with its role as a reactive intermediate.
Figure 3-5 demonstrates that in the pH range examined the formation of cyclic
imide from either FNG (ki) or FisoNG (k^) are well described by Eqns. 1 & 2, which
assume hydroxide-ion dependent pathways involving the peptide with either a protonated
phenylalanine amino terminus or a neutral terminal amino residue. As shown in Table 32, the rate constants when the amino terminus is protonated are elevated by 4-6 fold,
assuming that the pKa for phenylalanine-NH2 is 8.76, as determined kinetically from the
pH dependence of diketopiperazine formation. The kinetically determined pKa, which
reflects that for the amino terminus on the succinimide, exceeded the values obtained
from microtitration of FNG, FisoNG, FDG, and FisoDG by 0.7 - 1.1 units. Some of this
difference may be due to the higher ionic strengths in the kinetics experiment though
conformational effects may also be involved.
Succinimide formation involves proton removal from the backbone amide to form
the highly nucleophilic amide anion, and thus would be expected to exhibit specific base
catalysis,'*'* but this is often not observed.Tyler-Cross and Schirch'*^ reported a
slope of only 0.2 for a plot of log kobs versus pH in their studies of the deamidation of the
peptide VANSV from pH 6 to 10 in 20 mM sulfonate buffers, and on this basis
concluded that the reaction was not subject to specific base catalysis. Patel and
Borchardt obtained a slope of 0.54 for the pH-profile of an asparagine-containing
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hexapeptide fragment of adrenocorticotropic hormone over the pH range 5 to 12, which
they were able to rationalize by considering the various ionized species present over that
pH range.The slopes of log k| and log k4 versus pH obtained in the present study (not
shown) were 0.77 and 0.68, respectively, which could be fully accounted for by specific
base catalysis combined with different reactivities for the peptide depending on whether
or not the Phe-NH2 was ionized or unionized.
Tyler-Cross and Schirch"*^ suggested that ammonia is an effective general base
catalyst for deamidation of Asn residues and that when pH is adjusted with NH4OH, as in
a study of the deamidation of calmodulin,

the increase in ammonia concentration rather

than the increase in pH was probably the most important factor increasing the rate of
deamidation. The results of our present study do not support such an important role for
ammonia as a catalyst for the deamidation of FNG or FisoNG. No increase could be
detected in ki at pH 10 with ammonia concentrations varying from 0.2-2 M while a
modest increase could be detected in k4 with increasing ammonia concentration but the
slope was not significantly different from 0 as judged by the 95% confidence interval.
The influence of catalysis by externally added general bases may be diminished when the
Asn is in the penultimate position, as intramolecular general base or general acid catalysis
by the terminal amino residue may provide a high local (i.e., effective) concentration of
general acid or base catalyst.
We are unaware of previous reports of the relative kinetics of succinimide
formation from Asn versus isoAsn-containing peptides. At each pH explored in this
study, the rate constant for cyclic imide formation from FisoNG (k4) exceeded that from
FNG by 2-6-fold. Similarly (vide infra), the rate of formation of FisoNG from the cyclic
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imide in the presence of ammonia also exceeded that for the formation of FNG,
indicating that the transition state along the FisoNG —> succinimide reaction pathway is
stabilized relative to the FNG ^ succinimide transition state. These results parallel
similar observations for the relative rates of isoaspartate/aspartate formation where a 3:1
ratio is frequently seen.'*’* Capasso'*^ suggested that the Asp and isoAsp residues exhibit
similar energy and flexibility, and therefore the higher concentration of isoAsp peptides
at equilibrium is due to the higher acidity of the isoAsp residue side chain. The
stabilization of negative charge (e.g., electron withdrawal) that leads to higher acidity in
isoAsp may similarly contribute an additional degree of stabilization to the anionic
FisoNG ^ succinimide transition state.

Imide hydrolysis - pH dependence ofFDG and FisoDG formation
In both the absence (Figure 3-4) and presence (Figure 3-5) of ammonia, FDG and
FisoDG form in similar proportions independent of the starting reactant (i.e., FNG,
FisoNG, or cyclic imide). In carbonate buffer at pH 9.45 (Figure 3-4) the FisoDG/FDG
ratio averaged 2.6 ± 0.5 at the completion of the reaction while in 0.5 M ammonium
chloride buffers the ratio of rate constants for formation of FisoDG to FDG (k2/k3) was
3.1 ± 0.4 (Table 3-1). At pH 10 but with varying concentration of NH4CI buffer, this
ratio was 2.9 ± 0.2. These observations are indicative of the central role of the cyclic
imide as an intermediate in the formation of both reaction products regardless of the
starting reactant.
As shown in Figure 3-5, the rates of formation of both FDG and FisoDG from the
succinimide intermediate are first-order in hydroxide ion. In contrast to succinimide
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formation, which is also specific base catalyzed, succinimide hydrolysis exhibits no
apparent sensitivity to the state of ionization of the Phe-NH2 terminus. This may be
rationalized by considering that the transition state for succinimide formation is relatively
late, resembling the product more than the reactant. Experimental^®'^' and computational
studies^^ suggest that the rate-determining step in cyclic imide formation is the
breakdown of the tetrahedral intermediate with the expulsion of ammonia. The terminal
Phe-NHs^, either through electrostatic effects or as a general acid, evidently stabilizes this
transition state. In the succinimide hydrolysis reaction, stepwise and concerted
c'i

mechanisms are competitive, but experimental evidence favors the stepwise formation
of a tetrahedral intermediate with hydroxide anion attack being rate-determining at pH >
5.5 as indicated by the absence of '*0 exchange above this pH.^'* Delocalization of the
negative charge through the second carbonyl gives rise to an imine-like structure along
the reaction coordinate,^^ which may reduce the need for catalysis by general acids or
bases. This is consistent with our observations that neither ionization of the amino
terminus nor increasing concentrations of ammonia buffer altered k2 or k3.

Reaction ofAmmonia with the Succinimide Intermediate
Under the sink conditions typical for reactions conducted in buffers other than
ammonium buffers, the expulsion of ammonia leading to succinimide formation is
irreversible. However, as demonstrated in Figure 3-5, the degradation of FNG in 0.5 M
NH4CI buffers produced measurable quantities of FisoNG while similar studies of the
decomposition of FisoNG produced FNG as a significant reaction product. These
reactions were demonstrated to be first order in hydroxide ion over the pH range explored
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(Figure 3-6), confirming the anionic nature of the transition state identified for specific
base catalyzed deamidation leading to succinimide formation. Although the reaction rate
would be expected to increase with pH due to an increasing fraction of ammonia in its
free base form, the dependence of k.i and k4 on pH is evident at pH values well above
the pKa of ammonia (9.25). At lower pH (8.4), neither FNG nor FisoNG formation could
be detected from the succinimide, indicating that it is the neutral ammonia species that is
involved in this reaction.
The pseudo-first order rate constants for both FisoNG (k^) and FNG (k.i)
formation increased with increasing concentrations of ammonia (always in excess) at pH
10 (Table 3-1), as one would anticipate for reactions involving ammonia as the attacking
nucleophile. An inspection of the pseudo-first order rate constants in Table 1 indicates
that the forward and reverse reactions involving either FNG or FisoNG proceed at
virtually identical rates at pH 10 when the concentration of ammonia is 1 M. As
illustrated in Figure 3-8, k_i exhibited a first-order dependence on ammonia concentration
as indicated by the slope of zero in a plot of k.|/[NH3]x versus [NHsJt while the plot of k.
4/[NH3]t increases linearly with [NH3]t from a non-zero intercept indicating that k4 must
contain a first-order and second-order term with respect to ammonia concentration as
expressed by Eqn. 7. Thus, the nucleophilic attack of ammonia on the succinimide
intermediate leading to FisoNG formation can be either specific base catalyzed or
catalyzed by ammonia acting as a general base in addition to its role as a nucleophile.

Diketopiperazine Formation - Intramolecular Attack by the Phe-NH2 on the Succinimide
Intermediate
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The reversibility of cyclic imide formation in the presence of excess ammonia
clearly establishes the propensity for the succinimide intermediate to react with
nucleophiles other than water or hydroxide ion. Herein we have found that the
succinimide intermediate also plays a central role in the formation of both cis- and trans6-membered ring diketopiperazine (DKP) products (Figure 3-3), as demonstrated in
Figures 3-3 & 3-4. These reactions occur via the intramolecular nucleophilic attack of
the phenylalanine amino terminus in its neutral form on the succinimide intermediate
while it is undergoing racemization.
Figure 3-4C provides direct evidence for the formation of DKP from the
succinimide intermediate at pH 9.45, which occurs with no evidence of a lag time and to
a similar extent from the cyclic imide as from either FNG or FisoNG. The fractional
conversions of FNG, FisoNG, and succinimide intermediate to the DKP, estimated from
the fitted curves in 3-4, were 53%, 50%, and 45% at the completion of the reactions.
The rate equation governing this reaction can be derived from the pH dependence
of the pseudo-first order rate constant for DKP formation (ks) listed in Table 3-1 and the
semi-logarithmic plot of ks versus pH (Figure 3-7) to involve simple intramolecular
nucleophilic attack by the neutral Phe-NH2 as described by Eqn. 5. A pKa of 8.76 for
this, amine was generated from fitting Eqn. 5 to the kinetic data shown in Figure 3-7.
While there appeared to be no significant influence of increasing ammonia concentration
at concentrations above 0.2 M on this reaction, the rate constant in carbonate buffer at pH
9.45 -is approximately 1/3 of that in 0.5 M ammonia buffer at approximately the same pH.
It is unlikely that catalysis by ammonia would be observed between 0-0.2 M ammonia
concentrations but not between 0.2-2 M concentrations. It is more likely that the
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reactivity of the Phe-NH2 is suppressed in carbonate buffer, due to the formation of a
carbamate adduct through the reaction of the amine with carbonate in solution.
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Unlike the reaction of ammonia with the succinimide intermediate, which is
specific-base catalyzed, the rate of DKP formation was found to depend only on the
fraction of the amino terminus present as fi'ee base (Figure 3-7). Consequently, the
relative importance of diketopiperazine formation is highly dependent on pH, as
illustrated in Figure 3-8. At pH < 8 DKP formation becomes the predominant reaction
and deamidation products may not be detectable. At pH > 10 deamidation products
dominate. These results are consistent with those reported by Smyth and Tuppy^^ in
reactions involving cystine and maleimide where they observed an increase of hydrolysis
products in basic conditions (pH 9.5) and intramolecular aminolysis dominated at slightly
basic conditions (pH 8.5).
The ability of potent amine nucleophiles such as hydroxylamine to react with
succinimide intermediates generated during the decomposition of asparagine and
aspartate-containing peptides and proteins has been reported previously.However, the
prevailing view in the literature is that diketopiperazine formation in peptides containing
an'asparagine residue in the penultimate position does not involve the cyclic imide.'*^
Rather, Lura and Schirch"*^ proposed that the tetrapeptide VNGA formed a sevenmembered cyclic amide under slightly basic conditions by way of direct intramolecular
attack by the N-terminus on the Asn side-chain amide.
We synthesized the cis-diketopiperazine (cis-DKP) shown in Figure 3-3 and
demonstrated that it matched the chromatographic retention time of the product formed
ffoin FNG, FisoNG, and the succinimide intermediate according to the rate constant ks.
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The demonstration in Figures 3-3 & 3-4 that the extent of DKP formation is the same
when starting from FNG, FisoNG, or the cyclic imide rules out the seven-membered ring
mechanism proposed by Lura and Schirch for this peptide, as their mechanism requires
direct reaction at the asparagine side-chain amide. Rather, the results presented herein
support a mechanism involving intramolecular attack at the succinimide a-carbonyl.
Jomvall also observed DKP formation during trypsin cleavage of yeast alcohol
dehydrogenase which led to an Ala-Asn-Gly- terminal sequence."*' Jomvall proposed the
diketopiperazine was produced by intramolecular attack of the Ala-NH2 at the a-carboxyl
group in the isoaspartate decomposition product resulting from Asn deamidation, which
resulted in formation of a six-membered ring. This proposed mechanism of formation
would not be likely under basic conditions where the a-carboxyl group is largely ionized
making it a very poor electrophile. Indeed, De Boni et al.^' were unable to detect DKP
formation in the pH 10 degradation of FDG, despite the generation of the isoaspartate
product. In contrast, they did find a diketopiperazine fragment cyclo(Phe-Asp) under
acidic conditions, which they speculated must have formed by direct attack of the Nterminus on the backbone amide carbonyl between Asp and Gly.
Our proposed mechanism for DKP formation in aqueous buffers appears to be in
agreement with that proposed by Schon and Kisfaludy who identified the six-membered
cyclo[Leu-Asp-Phe-NH2] as a product formed from the succinimide Leu-Asu-Phe-NH2 in
organic solvents in the presence of pyridine or triethylamine.

Cis- and trans-DKPformation
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The peak eluting at ~ 45 min in the HPLC chromatogram shown in Figure 3-1 and
identified as a diketopiperazine was separable into two components when the mobile
phase was modified to contain 6% rather than 2% acetonitrile. The synthetic cis-DKP
reference standard matched the retention time of the first of these two components,
eluting at 19.7 min. The second peak eluting at 21.8 min exhibited the same mass
spectrum and, like the cis-product, formed directly from the succinimide intermediate
though at a slower rate (~13% of the rate for cis-DKP formation). On the basis of these
observations, we attribute the second peak to trans-DKP which likely forms to a small
extent due to partial racemization of the L-succinimide intermediate to the Dsuccinimide. Li et al provide support that the racemization can occur before the
formation of the imide intermediate when an asparagine residue forms a transitions state
intermediate^^. While imide racemization may be the dominate pathway of racernizatibn,
the research by Li et al cannot be ruled out.
Lura and Schirch"*^ reported that their postulated seven-membered ring produced
from VNGA converted to a second degradation product that differed only in inversion of
configuratibh at the asparaginyl a-carbon, as shown by 'H NMR spectra. Smith and
Baurh examined racemization of DKP compounds and dipeptides at pH 8.0 and 120°C
and determined that diketopiperazines racemized rapidly in comparison to the dipeptides
under these conditions.
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In light of the above observations we incubated the synthesized cis-DKP and a
collected HPLC fraction of the putative trans-isomer in pH 9.5 carbonate buffer at 25 °C
and monitored both reactant disappearance and formation of cis- or trans-DKP to confirm
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their interconversion. These results provide further support for the structure of the
unknown product as the trans-diketopiperazine.

Conclusion
These studies implicate the succinimide as a potential reactive intermediate in a
variety of degradative processes that Asn-containing peptides and proteins may undergo,
beyoiid the traditional ones involving racemization and the formation of Asp and isoAspcontaining degradation products. The tendency for the cyclic imide to undergo attack by
amine nucleophiles either intramolecularly or intermolecularly may contribute to the
formation of novel, unexpected degradants, particularly in amorphous solid formulations
of peptides and proteins such as lyophilized drug formulations. Covalent aggregates often
observed in protein formulations, may also play a role in various disease states. The
results from these experiments warrant further investigation under conditions where the
concentration of water is minimized and the concentrations of competing nucleophiles on
other protein or excipient molecules are elevated.
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Rate Constant Value (10^*min‘
0.2 M
Carbonate

Buffer

0.5 M N'H4C1 (I= 0.5 (NaCl))

a=o.5

pH 10.00 NH4CI

(NaCl))
pH or [Ammonia]

pH 0.45 (0

pH 8.37

pH 9.37

pH 10.05 pH 10.41

0.2 M

1.0

M

2.0 M

Rate Constant
0.38
ki (FNG —f Imide)

k.] (Imide ^ FNG)

0.065

. '

1.2

0 2

(0.35-0.41) (0.056-0.073) (0.23-0.32) (1.0-1.4)
0.24

0.91

2.3

0.9

(1.7-2.8) (0.64-1.2)
2.9

0.38

1.1

1.1

(0.8-1.3) (0.9-1.3)
1.4

4.1

NT)

NT)

6

0.78

9.7

22

134

19

23

33

(5.5-6.4)

(0.57-0.99)

(6.6-12.7)

(17-27)

(92-176)

(14-25)

(17-29)

(22-43)

3

0.27

2.9

7.8

38

11

(2.6-3.3)

(0.19-0.34)

(2.0-3.7)

(6.0-9.7)

(26-49)

(5.2-8.S)

7.3
(5.5-9.1)

1

0.21

1.4

2.3

6.5

2.1

2.8

(0.98-1.1)

(0.18-0.23)

(1.3-1.6)

(2.1-2.6)

(5.4-7.6)

(1.9-2.4)

NT)

0.9'?

2.2

ND

8.9

0.55

(0.42-1.5)

(1.4-3.1)

12

11

34

36

35

35

32

50

(11-13)

(8-13)

(25-44)

(28-44)

(24-46)

(26-43)

(25-40)

(34-65)

k-i.Ici

NT)

NT)

0.89

0.76

1.26

NT)

NT)

NT)

k.4(1C4

NT)

NT)

0.69

0.96

1.37

NT)

NT)

NT)

k2 (Imide ^ FisoDG)
k3 (Imide —► FDG)
kr (FisoNG

Imide)

k^ (Imide —» FisoNG)
kj (Imide —‘ DKP)

(0.16-0.32) (0.63-1.2) (1.7-4.0) (0.25-0.51) (0.9-1.9) (2.7-5.6)

(8-15)
4.5

(2.4-3.2) (3.4-S.5)
5.1

(5.1-12) (0.24-0.87) (3.3-7.0)

19
(11-27)

Table 3-1. Pseudo-first order rate constants for various reaction steps involved in the solution decomposition of
FNG and FisoNG (Figure 3-3) in buffers varying in pH and ammonia concentration at 25°C. ^'Values in
parentheses are 95% confidence limits of the estimated rate constant.

as

VO

Table 3-2. Species-specific rate constants for various reaction steps involved
in the solution decomposition of FNG and FisoNG (see Figure 33 and Figures 3-4 & 3-5) in buffers varying in pH and ammonia
concentration at 25 °C.
Rate constant

Calculated
Value

Standard
Deviation

31
8.6
17
279
93
126
19
21
0.0035
0.038

17
2.7
1
50
16
64
8
5
0.001
0.008

a,bi
RNH3+
K|[0H]
a,bi
RNH2
Ki[OH]

^k2[0H]
‘‘k3[OH]
a,bi
RNH3+
M[OH]
a,b,
RNH2
K4[0H]
k-4[OH]
k-4gb

"’■‘‘ks

^Units are (min'‘M ‘); '’protonated and neutral species
fractions were based on a kinetic pKa of 8.78
obtained from fits of the data in Table 1; ‘^min 'M’^;
d min
• -1
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FNG 13.54

/

FDG
12 15
DKP 45 43

FisoDG
10 27

A

Imide 27 76

iVA;

V

1

I

Figure 3-1. Representative chromatograms obtained during the reactions of
FNG (panel A) and FisoNG (panel B) in pH 9.5 carbonate buffer
at 25 °C.
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H

Figure 3-2. NMR spectra of DKP collected from HPLC fractions (A) and
synthesized DKP (B). The peak at ~4.8 ppm is assigned to
residual water. Extra peaks in the 2-3 ppm range (panel A) for
the DKP isolated by HPLC separation from the reaction mixture
are attributed to residual acetonitrile and acetic acid.
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v^NHj

.

F-D-isoNG

F-D-isoDG

trans-DKP O

Figure 3-3. Pathways involved in the degradation of FNG and FisoNG in aqueous
buffers in the presence or absence of ammonia. The succinimide intermediate mediates
the formation of all degradation products. In the presence of ammonia the cyclic imide
can also react with ammonia to regenerate FisoNG and FNG or their isomers.
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Fi^re 3-4. Plots illustrating the loss of each starting compound (FisoNG (A),
FNG (B), and Imide (C)) and degradant formation when stored
in carbonate buffer at pH 9.45 at 25 °C. FisoNG - A, FNG - o,
Imide - □, DKP -

, FisoDG - ■, FDG - •.
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Figure 3-5. Semi-logarithmic (left side) and linear plots (right side) of
concentrations versus time for EisoNG (A) and FNG (B) in 2M
ammonia at pH 10.00. Lines are nonlinear fits to differential
equations for each reaction step based on Figure 3-3. FNG - o,
FisoNG - A, FDG -

FisoDG -
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DKP - 'l^,Imide-n.

Figure 3-6. Plots of k| (■) and k4 (•) for theformation of the cyclic
succinimide intermediate from FNG and FisoNG (semilogarithmie seale) versus pH, respectively, along with the rate
eonstants for the reverse reaction of the cyclic imide with
ammonia, k.| (□),and k.4 (o), as a function of pH in 0.5 M NH4CI
buffers. Solid lines represent computer fits of ki and loj using
Eqns(l)&(2).
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pH
Figure 3-7. Plot of rate constants (semi-logarithmic scale) versus pH, in
ammonia buffer, for the formation of DKP (ks, •), FisoDG (k2,
A), and FDG (k3, ■). Lines represent non-linear least squares
fits to Equations 3, 4, and 5 for FisoDG, FDG, and DKP,
respectively. Error bars represent 95% confidence intervals.

77

iSc

100%

ra

2

80%

Q
■5

60%

cn
HI

: □ FisoDG
■□FDG

.5

40%

c
o

20%

£

0%

Vu

laDKP

7.5

8.4

9.4

10

10.31

pH

Figure 3-8. Plot of the fraction of FisoDG, FDG, and DKP degradation
products at the completion of the reactions based on the
calculated rate constants from Eqns. 3, 4, and 5, respectively.
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[NH3]t (M)

Figure 3-9. Plots of k.|/[NH3]T (•) or kV[NH3]x (■) vs. total ammonia
concentration ([NH3]t) The increase in k.4/[NH3]j with
increasing ammonia indicates a second-order dependence on
ammonia concentration for the back-reaction of the cyclic
imide to form FisoNG as described by Eqn. 7.
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CHAPTER 4 - KINETICS AND MECHANISMS OF DEAMIDATION AND
COVALENT AMIDE-LINKED ADDUCT FORMATION IN AMORPHOUS
LYOPHILES OF A MODEL ASPARAGINE-CONTAINING PEPTIDE
Introduction
The chemical and physical instability of proteins and peptides in aqueous
formulations has been a topic of considerable interest in the pharmaceutical literature and
the subject of several excellent reviews

Generally, the chemical instability of proteins

and peptides can be attributed to specific amino acid side chains and sequences that are
particularly likely to participate in chemical reactions, such as residues that contain
reactive amine or thiolate nucleophiles (e.g., lysine or cysteine)

residues prone to

oxidation (e.g., methionine, cysteine, histidine, tryptophan, and tyrosine)

or cystine

residues that are susceptible to thiol-disulfide exchange or P-elimination reactions that
can lead to reducible or non-reducible aggregate formation

Of the numerous so-

called “hot spots” demarcating locations particularly prone to chemical degradation,
asparagine and to a lesser extent glutamine residues are among the most frequently
involved

Side-chain deamidation, peptide backbone isomerization, and

racemization reactions occurring at asparagine and glutamine residues in proteins and
peptides all appear to be linked to the formation of a reactive cyclic imide intermediate
At asparagines, formation of a reactive five-membered succinimide ring is the result
of a nucleophilic attack by the adjacent backbone amide nitrogen on the C-terminus side
at the amide side-chain, accompanied by the liberation of ammonia (hence, deamidation).
The reactive cyclic imide intermediate can be attacked by a molecule of water at either
carbonyl, leading to aspartate or isoaspartate-containing degradation products. In
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aqueous solution, isoaspartate formation in peptides is usually preferred by
approximately 3:1
microenvironment

but this ratio depends on the solvent

and local

Racemization at the a-carbon of asparagine also occurs, and has

been linked to the enhanced acidity of the hydrogen on the a-carbon in the succinimide
intermediate

though tetrahedral intermediates along the reaction coordinate may also

undergo racemization
While the central role of cyclic imide intermediates in the reactions
summarized above is widely recognized, the enhanced susceptibility of this intermediate
to nucleophilic attack raises the possibility that other degradants may arise from reactions
with nucleophiles other than water

In the case of insulin, deamidation of the

asparagine residue at the A-21 terminus in aqueous solutions leads to parallel formation
of covalent amide-linked dimers

However, both deamidation and covalent dimer

formation at the A-21 position of insulin were shown to proceed through a highly reactive
cyclic anhydride rather than a cyclic imide intermediate, with covalent dimers stemming
from the intermolecular attack of primary amino groups in neighboring insulin molecules
on the anhydride. Competition between water and protein amino groups for reaction with
the cyclic anhydride was also observed in amorphous lyophile formulations, where the
relative amounts of degradants produced depended on various formulation factors
including protein concentration, water content, and apparent pH

28-30

In a recent publication from these laboratories, we demonstrated the potential for
Asn-containing proteins and peptides to generate a more diverse set of degradants due to
the reaction of nucleophilic amines with a succinimide intermediate
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The

decomposition kinetics of the tripeptides Phe-Asn-Gly and Phe-isoAsn-Gly in aqueous
solutions ranging from pH 8.5-10.5 indicated that, in addition to deamidation to form
isoAsp and Asp peptides in a ratio of approximately 3:1, cis-and trans-diketopiperazines
were produced via intramolecular attack of the peptide amino terminus on the
succinimide. The formation of both cis- and trans-isomers was attributed to partial
racemization of the cyclic imide or a precursor prior to formation of the diketopiperazine.
In ammonia containing buffers, Phe-Asn-Gly and Phe-isoAsn-Gly isomerization was
demonstrated as the result of the back reaction of ammonia with the succinimide
intermediate. These observations established the plausibility that a wide range of
heretofore unidentified degradants may form via intra- or intermolecular attack by
nucleophilic amines at cyclic imide intermediates generated during Asn or Gin
deamidation or Asp isomerization reactions, even in aqueous solutions.

In amorphous lyophiles of Asn-containing peptides or their mixtures with
polymeric excipients, deamidation proceeds through cyclic imide formation as in aqueous
solution but the product distribution (isoAsp/Asp ratio) and kinetics are altered depending
on water content

Recently, Desfougeres et al.

prepared hen egg-white lysozyme

with variable numbers of succinimide residues by heating lysozyme powder freeze-dried
from pH 3.5 solutions (pH conditions that favor succinimide formation from Asp
residues) for up to 7 days at 80 °C. Under these conditions, the sites that were converted
to succinimides were identified as Aspl8, Asp48, Asp66, Asp 101, and Asnl03. Using
SDS-PAGE to detect covalent dimer formation, they demonstrated a linear relationship
between the quantity of dimeric species and the % of succinimide in the derivatives. The
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mechanism proposed to account for these results was one in which nucleophilic attack of
an amine containing side-chain (i.e., lysine) in one molecule occurred on either of the two
carbonyl carbons in a succinimide intermediate present on an adjacent molecule. Thus,
there is growing evidence that lyophilized formulations of proteins and peptides that
contain Asn, Gin, or Asp residues may degrade to form covalent dimers, trimers, and
other aggregates via reactive cyclic imide intermediates.

\
The aim of the present study is to test the following hypotheses: a) covalent,
amide-linked adducts can form in amorphous lyophiles from the intermolecular reaction
of primary amine nucleophiles in neighboring peptide molecules with Asn-containing
peptides; and b) adduct formation occurs through a reactive cyclic imide intermediate.
The model peptides chosen for this study were Gly-Phe-L-Asn-Gly along with the D- and
L-cyclic imides, Gly-Phe-L-Asu-Gly and Gly-Phe-D-Asu-Gly. If the above hypotheses
are correct, lyophiles containing only the tetrapeptide Gly-Phe-L-Asn-Gly should have a
tendency to form amide-linked dimers, trimers, tetramers, and higher order aggregates as
well as their isomers and racemates. Therefore, to reduce the number of possible
degradants likely to form, kinetic studies of Gly-Phe-L-Asn-Gly degradation were
conducted in the presence of an excess of Gly-Val. Because both Gly-Val and any
amide-linked covalent adducts produced between these two peptides would no longer
contain an Asn residue, they were expected to have a reduced tendency to form higher
order aggregates.

Materials and Methods
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Chemicals and Reagents
The peptides Gly-Phe-L-Asn-Gly (95.4%), Gly-Phe-D-Asp-Gly (99.5%), GlyPhe-L-Asp-Gly (99.5%), Gly-Phe-D-isoAsp-Gly (97.2%), and Gly-Phe-L-isoAsp-Gly
(99.5%) were synthesized by GenScript (Piscataway, NJ), and provided as theirtrifluoroacetate salts. The percentages listed in parentheses are HPLC purities
determined at 220 nm as reported in certificates of analysis from GenScript. Purities
were also assessed by comparing peak areas of each peptide to phenylalanine (Sigma,
purity >99% by TLC) standards at 257 nm since phenylalanine is the only amino acid
contributing to the UV absorbance at this wavelength. The polymer, hypromellose,
(HPMC, Methocel E5) was a donated by Dow Chemical (Midland, Ml) and used as
received. The dipeptide Gly-Val was purchased from Bachem (Torrance, CA) as the
zwitterion (purity 99.0% by TLC). Acetonitrile was HPLC grade and purchased from
Fisher Scientific (Springfield, NJ). Sodium bicarbonate (ACS grade) was purchased
from EM Science (Gibbstown, NJ) and succinic acid was purchased from Aldrich (St.
Louis, MO). Deionized water was used for all experiments.
Cyclic Imide Synthesis
The D- and L- forms of the cyclic imide intermediates, Gly-Phe-L-Asu-Gly and
Gly-Phe-D-Asu-Gly, were synthesized by incubating the corresponding aspartate (~3-4
rhg) in a 9:1 mixture of acetic acid and hydrochloric acid (2 mL) for two days ' . The
desired product was purified by HPLC using a Waters Alliance LC system with the
autosampler at 4 °C, a Supelcosil ABZ+ column (15 cm x 3.5 mm, 5-pm pore size), and a
mobile phase consisting of 5% acetonitrile and 95% water adjusted to pH 4.1 with acetic
acid. Peaks containing the succinimide were collected in a 20-mL scintillation vial.
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frozen overnight at -20 °C, and freeze-dried at 0 °C under a vacuum (100 mtorr) for two
days. Approximately 1.5 mg of a fluffy, white powder was obtained and stored in a
dessicator at -20 °C.
Purity of the L-succinimide was determined by overnight hydrolysis of an
accurately weighed sample in an aqueous solution at pH 10.5 and ambient temperature.
The pH of the hydrolyzed sample was lowered to 4.0-4.2 with hydrochloric acid (1 N)
and analyzed by HPLC (see HPLC Analyses). Complete hydrolysis of the L-succinimide
resulted in the formation of D- and L-iso aspartates and aspartates, the amounts of which
were determined from peak areas using synthetic standards. By comparing the total
quantity of hydrolysis products generated to the initial quantity of succinimide, the imide
purity was determined to be 97.2% ± 1.1% (n = 2). HPLC response factors of the D- and
L-succinimides were assumed to be the same. Therefore, the L-succinimide was used as a
standard to represent both.
Covalent Adduct Syntheses
Covalent adducts between Gly-Phe-L-Asn-Gly or Gly-Phe-D-Asn-Gly and GlyVal were formed in lyophiles prepared from 0.2 mM Gly-Phe-L-Asu-Gly or Gly-Phe-DAsu-Gly solutions containing a 30-fold molar excess of Gly-Val and adjusted to pH 9.5
with NaOH. Aliquots were transferred into sample vials, immediately frozen, and
lyophilized. The lyophiles were then incubated at 40 °C and 40% relative humidity for
six hours and stored in a freezer (-20 °C) under dessicant for later analysis by HPLC or
mass spectrometry.
Preparation of Gly-Phe-L-Asn-Gly and Gly-Phe-Asu-Gly Lyophiles for Kinetic
Analyses
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Gly-Phe-L-Asn-Gly solutions (1 mM) were prepared by adding approximately 1
mg of the TFA salt of Gly-Phe-L-Asn-Gly to 2 mL of a solution containing HPMC (10
mg), and either a combination of 2.6 mg Gly-Val and 7.8 mg sodium bicarbonate .
(forniulation A) or 10.5 mg Gly-Val (formulation B) adjusted to pH 9.5 with dilute
sodium hydroxide. The compositions of formulations A and B are listed in Table 4-1.
To examine variability between formulation preparations, formulation A was prepared in
duplicate and exposed to the same storage conditions. When the starting reactant was
either the D- or L-cyclic imide, 150 pg of the respective peptide was added to 2 mL of the
same buffer/polymer solution described above (final concentration of cyclic iniide was ~
0.2. mM). The solutions were mixed and 100 pL aliquots were transferred into glass
autosampler vials. Vials were immediately placed on a pre-chilled lyophilization shelf (45 °C) for approximately 5-8 min to fi-eeze the samples after which the lyophilization
cycle was initiated. Lyophilization was performed on a Virtis Advantage (Stoneridge,
NY) tray dryer and the cycle consisted of primary drying at -40 °C for 1420 minutes
followed by a ramp to 40 °C in 180 minutes and secondary drying at 40 °C for 120
minutes, The pressure was held constant at 100 mtorr throughout the cycle.
.Kinetic Studies
Lyophiles containing Gly-Phe-L-Asn-Gly were pre-equilibrated at 40% RH (over
saturated potassium carbonate solution) and ambient temperature for 12 hours then
placed in a dessicator at the same relative humidity and 40 °C. Lyophiles containing
either Gjy-Phe-L-Asu-Gly or Gly-Phe-D-Asu-Gly formulations were placed directly in a
desiccator at 27 °C and 75% RH. These storage conditions were chosen due to a reduced
rate of degradation for the succinimide and to ensure that all eight degradants are
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observed with the succinimide. At predetermined time intervals, individual sample vials
was removed from the incubation chamber, reconstituted with deionized water, and the
pH was adjusted with 1 N hydrochloric acid (~4-6 pL) to pH 4.1 to match the mobile
phase and to limit further degradation. Samples were either analyzed immediately by
HPLC or stored in a -20 °C freezer until analysis. Both the disappearance of starting
peptide and initial rates of formation of degradants were monitored.
For kinetic analyses, only data up to 25% disappearance of the starting peptide
were utilized, as in this region degradant concentrations increased linearly with time and
mass balances >95% were maintained. Individual peak areas for all hydrolysis products,
L- or D-succinimides and covalent adducts were pooled and labeled as either
“Aspartates,” “Imides,” or “Adducts,” respectively. Differential equations based on the
pathways depicted in Figure 4-1 were derived to fit the concentration versus time profiles
(Equations 1-4). Figure 4-1 illustrates the formation of the succinimide intermediate
from Gly-Phe-L-Asn-Gly followed by its subsequent breakdown to either aspartates or
covalent Gly-Val adducts. Fits were performed by non-linear least squares regression
analysis using commercially available computer software (Scientist, Micromath
Scientific Software, St. Louis, MO). Data from the duplicate preparations of formulation
A were fit simultaneously using the same rate constants for parallel reaction pathways in
the two formulations.
d[GFNG]
= -k,„„XGFNG]
dt
d\imide'\
dt

^imide [GFNG] k„^p\imide] - k„^^,,Jimide]
-

d[Aspartates]
dt
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(3)

d[ Adducts}
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HPLC Analyses
Separation of Gly- Phe-L-Asn-Gly and its degradants was performed on a Waters
Alliance LC system with the autosampler set at 4 °C using a Supelcosil ABZ+ column
(15 cm X 3.5 mm, 5-pmpore size) and a mobile phase consisting of 100% aqueous buffer
(20 mM succinic acid, pH 4.1) for 16 minutes followed by a step gradient to 5:95
acetonitrileibuffer for 19 minutes at 1.6 mL/min with UV detection at 220 and 257 nm.
Each injection was followed by a wash (75:25 acetonitrile:buffer for five minutes) and a
15 minute re-equilibration to 100% aqueous buffer.
Concentrations of Gly-Phe-L-Asn-Gly, succinimides and hydrolysis products
were determined by comparison of peak areas at 220 nm to those of reference standards
at the same wavelength after adjusting standard concentrations for their purity. Purities
of the L- and D-succinimide reference standards were determined from the amounts of
aspartate products produced on hydrolysis in aqueous solution as described above while
the purities of Gly-Phe-L-Asn-Gly and all hydrolysis product reference standards were
determined from response factors at 257 nm relative to phenylalanine. Covalent adduct
response factors at 220 nm relative to Gly-Phe-L-Asn-Gly were determined by
reconstituting lyophilized covalent adduct mixtures (see Covalent Adduct Syntheses) with
a stock solution containing a known concentration of Gly-Phe-L-Asn-Gly and analyzing
by HPLC at both 220 and 257 nm. Peak areas of adducts were converted to
concentrations by assuming that adducts have the same molar absorbance at 257 nm as
Gly-Phe-L-Asn-Gly due to the presence of one phenylalanine in each. The calculated
adduct concentration was then used to convert peak areas at 220 nm to adduct response
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factors relative to Gly-Phe-L-Asn-Gly. These relative response factors were then used to
determine the amounts of adducts present in samples being monitored during stability
studies.
Mass Spectrometry
Four adduct peaks were detected by HPLC and collected for tandem mass
spectrometry to determine their molecular weights and primary sequence information.
The peaks were isolated using a mobile phase consisting of 80 mM formic acid adjusted
to pH 4.1 with ammonium hydroxide and the same HPLC system described above,
concentrated under a nitrogen flow, re-diluted 1 Ox in acetonitrile/water (1:1), and
introduced by a syringe pump at 3 pL/min into a Finnigan LCQ ion trap mass
spectrometer using electrospray ionization (ESI) in the positive ion mode as the method
of detection.
Lyophile Characterization
Water Content: Lyophiles were analyzed for water content post-lyophilization
and at the end of the kinetic experiments by a Karl-Fischer titration (Metrohm,
Riverview, FL). Samples (15 mg) were dissolved in approximately 400-600 pL of
anhydrous dimethylsulfoxide (DMSO, Acros Organics, Morris Plains, NJ) for analysis
and the water determined from the same volume of a DMSO blank was subtracted.
Samples were analyzed in triplicate and the average value is reported.
Reconstituted solution pH:

Lyophiles were reconstituted with the original fill

volume (100 pL) of deionized water both at the beginning and end of kinetic
experiments. pH measurements were taken using a MI-40 combination micro-pH probe
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(Microelectrodes, Inc., Bedford, NH) attached to a Beckman pHI 40 pH Meter (Brea,
CA).
Polarized Light Microscopy: Lyophile formulations A and B were analyzed by
polarized light microscopy post-lyophilization and after incubation at 40 °C and 40%
relative humidity over the time course of the experiment. Cakes were removed fi-om their
original vial, placed on a glass slide and dispersed with silicon oil to isolate three
different regions that were then covered with a glass coverslip and examined for
crystallinity using a polarizing microscope (Olympus BX51) equipped with a 522 nrn
filter.

Results
HPLC Analyses
Shown in Figure 4-2 are HPLC chromatograms illustrating the baseline separation
of Gly-Phe-L-Asn-Gly and its degradation products after storage of formulation A at 40
°G/40% RH for 22.5 hours (upper chromatogram), the same formulation at tzero (middle
chromatogram), and a blank formulation without Gly-Phe-L-Asn-Gly (lower
chroTfiatogram). A total of 10 degradants (i.e., D- and L-succinimides, D- and Lisoaspartates and aspartates, and four covalent Gly-Phe-L-Asn-Gly/Gly-Val adducts)
could be monitored using this separation method. With the exception of the covalent
adducts, identification of each peak was confirmed by comparing retention times against
synthetic standards.
Separation of the D- and L-isoaspartates, aspartates, and succinimides fi-om GlyPhe-L-Asn-Gly was achieved in the isocratic mode by optimizing the pH of the buffered
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aqueous solvent system. At pH values near 4.1, Gly-Phe-L-Asn-Gly was relatively
unaffected by changes in the mobile phase pH, allowing the selection of a pH where the
more negatively charged isoaspartates eluted before Gly-Phe-L-Asn-Gly and the
aspartates eluted after, due to their greater hydrophobicity

At a pH of 4.1, the

isoaspartates elute first due to their greater negative charge. While both isoaspartates and
aspartates have an additional ionizable -COOH, isoaspartates have a lower pKa
compared to their aspartate counterparts

Using software fi-om Advanced Chemistry

Development, Inc., the pKa of the aspartyl a-COOH in Gly-Phe-isoAsp-Gly is predicted
to be 2.96 compared to a value of 4.28 for the P-COOH in Gly-Phe-Asp-Gly. Thus, at
pH 4.1, the P-COOH in aspartate-containing peptides is mostly protonated and the
compounds are retained longer in reversed phase chromatography. Changes in pH had
little effect on separation of the diastereomeric pairs (e.g., Gly-Phe-D-Asp-Gly and GlyPhe-L-Asp-Gly). The chromatographic separation of the D- and L-succinimides is more
clearly illustrated in Figure 4-3.
As shown in Figure 4-2, four peaks eluting at later retention times (23-27
minutes) were observed after lyophiles containing Gly-Phe-L-Asn-Gly were incubated at
40 °C/40% RH for 22.5 hr. These were identified (see below) as covalent adducts of
Gly-Phe-L-Asn-Gly with Gly-Val. Achieving elution of the four covalent adduct peaks
within a reasonable time fi-ame required an increase in acetonitrile percentage fi-om 0% to
5%, which could be accomplished using a step gradient at 16 min. The four adduct peaks
were well resolved within a pH range of 3.9 to 4.2 while mobile phase pH values outside
of this range resulted in partial co-elution of two or more peaks.
Covalent Adduct Characterization
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The four unknown degradants having retention times between 23-27 min (Figure
4-2) were postulated to be products of Gly-Val attack on L- and D-succinimide
intermediates formed from Gly-Phe-L-Asn-Gly. To further test this hypothesis,
lyophiles containing either the L- or D-succinimide (i.e., Gly-Phe-L-Asu-Gly or Gly-PheD-Asu-Gly) were prepared in the same formulation as that employed for the stability
study of Gly-Phe-L-Asn-Gly in Figure 4-2, stored for two hours at 27 °C and 75% RH,
and monitored by HPLC. As shown in Figure 4-3, the same degradant peaks observed in.
Figure 4-2, apart from the succinimides themselves, were detected when the starting
reactant was either the L- or D-succinimide. Breakdown of the L-succinimide (Figure 43A) resulted in the formation of the two major hydrolysis products, Gly-Phe-L-Asp-Gly
and Gly-Phe-L-isoAsp-Gly, and two major adduct peaks at relative retention times (RRT)
of 3.6 and 3.9 (normalized to the retention time of Gly-Phe-L-Asn-Gly). Gly-Phe-D-AspGly and Gly-Phe-D-isoAsp-Gly and two minor adduct peaks were also detected (Figure
4-3A). Similarly, when the D-succinimide was incubated under the same conditions the
rnajor degradants were Gly-Phe-D-Asp-Gly and Gly-Phe-D-isoAsp-Gly with smaller
amounts of their L-counterparts, along with two major adduct peaks with RRTs of 3.7
and 4.1 (Figure 4-3B) and two minor adduct peaks. These results are consistent with
partial racemization of the succinimides concurrent with hydrolysis and covalent adduct
formation.
To tentatively assign a primary sequence to each adduct peak, fractions of the
individual peaks were collected and analyzed by electrospray mass spectrometry. The
mass spectrum of each HPLC peak indicated a molecular ion at m/z of 551 (M+H^)
consistent with the expected molecular weight for covalent adducts between Gly-Val and
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either an L- or D-succinimide. Fragmentation analysis by MS/MS (Figure 4-4) indicated
similar fragmentation patterns for the two peaks with RRTs of 3.6 and 4.1 (panels A and
D) and similar patterns for the peaks with RRTs of 3.7 and 3.9 (Panels B and C). The
intensities of several peaks in the fragmentation pattern differ significantly between the
two sets of spectra (e.g., 377 and 476 amu) and may offer insight as to the structure of
each adduct. Lehmann et al.

assumed that fragmentafion.of peptides occurs primarily

between the amide bonds of the peptide backbone, as facilitated by the formation of a
five-membered oxazolone ring formed via intramolecular attack by the carbonyl oxygen
on the N-terminal side of the peptide linkage undergoing cleavage. Incorporation of a
methylene group into the peptide backbone in an isoaspartyl peptide hinders this
fragmentation pathway as the intramolecular reaction would then involve formation of a
less favored six-membered ring.
The above concept was applied to the MS/MS patterns from each covalent adduct
peak in an attempt to obtain information pertaining to the primary sequence. Figure 4-5
illustrates the structures of the two adducts formed from Gly-Val attack at either the P- carbonyl (Figure 4-5A) or the a-carbonyl (Figure 4-5B) of Gly-Phe-L-Asu-Gly or GlyPhe-D-Asu-Gly. As illustrated in Figure 4-5A, intramolecular attack by the adjacent Nterrriinal side carbonyl oxygen would be expected to favor formation of a five-membefed
oxazolone ring fragment (m/z = 476 Da) over the six-membered ring (m/z = 377 Da),
while in Figure 4-5B, the same preference for a five-membered oxazolone ring would be
expected to shift the ratio in favor of a fragment having a mass of 377 Da. An
examination of panels A and D in Figure 4-4 reveals a strong preference for the 476 Da
fragment compared to the fragment at 377 Da, consistent with the above expectations.
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while the ratio of these peaks in panels B and C of approximately one indicates a distinct
shift in favor of the 377 Da fragment. The 377 Da fragment reflecting loss of Gly-Val
does not become dominant over the 476 Da fragment in panels B and C possibly due to
other avenues for Gly removal in the adducts. This leaves some uncertainty in the
structure assignments.
Combining the mass spectrometry data and HPLC degradation profiles for the Land D-succinimides allowed each peak in Figure 4-3 to be assigned a primary sequence.
Accordingly, peaks with RRTs of 3.6 and 4.1 were tentatively assigned the sequence
shown in Figure 4-5A with the L- diastereomer eluting at a RRT of 3.6 and the Ddiastereomer at RRT 4.1. The peaks with RRTs of 3.7 and 3.9 were then assigned the
primary sequence in Figure 4-5B with the D- and L-diastereomers eluting at 3.7 and 3.9,
respectively. The structures assigned for all compounds of interest in this study are listed
in Table 4-2 along with their relative retention times (RRT = 1.0 for Gly-Phe-L-Asn-Gly).
Determination of Relative Response Factors
The purity of each reference peptide was estimated based on the assumption that
chromatographic molar response factors of each peptide are equal at 257 nm, as only the
phenylalanine residue contributes to the UV absorbance at this wavelength.
Consequently, the dipeptide Gly-Val does not exhibit a UV absorbance at 257 nm. To
maximize the sensitivity of the HPLC assay for kinetic studies, a wavelength of 220 nm
was selected. Relative response factors in relation to Gly-Phe-L-Asn-Gly for each
peptide were therefore also determined at 220 nm taking into consideration the purity of
each peptide. These results are shown in Table 4-2 along with the compound identities
and relative retention times. Isoaspartate response factors were higher and those for
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aspartates were lower when compared to Gly-Phe-L-Asn-Gly which is consistent with
previous reports in which response factors of Asn, Asp, and iso Asp-containing peptides
have been compared

Generally, molar response factors at 220 nm increase with an

increase in the number of peptide bonds contributing to the overall absorbance
accounting for the increase in response factors of the covalent adducts. The contribution
of a succinimide residue to the response factor at 220 nm appears to be significantly
higher than that of a normal peptide bond.
Characterization of Lyophiles Employed in Kinetic Experiments
Immediately after lyophilization, both formulations yielded white solid cakes
occupying the same volume as the original solutions from which they were ffeeze-dried.
After exposure to 40 °C/40% RH for over 24 hours formulation A samples were
unchanged in appearance while formulation B lyophiles exhibited partial shrinkage to
approximately 50% of their original fill height. The pH of reconstituted samples post
lyophilization and at the end of kinetic experiments remained constant for both
formulations. The average pH values for formulations A and B were 9.56 ± 0.01 and
9.60 ± 0.02, respectively. Polarized light microscopy indicated that samples of
formulation A were completely amorphous and remained so after exposure to 40 °C/40%
RH. Slight evidence of birefi-ingence was detected in formulation B lyophiles postlyophilization, which became increasingly apparent after storage at 40 °C/40% RH
(results not shown). This was attributed to partial crystallization of Gly-Val that
continued to increase with time. Moisture contents in lyophiles were determined by the
Karl-Fischer titration method. Inorganic oxides, including carbonate, are known to
contribute a stoichiometric amount of water to the apparent water content determination
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by Karl-Fischer titrations

. This was verified in our studies by comparing the apparent

water content in vacuum dried Gly-Val/carbonate lyophiles varying in carbonate content
with lyophiles containing only Gly-Val. The contribution of carbonate buffer was
therefore subtracted from the apparent water content determined for formulation A. After
equilibration at 40% RH, water content was very similar for both formulations (16.9 ±
1.6% in formulation A and 14.0 ± 1.7%, in formulation B) and was unchanged at the end
of the kinetic studies. Based on these results, the most significant difference between tfie
two formulations was the partial crystallization of Gly-Val in formulations containing
higher concentrations of Gly-Val. The theoretical compositions of each lyophile are
summarized as weight percentages in Table 4-1 (after equilibration at 40% RH).
Kinetics of Gly-Phe-L-Asn-Gly Deamidation and Degradant Formation
Lyophile formulations A and B were stored at 40 °C/40% RH and reconstituted to
their original solution volume at various times for HPLC analysis. The concentration
oyer time for the duplicate preparations of formulation A is shown in Figures 4-6A and 4'6G. The concentration of the adducts and hydrolysis degradants, along with Gly-Phe-LAsn-Gly, are almost identical. This indicates that the variability between formulations on
the total amount of adduct or aspartates formed is minimal. However, there is some
pbservable variability in the succinimide concentration over time which directly
correlates to larger confidence intervals in the calculated rate constant. The average
confidence limit is for formulation A prepared in duplicate is approximately 29% of the
calculated value compared to 22% for the single preparation of formulation B.
Therefore, the precision of the calculated rate constants showed no improvement for
formations prepared in duplicate.
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Shown in Figures 4-6A and B are the Gly-Phe-L-Asn-Gly and degradant
concentrations in the two formulations plotted versus time on a semi-log scale. The
degradant concentrations are shown on a linear scale in Figure 4-6C and D. For clarity
and to illustrate the competition between hydrolysis and covalent adduct formation, the
D,- and L- isoaspartate and aspartate concentrations were combined and represented in
Figure 4-6 as “aspartates” while the four covalent adducts were summed together and
displayed as “adducts”. These degradants accounted for the bulk of the products forrhed
from the degradation of Gly-Phe-L-Asn-Gly over the first ~25% decomposition as
supported by the finding that the mass balances within this window were >95%.
As evident in Figure 4-6, the succinimide concentrations in either formulation
remained at a steady-state concentration of ~1% of the starting peptide concentration
throughout the experiments, indicating that the succinimide is a reactive intermediate and
that its formation is rate-determining. Aspartates were the dominant products formed in
formulation A (Figure 4-6C), in which the Gly-Val concentration was present at an ~8fold molar excess over Gly-Phe-L-Asn-Gly, while in formulation B containing a ~30-fpld
mofar excess of Gly-Val, covalent adduct formation dominated (Figure 4-6D).
Differential equations based on Figure 4-1 were used to simultaneously fit the
Gly^Phe-L-Asn-Gly, succinimide, aspartates and covalent adduct concentrations versus
time as illustrated by solid lines in Figure 4-6. The excellent fits provide support for the
applicability of the reaction pathways described in Figure 4-1 to the degradation of GlyPhe-L-Asn-Gly in these solid-state lyophile formulations. Pseudo-first order rate
constants for the disappearance of Gly-Phe-L-Asn-Gly and the formation of aspartates
and adducts were calculated based on Figure 4-1 as summarized in Table 4-3. The

104

estimated rate constants for succinimide formation (0.01 hr ) were not significantly
different in the two formulations and the overall rate of breakdown of the succinimide
also did not differ significantly. However, the rate constants for succinimide hydrolysis
and covalent adduct formation were highly sensitive to formulation. In formulation B
where the Gly-Val concentration was far in excess (i.e., 30-fold) of the Gly-Phe-L-AsnGly concentration, the rate constant for covalent adduct formation exceeded that for
imide hydrolysis by >10-fold when both were expressed in first-order units. In contrast,
the lower Gly-Val concentration in formulation A resulted in a commensurate reduction
in the rate constant for covalent adduct formation. This can be rationalized by
considering the dilution effect expected for a bimolecular reaction as illustrated by Eq. 5.
d[Adduct]
dt

= kadduct[Glyy(^l]yT^ide]

(5)

When the differences in Gly-Val concentration were taken into account by calculating 2

nd

order rate constants for covalent adduct formation, the bimolecular rate constants were
similar, suggesting that covalent adduct formation is first-order in the solid-state
concentration of Gly-Val. The pseudo first-order rate constant for succinimide hydrolysis
increased significantly in formulation A compared to formulation B, despite the fact that
the water content in the two lyophiles was simitar.

Discussion
Deamidation Pathway in Amorphous Lyophiles
Although quantitative differences have been noted, most mechanistic comparisons
of the pathways for deamidation of asparagine-containing peptides in aqueous solutions
and amorphous solids have concluded that deamidation proceeds through a succinimide
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intermediate in both cases except perhaps at low pH. In aqueous solutions from
approximately pH 5-12, cyclic imide intermediate

formation is the rate-determining

step and leads to a mixture of L- and D-aspartyl peptides and isoaspartyl peptides
Primary structure is very important in determining the rates of succinimide formation
with reactions at X-Asn-Gly- sequences being particularly favorable

Ratios of

isoaspartyl/aspartyl hydrolysis products in aqueous solution typically range from 3:1 to
4:1, reflecting more favorable water attack at the a-carbonyl of the succinimide. Geiger
and Clarke, for example, found that deamidation of a model hexapeptide Val-Tyr-Pro-LAsn-Gly-Ala at pH 7.4 and 37 °C produced approximately 71% L-hydrolysis products
with an isoaspartyl/aspartyl ratio of 3.6 and 29% D-hydrolysis products with an
isoaspartyl/aspartyl ratio of 3.1. Patel and Borchardt explored the pH dependence for
deamidation of the same hexapeptide from pH 5-12 in various buffers and obtained
isoaspartyl/aspartyl peptide ratios that were nearly constant with pH, ranging from ~3.5 at
pH 6 to 4.2 at pH 12 and comparable to the ratios obtained when using the cyclic imide
as the starting reactant

The detection of isoaspartyl peptides is often taken as evidence

for the involvement of a succinimide intermediate, as this is the only known pathway
leading to these products. Moreover, the nearly identical isoaspartyl/aspartyl product
ratios found by Patel and Borchardt when starting with either the Asn-containing peptide
or the succinimide suggests that deamidation proceeded entirely via this intermediate
under the conditions employed in that study. The extent to which racemization in
aqueous solutions is mediated by the cyclic imide, as originally proposed by Geiger and
Clarke

is less clear. Li et al.

found partial racemization of Gly-Gln-L-Asn-Glu-Gly

(GQ-L-Asn-EG) to GQ-D-Asn-EG and vice versa during deamidation at pH 10 and 70
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°C, which they attributed to tetrahedral intermediate involvement in the racemization.
Regardless, there is no dispute that racemization occurs along the cyclic-imide-mediated
reaction pathway ultimately leading to deamidation.
Lai and Topp ^ noted that the mechanisms for peptide deamidation in amorphous
lyophiles appear to be similar to those in solution but with some significant quantitative
differences. For example, Oliyai et al."*^ detected cyclic imide formation in amorphous
solids during deamidation of the same hexapeptide originally explored by Geiger &
Clarke, but were unable to find the isoaspartyl hydrolysis product. Lai et al.

examined

the stability of this hexapeptide in poly(vinyl alcohol) and poly(vinyl p}^olidone) (PVP)
glassy state formulations and were able to detect the isoaspartyl hydrolysis product as one
of the dominant degradants along with the succinimide, again consistent with a cyclic
imide mediated pathway. Song et al.

monitored the same reaction in PVP as a function

of effective ‘pH’ in both glassy and rubbery states, defined as the pH measured in
aqueous solution either prior to lyophilization or after reconstitution. At ‘pH’>5 and 70
°C, the isoaspartyl/aspartyl deamidated product ratios were in the range of 3.0-5.0 in
rubbery PVP solids, glassy PVP solids, and in solution, again suggesting that cyclic imide
formation plays a central role in the deamidation of this peptide in both solution and
amorphous solid formulations.
As demonstrated in Figure 4-2, the degradation of Gly-Phe-L-Asn-Gly in
amorphous lyophiles resulted in the formation of both L- and D-succinimides as well as
the L- and D-isoaspartyl and aspartyl hydrolysis products (i.e., four hydrolysis products).
Plots in Figure 4-6 for the formation of aspartates from Gly-Phe-L-Asn-Gly in amorphous
lyophiles stored at 40 °C/40% RH could be fit by the model described in Figure 4-1,
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which assumes that aspartates form via a cyclic imide intermediate. While
isoaspartyl/aspartyl product formation rates were not a focal point of this study, a more
detailed kinetic model that ineludes all degradant species is being developed (to be
published). Preliminary results indicate that the isoaspartyl to aspartyl formation rate
constant ratios in amorphous lyophiles under the conditions described herein are 2.6 and
2.2, respectively, from the L- or D-succinimide. Both primary sequence in peptides
and the local microenvironment resulting from the three-dimensional structure in proteins
can influence the ratios of products formed from deamidation. Likewise, the local
microenvironment within amorphous lyophiles may also influence this ratio. The finding
that the same four hydrolysis products are formed in approximately the same ratios when
starting from either the intact L-Asn containing tetrapeptide or its corresponding Lsuecinimide, combined with the excellent fits of the data obtained when applying the
model in Figure 4-1 to fit the concentration versus time data in Figure 4-6, establish that
the deamidation of the tetrapeptide occurs via a succinimide mediated mechanism in the
amorphous solid formulations explored herein.
Covalent Adduct Formation between Gly-Phe-L-Asn-Gly and Gly-Val in
Amorphous Lyophiles
Our own previous finding that deamidation at the A-21 asparagine residue in
insulin is accompanied by covalent amide-linked dimer formation and that both the
aspartate hydrolysis product and covalent dimers form via a highly reactive cyclic
anhydride intermediate

led to the hypothesis that similar opportunities for covalent,

amide-linked aggregate formation may be available for reactions that involve reactive
cyclic imide intermediates, even though cyelic imides are less reactive than cyclic
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anhydrides. Given this possibility, it is curious that there are few reports in the literature
outside of those pertaining to insulin in which amide-linked covalent aggregates have
been identified. Some reports of non-reducible aggregate formation have considered the
possibility for succinimide intermediate involvement, as summarized below, but have
offered no mechanistic proof
Paranandi et al.

reported that deamidation of synapsin leading to

isoaspartate formation in pH 7.4 buffers at 37 °C was accompanied by intermolecular
cross-linking reactions to produce both reducible, disulfide linked aggregates as well as
non-reducible, irreversible aggregates. The authors speculated that the non-reducible
aggregates may have been due to lysinoalanine cross-linking to dehydroalanine formed
by via p-elimination in cystine residues but they also offered another possibility - that the
covalent aggregate formation may have been linked to isoaspartate formation. Thus, they
postulated that intermolecular nucleophilic attack by the e-amino group of a lysine
residue in one synapsin molecule at either the a- or P-carbonyl of a succinimide
intermediate on a second synapsin molecule could be the source of the non-disulfide
linked aggregates.
Stabilization of phage capsid proteins such as phage HK97 occurs through
covalent amide cross-linking between lysine residues and Asn^^^ side-chains of adjacent
subunits. Such cross-links may be widespread in gram-positive bacteria

Wikoff et al.

suggested that this reaction may be mediated through cyclic imide formation fi-om
asparagines followed by nucleophilic attack by lysine. Glu^^^ is a critical catalyst for this
reaction, which the authors suggested may increase the nucleophilicity of the backbone
amide nitrogen of the Asn

. However, Dierkes et al.
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advocated an alternative

mechanism involving direct Glu

■> z

assisted lysine attack on the amide side-chain of

Asn^^^ because they were unable to find any compelling evidence for the presence of
succinimide.
In 2002, Simons et al.

demonstrated that storage of lyophiles produced fi'om a

pH 7 solution of RNase A under vacuum at 85 °C for successive 24 hr periods resulted in
the formation of covalent cross-linking to form dimers, trimers, and tetramers. This
“zero-length” cross linking was attributed to the formation of intermolecular amide bonds
between residues on different RNase molecules that were located in close proximity to
each other in the lyophiles. The yield of covalent dimers was approximately 30% but in
the presence of increasing ratios of the excipient trehalose, dimer formation was reduced
dramatically. Despite the known involvement of Asn and Gin deamidation in the
instability of RNase A at pH 7, ^ cyclic imide involvement was not considered. Maroufi
et al.

later employed the same method to produce an amide-linked dimer of hen egg-

white lysozyme.
The recent observation of a linear relationship between the quantity of dimers
formed and the % of succinimide in fi-eeze-dried lysozyme powder stored for up to 7 days
at 80 °C

is the most definitive evidence we had seen, prior to our own work, suggesting

a role for this intermediate in covalent aggregate formation. The formation of covalent
adducts in amorphous lyophiles of Gly-Phe-L-Asn-Gly in the presence of excess
quantities of Gly-Val found in the present study directly demonstrates that succinimide
formation can lead to nonreducible, covalent amide-linked peptide aggregates.
As illustrated in Figure 4-2, in addition to the normally expected degradants
produced by succinimide formation, racemization, and hydrolysis, four covalent adducts
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were also observed during storage of amorphous lyophiles of Gly-Phe-L-Asn-Gly in the
presence of excess Gly-Val under accelerated storage conditions (40 °C and 40% RH).
Each adduct exhibited a molecular ion ((M+H)^ = 551 Da) by electrospray mass
spectrometry consistent with the combination of Gly-Phe-L-Asn-Gly and Gly-Val (minus
a molecule of water). Tandem MS/MS analysis (Figures 4-4 and 4-5) also indicated
fragmentation patterns consistent with Gly-Val attack at either the a- or P-carbonyls of
Gly-Phe-L-Asu-Gly or Gly-Phe-D-Asu-Gly. These fragmentation patterns, along with the
results in Figure 4-3 showing that adduct peaks 1 and 3 originate from Gly-Phe-L-AsuGly and adduct peaks 2 and 4 predominate when Gly-Phe-D-Asu-Gly is the initial
reactant, enabled us to tentatively assign the structures indicated in Figure 4-2 and Table
4-2. The number of adducts was limited to just four by the use of an excess of Gly-Val,
which minimized the extent to which Gly-Phe-L-Asn-Gly dimers, trimers, etc. could
form.
Under the experimental conditions described, covalent adducts form exclusively
through the succinimide intermediates generated during deamidation of asparagines as
supported by the following observations: 1) The same products, including adducts, are
produced when the initial reactant is Gly-Phe-L-Asn-Gly, Gly-Phe-L-Asu-Gly; or GlyPhe-D-Asu-Gly; and 2) the kinetic model in Figure 4-1 is successful in simultaneously
fitting concentration vs. time data in Figure 4-6 for the disappearance of Gly-Phe-LAsn-Gly, succinimide intermediates, isoaspartate and aspartate hydrolysis products
resulting from succinimide hydrolysis, and covalent adducts forming from reaction of the
succinimide with Gly-Val in two formulations varying in the amount of excess Gly-Val.

Ill

Kinetics and Succinimide Intermediate Partitioning to Hydrolysis Products or
Covalent Adducts - Effect of Giy-Val Dilution in Lyophiles
The complexity and multi-step nature of the reactions involved in peptide
deamidation and covalent adduct formation, even when using a simplified model such as
that depicted in Figure 4-1, suggests that attempts to interpret reaction rates or relative
amounts of degradant production based solely on the notion that reactivity should be
coupled to mobility as measured by various structural relaxation parameters

may fall

short of expectations. A detailed examination of the parameter values generated from the
application of the model in Figure 4-1 to the kinetic data in Figure 4-6, as listed in Table
4-3, suggests that attempts to rationalize changes in reactivity in amorphous solids in
terms of a coupling constant to molecular mobility should consider each reaction step
separately as well as the nature of each step. In the two formulations being compared, the
rate constants for rate-determining formation of succinimide did not differ significantly,
despite the fact that partial collapse and partial crystallization of Gly-Val in lyophile
formulation B were observed after exposure to 40% RH while no changes were detected
in formulation A, suggesting greater structural relaxation and mobility in formulation B.
Given that succinimide formation is an intramolecular reaction involving only local
conformational changes (although ammonia diffusion away from the reaction site must
ultimately occur), perhaps it would not be surprising that motions governing structural
relaxation may not be relevant. It is more likely that a bimolecular reaction, such as the
attack of Gly-Val on the succinimide, would exhibit a greater degree of coupling to
mobility. However, the differences in apparent first-order rate constants for covalent
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adduct formation could be adequately accounted for by a dilution effect (Eq. 5 and Table
4-3), without regard to mobility.
Amorphous lyophile formulations differ from aqueous solutions both in terms
reactant mobility but also with respect to their chemical microenvironment (i.e., proteins
and excipients employed in such products would create a solvent environment most
closely resembling polar organic solvents). Severs & Froland recently explored organic
solvents to stabilize a 31 amino acid containing polypeptide that underwent deamidation
in aqueous solution at two Asn residues, with the expectation that stability in an organic
solvent would be superior

Instead, in DMSO they observed the formation of multiple

covalent dimers and higher order multimers. The hjqjothesis advanced by the authors
was that cyclic imides could form from either the two Asn or two Asp residues in the
molecule followed by nucleophilic attack by one of nine possible nueleophiles (including
lysine, serine, and threonine residues), thus generating a large number of reaction
products, including dimers, polymers, cyclic imides, and conformational isomers.
Possibly, eovalent aggregates are seldom detected or identified in Asn-containing
peptide and protein lyophiles during long-term storage because the population of covalent
aggregates generated may be widely distributed among numerous reaction products.

Conclusion
Kinetic studies of the decomposition of a model asparagine-containing peptide in
amorphous lyophile formulations in the presence of an excess of a second peptide (GlyVal) demonstrated that deamidation and racemization proceed through a succinimide
intermediate. Moreover, a total of ten degradants were monitored, four of which were
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characterized as covalent adducts resulting from the attack of Gly-Val on the D- and Lsuccinimide intermediates. The same degradant profiles were found in lyophile
formulations containing the succinimide as the starting reactant. A model based on the
assumption that the succinimide lies on the reaction pathway for formation of all
degradants was quantitatively consistent with the kinetic data. The reaction pathways
presented in this study suggest a potentially important mechanism for the formation of
non-reducible, covalent aggregates in lyophilized protein and peptide formulations.
While factors that affect molecular mobility (e.g., excipients, water content, etc.) clearly
need to be considered in predicting or at least rationalization reaction rates and degradant
profiles in solid-state formulations, the observations herein highlight the importance of
the underlying chemistry and the complexity of drug degradation processes in solid-state
formulations, most of which involve one or more reactive intermediates and multiple
reaction steps that may vary in reaction order.
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Table 4-1. Composition of Gly-Phe-L-Asn-Gly lyophile formulations prepared
for kinetic studies. Water contents measured are post-lyophilization and at the
end of the kinetic study after correction for the carbonate contribution to
apparent water content.

Formulation A
(~8x Gly-Val molar excess)
moles/L“
w/w
2.92%
0.096
9.88%
0.738
21.5%
9.27%
39.5%
0.895%

Formulation B
(~30x Gly-Val molar excess)
moles/L“
w/w
0.098
2.94%
39.2%
2.93

Ingredient
Gly-Phe-L-Asn-Gly
Gly-Val
Carbonate
—
—
Sodium
4.46%
38.5%
HPMC
0.902%
TFA
Water content;
2.4 ± 0.6%
3.5 ±0.7%
Initial
—
@ 40% RH
16.9 ± 1.6%
14.0 ± 1.7%
PH^
9.60
9.56
^Molar concentrations were estimated by assuming a solid density of 1.3 g/mL;
^pH after reconstitution in deionized water
—

—

—

—

—

—

—

—

—
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Table 4-2. Relative HPLC retention times and response factors at 220 nm for
the ten degradation products monitored in degraded formulations of Gly-PheL-Asn-Gly. Retention times and response factors were normalized to those for
Gly-Phe-L-Asn-Gly, which exhibited a retention time of 6.75 min.

Peptide
Gly-Phe-L-Asn-Gly (RT = 6.75 min)
Gly-Phe-L-isoAsp-Gly
Gly-Phe-D-isoAsp-Gly
Gly-Phe-L-Asp-Gly
Gly-Phe-D-Asp-Gly
Gly-Phe-D-Asu-Gly
Gly-Phe-L-Asu-Gly
Gly-Val
1
G ly-Phe-(L-Asp)-G ly
Gly
1
Gly-Phe-(D-Asp)-Gly-Val
Gly
1
Gly-Phe-(L-Asp)-Gly-V al
Gly-Val
Gly-Phe-(D-Asp)-Gly
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Relative
Retention
Time

Relative
Response Factor
@ 220 nm

1.0
0.77
0.87
1.1
1.4
2.0
2.1

1.00
1.15
1.17
0.871
0.794
1.47

3.6
3.7
1.39
3.9
4.1

Pseudo-First Order
Rate Constants (hr^)
Parameter

Formulation A*

Fonnulation B

ISiwds
(Gly-Phe-L-Asn-Gly —* Imide)

0.0104
(0.008-0.013)

0.0106
(0.009-0.0119)

Hasp,
(Imide ^ Aspartates)

1.35
(0.95-1.76)

0.109
(0.065-0.152)

HaddiKt,
Adducts)
(Imide

0.36
(0.25-0.47)

1.38
(1.20-1.57)

Second Order
Rate Constants (M‘^ hr‘^)
Fonnulation A

Fonnulation B

0.49
(0.34-0.65)

0.47
(0.41-0.54)

*Rate constants represent the calculated value from the simultaneous fit of duphcate
fonnulations

Table 4-3. Rate constants for the parameters described in Eqs. 1-4 and Figure 4-1 generated from kinetic studies of
lyophilized formulations A and B at 40 °C/40% RH. Rate constants were assumed to be first-order or pseudo-first
order with units of hr‘'. For covalent adduct formation, 2"^* order rate constants were also generated by dividing firstorder rate constants by the calculated molai' concentrations of Gly-Val in the two formulations (Table 4-2). 95%
confidence intervals are reported in parentheses.

Aspartates

Gly-Phe-Asn-Gly
(GFNG)

Imide Intermediate
+ Gly-Val
'adduct

Adducts
Figure 4-1. Simplified model used to generate rate constants for the formation
of the succinimide intermediate from Gly-Phe-L-Asn-Gly, imide hydrolysis to
form aspartates, and covalent adduct formation from the reaction the
succinimide with Gly-Val.
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Figure 4-2. Overlay of HPLC chromatograms generated at 220 nm. Peak at ~18 min was due to
the step gradient at 16 min. Lower chromatogram: blank formulation without Gly-Phe-L-Asn-Gly.
Middle chromatogram; Gly-Phe-L-Asn-Gly formulation A at Lero- Upper chi'omatogram: GlyPhe-L-Asn-Gly formulation A after storage for 22.5 hr at 40 °C and 40% relative humidity
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Figure 4-4. MS/MS fragmentation patterns for the individual adduct peaks at RRT 3.6
(A), 3.7 (B), 3.9 (C), and 4.1 (D). Similar fragmentation patterns are observed between
Panels A and D and between Panels B and C. The fragmentation patterns suggest that the
peptides at RRT 3.6 and 4.1 are structurally similar to each other and significantly
different than the peptides at RRT 3.7 and 3.9. The tentative primary sequences assigned
are listed in Table 4-2.
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oxazinone
(377 Da)

V

(476 Da)
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Figure 4-5. Proposed structures (left) of the L- or D-adducts formed by attack
of Gly-Val at the P* (A) or a- (B) carbonyls of the L- or D-succinimide
intermediates (Gly-Phe-Asu-Gly). The chiral carbon where the changes in
stereochemistry occur is circled. Labeled as a and p are points where peptide
fragmentation may produce the fragments shown along with their molecular
weights.
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Figure 4-6. Concentrations of Gly-Phe-L-Asn-Gly (*), succinimide (•), Land D-aspartate and isoaspartate hydrolysis products (A) and L- and Dcovalent adducts (■) in lyophile formulations as a function of time at 40
°C/40% RH. Concentrations in lyophiles of formulation A prepared in
duplicate and single preparation of formulation B are displayed
semilogarithmically in panels A and B, respectively. Shown in Panels C and D
are the degradant concentrations from formulations A (in duplicate) and B
(single), respectively, on a linear scale.
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CHAPTER 5 - A MECHANISM-BASED KINETIC ANALYSIS OF SUCCINIMIDE
MEDIATED DEAMIDATION, RACEMIZATION, AND COVALENT ADDUCT
FORMATION IN A MODEL PEPTIDE IN AMORPHOUS LYOPHILES

Introduction
Proteins and peptides are often formulated as amorphous lyophiles to maximize
stability compared to aqueous solutions and to provide solids that can be readily
reconstituted prior to administration. While processes involved in physical and chemical
degradation may be significantly slower in the amorphous solid-state, they are not
completely arrested. The development of reliable quantitative methods to predict long
term stability of drugs in lyophilized and other amorphous solid formulations fi’om
kinetic data generated over short periods of time under accelerated conditions continues
to be an active area of investigation.
For reactions in solution, mechanism-based kinetic models and the rate equationsderived therefrom are often used to describe the influence of various factors on reactivity,
including drug concentration, pH, temperature, and formulation components. In contrast,,
publications in the pharmaceutical literature that attempt to address reaction kinetics in
amorphous systems quantitatively typically assume that molecular mobility is an
overriding factor, such that reactivity will be coupled to one or more indicators of
structural relaxation such as the glass transition temperature or relaxation times generated
from methods such as dielectric analysis' or NMR.^ For example. Sun et al found that
the Williams-Landel-Ferry (WLF) empirical equation relating relaxation processes in
amorphous polymers to temperature^ was useful in describing deviations from the
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Arrhenius equation observed in the inactivation of glucose-6-phosphate dehydrogenase at
temperatures below or above Tg/ Yoshioka et al^ observed that the rates of the Maillard
reaction and acyl transfer processes in lyophilized formulations containing various
polymeric excipients increase with a decrease in Tg of the formulations. Below Tg, the
variation in reaction rates with temperature was found to correlate with the temperature
dependence of structural relaxation times calculated using the Adam-Gibbs-Vogel
equation. Several groups have found that the empirical Kohlrausch-Williams-Watts
(KWW) equation used to describe heterogeneous relaxation in amorphous solids can be
applied to chemical degradation in amorphous solids as well as physical processes such
as protein aggregation.^'^
While reactant and matrix mobility are clearly important considerations, the
degree to which chemical degradation may be coupled to structural relaxation is likely to
depend on the nature of the rate-determining step.'*^ Such observations serve as a
reminder that despite the increased importance of molecular mobility in solid-state
formulations, the underlying reaction chemistry and mechanistic details are still critical in
determining both the rates of degradation and the degradants formed. Most chemical
degradation pathways of pharmaceutical relevance involve the generation of one or more
reactive intermediates. Consider, for example, some of the important pathways for
peptide and protein degradation. Peptide and protein deamidation occurs tlirough a
reactive succinimide intermediate.'' Covalent protein aggregate formation may involve
amide cross-linking mediated by succinimide'^ or anhydride intermediates,'^ '^ thioldisulfide rearrangement involving free thiol intermediates,'^ or lysinoalanine crosslinking via dehydroalanine residues generated during P-elimination of cysteine.
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The

Maillard reaction involves a Schiff base intermediate'* ultimately leading to a variety of
degradation products.
While the level of mechanistic understanding of these reactions currently
available originates largely from studies in aqueous solution, the same reaction pathways
may be operative in the amorphous solid-state. Thus, a firm understanding of the
mechanism of formation and the ultimate fate of reactive intermediates may prove useful
in predicting and explaining differences in reaction kinetics in amorphous solids when
compared to solutions. This has been a pursuit in several recent studies published from
the authors’ laboratories. For example, Luo and Anderson demonstrated that the amino
acid cysteine forms a reactive sulfenic acid intermediate in the presence of hydrogen
peroxide in aqueous solutions resulting in the ultimate formation of the disulfide cystine
when the intermediate reacts with another molecule of cysteine.

In amorphous solid

formulations, additional degradants were observed that could be traced to the same
reactive intermediate. Their preferential formation in an amorphous polymer glass was
attributed to competing reactions of the sulfenic acid intermediate with additional
molecules of hydrogen peroxide, which, due to its small size has a mobility advantage in
amorphous glasses.^® A detailed mechanism-based kinetic model was successfully
employed to account for both the decline in reactant concentrations and formation of
products as a function of time in various amorphous formulations.

Strickley and

Anderson demonstrated that covalent, amide-linked aggregates of insulin formed in
certain amorphous lyophiles via nucleophilic attack of a second insulin molecule on a
reactive cyclic anhydride intermediate.'"^ Despite the fact that covalent aggregate
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formation was in competition with hydrolysis, increasing water content increasingly
favored covalent aggregation, which was attributed to the plasticizing effects of water.
It is now well established that deamidation of asparagine residues in peptides and
proteins occurs by way of a cyclic imide intermediate, both in aqueous solutions"'^ and
in amorphous lyophiles^''^^. Quite recently we conducted kinetic studies to describe the
decomposition of a model asparagine-containing peptide in amorphous lyophiles
containing an excess of a second peptide (Gly-Val).

A total of ten degradation

products were monitored, including hydrolysis and racemization products as well as four
covalent adducts resulting from the attack of Gly-Val on the D- and L-succinimide
intermediates. The same degradant profiles were found when the succinimide was the
starting reactant in lyophile formulations, implicating the cyclic imide as the intermediate
for formation of all degradants.
In this manuscript, a comprehensive kinetic model has been developed to describe
the kinetics of degradant formation in two different Gly-Phe-L-Asn-Gly lyophile
formulations to explore the general applicability of a mechanism-based model for
rationalizing both the degradants formed as well as their relative amounts as a function of
time. This analysis highlights the potential utility of applying mechanism-based models
to reactions in amorphous glass formulations and, more specifically, the potential
importance of alternative pathways for breakdown of succinimide intermediates formed
in solid-state peptide and protein drug formulations, which can lead to a variety of
covalent adducts in addition to the normally encountered products of imide hydrolysis.

Materials and Methods
Reagents
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The peptide Gly-Phe-L-Asn-Gly and its hydrolysis products were synthesized by
GenScript (Piscataway, NJ) as trifluoroacetate salts with purities greater than 95% as
determined by HPLC. These compounds were further characterized as previously
described.The synthesis of the succinimide intermediates (Gly-Phe-D-Asu-Gly and
Gly-Phe-L-Asu-Gly) and the characterization of covalent adduct standards are described
elsewhere.^^ Hypromellose (HPMC, Methocel E5) was received as a free sample from
Dow Chemical (Midland, MI) and used as received. Gly-Val was purchased from
Bachem (Torrance, CA) as the zwitterion (purity 99.0% by TLC). HPLC grade
acetonitrile was purchased from Fisher Scientific (Springfield, NJ). Sodium bicarbonate
(ACS grade) was purchased from EM Science (Gibbstown, NJ) and succinic acid was
purchased from Aldrich (St. Louis, MO). Deionized water was used throughout the
experiments.
Preparation of Lyophile Formulations
Gly-Phe-L-Asn-Gly Formulation A: Two types of lyophile formulations were prepared as
described previously.

Formulation A lyophiles were prepared from a solution

containing the TFA salt of Gly-Phe-L-Asn-Gly (1 mM) and a 7.5-fold excess of Gly-Val
(7.5 mM) in an aqueous excipient mixture consisting of 0.5% HPMC and 0.39% sodium
bicarbonate. The formulation was adjusted to pH 9.5 with dilute sodium hydroxide prior
to lyophilization. Aliquots (100 pL) of the solution were quickly transferred into HPLC
autosampler vials, which were frozen by placing them on pre-chilled (-40 °C) shelves in a
tray freeze dryer (Virtis Advantage, Stoneridge, NY) for approximately five minutes.
Primary drying was carried out at -40 °C for 1420 minutes after which the shelf
temperature was increased at a rate of 0.2 °C /min. Secondary drying was performed at
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40 °C for 120 minutes. At each step during the freeze drying process, a constant pressure
of 100 mtorr was maintained.
Gly-Phe-L-Asn-Gly Formulation B: A separate formulation contained the same
concentration of Gly-Phe-L-Asn-Gly (1 mM) but with a greater molar excess of Gly-Val
(30-fold) in 0.5% HPMC. Sodium bicarbonate was omitted from this formulation in
order to compensate for the increased amount of Gly-Val and thereby maintain the same
concentration of Gly-Phe-L-Asn-Gly in the solid formulation after lyophilization as that
in Formulation A. Again, pH was adjusted to 9.5 with dilute sodium hydroxide.
Succinimide Formulations: Lyophiles were also prepared from 0.1 mM solutions of
either Gly-Phe-L-Asu-Gly or Gly-Phe-D-Asu-Gly in 0.5% HPMC and 30 mM Gly-Val to
approximate the composition of the Gly-Phe-L-Asn-Gly formulation B. The
concentrations of succinimide were reduced in these formulations by 10-fold relative to
the Gly-Phe-L-Asn-Gly concentrations in formulation B in an attempt to partially account
for the fact that cyclic imide concentrations in formulations of Gly-Phe-L-Asn-Gly
remain at a low-steady state relative to Gly-Phe-L-Asn-Gly. These formulations
contained a 300-fold molar excess of Gly-Val relative to the succinimides.
Lyophile Characterization
Water Content: Post-lyophilization, cakes were placed in a vacuum oven and dried at 50
°C under a maximum vacuum to achieve a constant weight. A portion of the cake was
analyzed by suspending the cake in anhydrous DMSO. The water content was measured
by injecting the suspension into the cell of a Karl-Fisher apparatus. Carbonate buffers
contribute a molar amount of water to the measured water content in the Karl-Fisher
analysis, which was subtracted from the measured water content to obtain initial water
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contents for each formulation. The dried cakes were then placed at various relative
humidities and monitored for weight change. The change in mass after equilibration was
attributed to the absorption of water.
Reconstituted solution pH:

The pH value for lyophiles reconstituted with 100 pL of

water was determined at the beginning and end of the kinetic experiments. The average
of the two measurements is reported. The measurements were obtained on a Beckman
pHI 40 pH Meter (Brea, CA) with a MI-40 combination micro-pH probe
(Microelectrodes, Inc., Bedford, NH).
Polarized Light Microscopy. Samples of each formulation were analyzed by polarized
light mieroscopy at the beginning and end of the kinetic studies. Cakes were suspended
in silicone oil, placed on a glass slide and then covered with a glass coverslip. Samples
were then examined for crystallinity using a polarizing microscope (Olympus BX51)
equipped with a 522 nm filter.
Kinetic Studies
Lyophiles containing Gly-Phe-L-Asn-Gly in formulation A (7.5-fold molar excess
of Gly-Val) were pre-equilibrated at 75% RH (over saturated sodium chloride solution)
and ambient temperature for 15 minutes then placed in a dessicator at the same relative
humidity and 40 °C. A lower temperature and relative humidity were necessary to
monitor the reactivities of Gly-Phe-L-Asn-Gly, Gly-Phe-L-Asu-Gly, and Gly-Phe-DAsu-Gly in formulation B to ensure that the breakdown of the succinimide intermediates
would be slow enough to allow the collection of multiple samples fi’om which complete
concentration versus time profiles could be generated. Lyophiles of formulation B (~30fold molar excess of Gly-Val) were therefore placed directly in a dessicator at 27 °C
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containing a saturated solution of potassium carbonate to provide a relative humidity
(RH) of 40%.
At specific time points, samples were removed from the chamber and
reconstituted with the original fill volume of water. Hydrochloric acid (1 N) was used to
adjust the pH of the reconstituted samples to quench the reaction and provide a similar
pH value as the HPLC mobile phase. Samples were either analyzed immediately by
HPLC or frozen until the time of analysis.
For kinetic analyses, only data up to 25% disappearance of Gly-Phe-L-Asn-Gly
starting peptide were utilized, while the succinimide intermediates were allowed to
degrade almost to completion. Individual peak areas for all hydrolysis products, L- or Dsuccinimides, and covalent adducts were monitored and converted to concentrations
using response factors as obtained in a previous publication.^^
HPLC Analyses
The identification, quantitation, and separation of Gly-Phe- L-Asn-Gly and ten of
its degradants are described elsewhere.^^ Briefly, separation was achieved using a Waters
Alliance LC system and a Supelcosil ABZ+ column (15 cm x 3.5 mm, 5-pm pore size).
To separate Gly-Phe- L-Asn-Gly, the hydrolysis products, and the succinimide
intermediates the mobile phase consisted of succinic acid (20 mM) in pure water with the
pH adjusted to 4.1 with dilute sodium hydroxide. After 16 minutes, a step gradient to 5%
acetonitrile and 95% buffer was necessary to elute the covalent adducts. A five min wash
step (25:75 bufferracetonitrile) was implemented at the end of each run to remove HPMC
that was retained on the column, followed by re-equilibration for 15 minutes with 100%
buffer.
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Mechanism-Based Kinetic Model Development
A comprehensive reaction scheme based on the known mechanism of
deamidation of Asn-containing peptides coupled with the assumption that racemization
and covalent, amide-linked adduct formation also proceed through a succinimide
intermediate is shown in Figure 5-1. Differential equations based on the various
pathways depicted in Figure 5-1 were derived to simultaneously fit the concentration
versus time profiles of each analyte (Equations 1-11). To simplify the differential
equations, the primary sequences of the individual compounds have been removed and
replaced with Roman numerals and subscripts to denote stereochemistry as listed in
Figure 5-1.
The reaction scheme shown does not include possible additional, potential
decomposition products formed, for example, by reactions between the succinimide
intermediate and a second Gly-Phe-L-Asn-Gly molecule or with excipient (i.e., HPMC)
molecules, or secondary degradation of the degradants described in Figure 5-1 to produce
other covalent adducts or hydrolysis products. In cases where mass balance was not
achieved (e.g., in formulations containing succinimide as the initial reactant) an
additional pathway leading from either succinimide to unknown products was included as
designated by a rate constant k^. Included in kx were rate constants for any pathways that
were not explicitly included in fitting the data due to the lack of ability to detect or
quantify degradant concentrations.
Simultaneous fits of all concentration vs. time profiles were performed by non
linear least squares regression analysis using commercially available computer software
(Scientist, Micromath Scientific Software, St. Louis, MO). Parameters for the initial
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concentrations of each degradant were initially included in the parameter set but those for
which the 95% confidence limits for the parameter estimate included zero were
eliminated and the initial concentrations in those cases were fixed at zero.
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Lyophile Characterization
Post-lyophilization, the cakes obtained were white in color and occupied the same
volume as the original fill height. After storage at 75% RH and 40 °C, lyophiles of
formulation A exhibited partial collapse as indicated by some retraction of the cakes fi'om
the vial walls. However, no evidence of crystallization was observed as indicated by the
lack of birefi-ingence under a polarizing microscope. Upon exposure to storage
conditions of 27 °C and 40% RH, lyophiles of formulation B underwent partial collapse
to approximately half of their original height. Evidence of partial recrystallization of
Gly-Val was obtained when lyophiles stored under these conditions were examined by
polarized light microscopy (data not shown).
The average pH of samples reconstituted with the original volume of water was
9.58 ± 0.02 for formulation A and 9.36 ± 0.06 for formulation B. The water content for
formulation A lyophiles was 2.4 ± 0.6% and increased to 13.6 ± 0.8 when exposed to 40
°C and 75% RH. The water content of formulation B lyophiles was 3.5 ± 0.7% postlyophilization and 4.53 ± 0.99% after storage at 40% RH and 27 °C.
Degradant Profiles from Giy-Phe-L-Asn-Gly in Formulation A
A total of 10 degradants were observed over time when lyophiles containing GlyPhe-L-Asn-Gly in formulation A were incubated at 40 °C and 75% RH^Figure 5-2).
These degradants were identified previously^^ as four covalent ainide-linked adducts of
Gly-Val, four hydrolysis products (D- and L-aspartates and isoaspartates), and the D- and
L-succinimide intermediates. The four covalent adduct and hydrolysis product peaks
result from nucleophilic attack of either Gly-Val or water at the a- or P-carbonyl of either
the D- or L-succinimide intermediate. In this formulation, which contained only a 7.5-
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fold excess of Gly-Val in relation to Gly-Phe-L-Asn-Gly and had a relatively high water
content (13.6%) as a result of its storage at 75% RH, hydrolysis products were the
dominant degradants with the minor degradants being covalent Gly-Val adducts.
Kinetic Analysis of the Degradation of Gly-Phe-L-Asn-Gly and Product Formation
in Formulation A
Previously, a simplified kinetic analysis was performed for the degradation of
Gly-Phe-L-Asn-Gly in formulation A at 40 °C and at lower humidity (40% RH) by
pooling the concentrations of hydrolysis products and Gly-Val adducts, to generate a
single rate constant for hydrolysis and another for covalent adduct formation.Data
generated herein from the degradation of Gly-Phe-L-Asn-Gly in formulation A at 40 °C
and 75% RH were used to evaluate a more comprehensive kinetic model that included a
rate constant for the formation of each degradant. This data set was selected because all
ten degradants formed in appreciable amounts and therefore reliable rate constants could
be estimated. The model described in Figure 5-1 assumes that the L-succinimide
undergoes racemization to the D-succinimide. The L- and D- succinimides are then
susceptible to nucleophilic attack at the a- and P-carbonyls by either water or Gly-Val to
yield hydrolysis products or covalent amide-linked adducts, respectively. The non-linear
simultaneous fits of Eqs. 1-11 to the data are seen in Figure 5-3 and a summary of the
rate constants and statistics are listed in Table 5-1. The initial concentrations for three of
the degradants (i.e., the normal aspartates, IVl and IVd, and the L-succinimide IIl)
differed significantly from zero and parameters for these impurities were therefore also
included in the model. Though they are not included in Table 5-1 their values can be
estimated from Figures 5-3B & 5-3D. Clearly, the kinetic model satisfactorily accounts
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for the simultaneous disappearance of Gly-Phe-L-Asn-Gly and the formation of all ten
degradants as a function of time in this formulation, at least during the period in which
approximately 25% of the starting compound has degraded.
The concentrations of both succinimides vs time are consistent with their role as
reactive intermediates in that the concentrations of the L-and D-succinimide rise to
maxima of ~3-4% and ~1% of the Gly-Phe-L-Asn-Gly concentration, respectively,
followed by gradual declines (Figure 5-3D). The individual rate constants for the
conversion of the L- to the D-succinimide and vice versa (kio = 1.685 hr' and ki i = 1.262
hr '), listed in Table 5-1, appear to be similar to each other but because these parameters
were found to be highly correlated, their 95% confidence intervals were quite broad.
Indeed the 95% confidence interval for kj i crossed zero indicating that the value of this
parameter could not be obtained with certainty from this data set. More reliable estimates
of the rate constants for interconversion of Gly-Phe-L-Asu-Gly and Gly-Phe-D-Asu-Gly
were determined in formulation B when the individual succinimides were used as starting
reactants (Table 5-2). In both sets of data, the calculated rate constants are approximately
equal to each other. A kinetic model that included the possible formation of Gly-Phe-DAsu-Gly directly from Gly-Phe-L-Asn-Gly was evaluated but showed no improvement in
the fits and negatively impacted the statistics.
Apparent lag times are evident in the formation of both hydrolysis products and
covalent adducts (Figures 5-3B and 5-3C), consistent with their formation from a reactive
intermediate. As seen in Figure 5-3B, normal aspartyl-containing peptides were present
as impurities at tzero but the concentrations of isoaspartyl-containing peptides showed a
rapid increase in concentration over time and eventually surpassed the aspartyl-
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containing peptides in concentration. Isoaspartyl peptide formation was favored over
aspartyl peptides by a 2.2 to 1 ratio when generated from L-succinimide intermediate and
by 2.6 to 1 when generated from the D-succinimide as determined by their respective rate
constants. The same trend was observed for the attack by the N-terminus of the Gly-Val
on the D-succinimide where a-carbonyl attack was favored by approximately 2:1, though
no significant difference could be shown for the rates of formation of iso- and normal
adducts from the L-succinimide from this data set.
Degradant Profiles of Gly-Phe-L-Asn-Gly, Gly-Phe-D-Asu-Gly and GlyTPhe-L-AsuGly in Lyophiles of Formulation B
Comparisons of the degradation of Gly-Phe-L-Asn-Gly, Gly-Phe-D-Asu-Gly and
Gly-Phe-L-Asu-Gly were conducted in formulation B which contained a greater excess of
Gly-Val than formulation A and under storage conditions (25°C and 40% RH) that led to
a reduced water content in these lyophiles in comparison to formulation A (i.e., 4.5% vs
13.6%). As a consequence, only trace quantities of hydrolysis products totaling less than
5% of the initial reactant concentration were observed when the succinimides, were the
starting compounds and no hydrolysis products were observed when Gly^Phe-L-Asn-Gly
was the starting reactant. As shown in Figure 5-4, the four major degradants that were
observed when Gly-Phe-L-Asn-Gly and the succinimide intermediates were the starting
compounds in Formulation B were the D- and L- diastereomers resulting frorh Gly-Val
attack at the a- and P-carbonyls of the D- and L- succinimide intermediates.
The major degradants formed from the L-succinimide were the respective Ladducts of Gly-Val with relatively smaller amounts of the D-adducts. Similarly,
incubation of the D-succinimide yielded mostly D-adducts with L-adducts as minor
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degradants. The interconversion between the D- and L-succinimides was relatively rapid
as shown in Figure 5-4C, albeit slower than the overall conversion of succinimide to
covalent adducts. Both covalent adduct diastereomers were observed when Gly-Phe-LAsn-Gly was the starting reactant (Figure 5-4B) though the L-adducts dominated.
Simultaneous Kinetic Analysis with Variation in the Initial Reactant in Formulation
B
Data generated from the degradation of Gly-Phe-L-Asu-Gly, Gly-Phe-D-Asu-Gly,
or Gly-Phe-L-Asn-Gly in amorphous formulation B lyophiles at 27 °C and 40% RH were
used to quantitatively test the self-consistency of the mechanism-based model proposed
for covalent adduct formation. As reported previously,the degradant profiles were the
same when either succinimide intermediate or the asparagine containing peptide were the
starting reactants supporting a central role for the succinimide in covalent adduct
formation. To quantitatively evaluate the kinetics of formation of the four diastereomeric
adducts from their respective succinimide intermediates, degradant concentration versus
time profiles from the Gly-Phe-L-Asu-Gly and Gly-Phe-D-Asu-Gly kinetic studies were
fit simultaneously over the time frame required for complete disappearance ofthe starting
compounds. Initially, the model accounting for only the four covalent Gly-Val adducts
did a poor job of fitting the disappearance curves for the starting succinimides. Evidently,
this model did not fully account for all of the decomposition products forming from the
succinimides. To account for this discrepancy it was necessary to add an additional rate
constant, kx, which incorporated any unknown degradation pathways along with the four
hydrolysis rate constants (k2, k3, Ici, ks in Figure 5-1) that had not been included in the
initial analysis. Incorporating kx into the model provided acceptable fits of the
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concentration versus time profiles for disappearance of the succinimides as starting
reactants along with the formation the corresponding succinimide diastereomer (Figure 54C) and all four covalent adducts from Gly-Phe-D-Asu-Gly (Figure 5-2D) and Gly-PheL-Asu-Gly (Figure 5-2E). The calculated values for the rate constants generated from the
two succinimide data sets are listed in Table 5-2 (right-hand column).
As a final test to confirm that the succinimide is the point of racemization and the
exclusive pathway for covalent amide-linked adduct formation from Gly-Phe-L-Asn-Gly
in amorphous formulation B lyophiles, concentration vs time profiles generated when
Gly-Phe-L-Asn-Gly and the D- and L-succinimides were the starting reactants were fit
simultaneously to the mechanism-based model that included the additional rate constant
kx- The results are shown by the solid lines in the five panels of Figure 5-4 and the rate
constants are summarized in Table 5-2. The rate constants for adduct formation were not
significantly altered when the Gly-Phe-L-Asn-Gly data set was included and fit
simultaneously with the succinimide data sets. This self-consistency lends further
support to the central role of the succinimide intermediates in the formation of covalent
peptide adducts.
As observed in the results for formulation A, nucleophilic attack by the Nterminus of Gly-Val occurred at both the a- and (5-carbonyls of the succinimide
intermediates. The ratios of rate constants for a/p attack in formulation B were 1.6 for
the L-adducts and 2.6 for the D-adducts. Preferential nucleophilic attack at the a-carbonyl
is consistent with previous literature for hydrolysis in aqueous solutions" and amorphous
solids,and when ammonia is the nucleophile in aqueous solutions.
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Discussion
As mentioned at the outset, many of the reaction pathways most prominent in
pharmaceutical systems are relatively well understood mechanistically, at least in
aqueous solution, as a result of many detailed investigative studies over several decades.
Given the importance of reactive intermediates in a majority of these pathways, an
underlying hypothesis of the present work was that this wealth of understanding of the
mechanisms of formation and the ultimate fate of reactive intermediates based on
solution studies may prove useful in predicting or at least rationalizing differences in
reaction kinetics in amorphous solid formulations when compared to solutions.
Deamidation of asparagine residues in peptides and proteins, for example, is well
known to occur via a reactive cyclic imide intermediate, both in aqueous solutions II 12
and in amorphous lyophiles,^''^^ leading to both iso-aspartyl and aspartyl hydrolysis
products accompanied by racemization. Recently, we demonstrated in aqueous solution
that a more diverse set of heretofore unidentified degradants may form from Asncontaining peptides and proteins when other nucleophiles such as amines are present at
sufficiently high effective concentrations to compete with water for the succihimide
intermediate.'^ More recently, this finding was extended to reactions of a model
asparagine-containing peptide (Gly-Phe-L-Asn-Gly) in amorphous lyophiles containing
an excess of a second peptide (Gly-Val).^^ A total of ten degradation products were
identified, including hydrolysis and racemization products as well as four covalent
adducts resulting from the attack of Gly-Val on the D- and L-succinimide intermediates.
The same degradant profiles were found when the succinimide was the starting reactant
in lyophile formulations, implicating the cyclic imide as the intermediate for formation of
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all degradants. The rationale for the incorporation of a second peptide (Gly-Val) in these
studies was to reduce the number of potential degradants that might form. Because both
Gly-Val and any amide-linked covalent adducts produced in the reaction of these two
peptides would no longer have an Asn residue, the tendency of the adducts to form higher
order aggregates was reduced.
In this manuscript, studies of the same model peptides and the D- and Lsuccinimide intermediates have been conducted with the aim of developing a
comprehensive, mechanism-based model to describe the kinetics of degradant formation
in two different Gly-Phe-z.-Asn-Gly lyophile formulations and storage conditions that
produce dramatic disparities in degradant profiles. This approach allowed us to test,the
general applicability of a mechanism-based model for rationalizing both the degradants
formed as well as their relative amounts as a function of time when changes in
formulation and/or storage conditions significantly alter the relative amounts of
degradants produced. The analysis highlights the potential utility of applying
mechanism-based models to reactions in amorphous glass formulations and also
reinforces the potential importance of alternative pathways for breakdown of succinimide
intermediates formed in solid-state peptide and protein drug formulations.

While the simple kinetic model employed in our preceding study in which all
hydrolysis products and all covalent adducts were pooled^^ was effective in
demonstrating the role of the succinimide intermediate in the formation of both
hydrolysis products and covalent adducts, it did not provide kinetic information on each
individual reaction pathway. The authors are unaware of any previous attempts to apply
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such a complex, mechanism-based kinetic model to reactivity in amorphous solid
formulations in a quantitative manner.
The first set of experiments monitored the simultaneous disappearance of GlyPhe-L-Asn-Gly, succinimide formation, and conversion to both hydrolysis products and
covalent adducts in a formulation (formulation A) containing a reduced ratio of excess
Gly-Val stored at 40 °C and 75% RH. In this formulation and at these storage conditions,
a total of 10 reactive intermediates or final degradants formed in appreciable amounts and
could be monitored quantitatively to allow nearly all of the relevant reaction parameters
to be reliably determined.
Recognizing that generating rate constants for the formation and, in some cases,
breakdown of ten reaction products with reliable precision and accuracy may be difficult,
we also examined a formulation containing a greater excess of Gly-Val (formulation B)
stored at 25°C and 40% RH. Under these conditions the degradant profile shifted to
predominantly the succinimide intermediates and covalent adducts. In this formulation,
the initial starting reactant was either Gly-Phe-L-Asn-Gly or one of the two succinimide
intermediates, Gly-Phe-L-Asu-Gly or Gly-Phe-D-Asu-Gly. The question to be addressed
with this set of data was whether or not the same kinetic model could simultaneously fit
the complete concentration vs. time profiles generated from each of the three initial
reactants. This exercise would also test in a more quantitative fashion the hypothesis that
the formation of covalent adducts proceeds exclusively through succinimide
intermediates.
Fate of the Succinimide Intermediate in Amorphous Lyophiles
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Hydrolysis Products. The lyophilized formulations in the present study were
prepared from pH 9.5 solutions. Deamidation of asparaginyl peptides in amorphous
lyophiles is known to proceed through a succinimide intermediate when the effective
lyophile pH is in the basic region,and this was also found in the present study.
Although the formation of isoaspartyl and aspartyl hydrolysis products resulting from the
attack of water at the succinimide a- or P-carbonyl in the second step of the reaction
would be expected to proceed at a slower rate in amorphous solids where the water
content is substantially reduced in relation to aqueous solutions, it is important to bear in
mind that the rate-determining step for deamidation is the formation of the cyclic imide
rather than its breakdown. Consequently, consideration of factors affecting nucleophilic
attack at the succinimide may be more important for ascertaining the ultimate reaction
products rather than the overall degradation rate.
Succinimide breakdown generally favors isoaspartyl (attack at the a-carbonyl)
over aspartyl degradants in a 3:1 to 4:1 ratio in aqueous solutions,"’^'* but the ratio can
depend on the type of solvent,^^ the solution environment,^^ primary sequence^^ and, in
the case of proteins, higher order structure.^* A preference for isoaspartyl over aspartyl
degradants has also been reported in lyophiles.^^'^' The present results.obtained in
formulation A, where hydrolysis products dominated, are consistent with these previous
observations. Hydrolysis products generated from Gly-Phe-L-Asu-Gly favored
isoaspartate over aspartate by 2.5 to 1. Ratios of iso aspartate/aspartate closer to one have
been previously reported in native proteins with higher order structure where proximal
amino acids are thought to influence the stability of transition states involved in
succinimide breakdown.

Primary sequence of a peptide can also affect the relative
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amounts of isoaspartyl and aspartyl containing peptides.For example, lysine located at
the N-1 position in small peptides increases the relative amounts of aspartyl containing
peptides. The slightly reduced preference for isoaspartyl over aspartyl hydrolysis
products of 2.5:1 observed here likely also reflects influences of the local
microenvironment in the vicinity of the succinimide on the stability of the transition
states leading to the isoaspartyl or aspartyl products.
Succinimide Involvement in Covalent, Amide-Linked Adducts. In solution, the
succinimide intermediate generated during the deamidation of Asn-containing peptides
may be susceptible to attack by nucleophiles other than water.In aqueous solutions,
intramolecular reactions involving neighboring amine residues with succinimides to form
diketopiperazines can be particularly important.'^ In non-aqueous solutions, covalent,
amide-linked dimers and higher aggregates may predominate.^*’ The recent literature also
eontains hints that suceinimide intermediates may be involved in the formation of amidelinked peptide or protein aggregates in lyophile formulations. For example, Simons et
al.^' observed the formation of covalent dimers, trimers, and tetramers when lyophiles of
RNase A were stored at high temperature, which they attributed to the formation of
amide bonds between RNase molecules located in close proximity to each other. Later,
Maroufi et al.^^ reported amide-linked dimer formation in amorphous hen egg-white
lysozyme. Desfougeres et al.^^ demonstrated a linear correlation between the %
succinimide and the amounts of covalent dimers formed in lysozyme lyophiles stored at
high temperature. In the present study, covalent Gly-Val adduct formation,in lyophiles of
Gly-Phe-L-Asn-Gly containing excess quantitites of Gly-Val has been shown to compete
with water for reaction with the succinimide intermediate.
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In formulation A lyophiles containing Gly-Phe-L-Asn-Gly and a 7.5-fold excess
of Gly-Val in a matrix consisting of HPMC and sodium bicarbonate stored at 40°C and
75% relative humidity, hydrolysis products were found to dominate but both hydrolysis
products and covalent Gly-Val adduct formation proceeded through succinimide
intermediates, as demonstrated in Figure 5-3 by the success of the kinetic model defined
by Eqs. 1-11 in simultaneously fitting the concentration versus time profiles for Gly-PheL-Asn-Gly (Fig. 3A), the succinimide intermediates (Fig. 3D), the L- and D- isoaspartyl
and aspartyl hydrolysis products (Fig. 3B) and the four Gly-Val adducts (Fig. 3C).
Increasing the molar excess of Gly-Val to ~30-fold in formulation B and
removing sodium carbonate to compensate for the additional mass of Gly-Val in the
lyophilized solids along with storage at 27°C and a lower humidity of 40% RH resulted
in a shift in the succinimide intermediate partitioning toward Gly-Val adducts as the
predominant products. Again, the central role of the succinimide intermediate was
confirmed by the demonstration that the mechanism-based kinetic model described by the
set of parameter values in Table 5-2 was successful in simultaneously fitting the kinetics
of Gly-Phe-L-Asn-Gly disappearance (Fig. 4A), succinimide and Gly-Val adduct
formation when Gly-Phe-L-Asn-Gly was the starting reactant (Fig. 4B), L- and Dsuccinimide disappearance and interconversion when these compounds were-the initial
reactants (Fig. 4C), and formation of the four Gly-Val adducts when either the Lsuccinimide (Fig. 4D) or D-succinimide (Fig. 4E) were the starting reactants.
Simultaneous fitting of the degradation profiles generated fi-om L-Asu, D-Asu, or
L-Asn as the starting reactant provided the same rate constants for formation for the
normal and isoadducts from the corresponding succinimide in formulation B (Table 5-2).
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The ratio of attack by the N-terminus of Gly-Val at the L-succinimide a-carbonyl versus
the P-carbonyl was ~1.6 to 1 while for the D-succinimide this ratio was ~2.6 (see Table 52), consistent with the preference for nucleophilic attack at the a-carbonyl found when
water is the reactant.
To successfully fit the formation of covalent amide-linked adduct concentration
profiles from the L-Asu, D-Asu, or L-Asn data set described in Fig. 4, the model did
require an additional degradation pathway (kx) to achieve mass balance. This rate
constant incorporates those pathways leading to isoaspartyl and aspartyl hydrolysis
products that could not be individually quantified in formulation B kinetic studies due to
their low concentrations, potential succinimide dimerization, downstream reactions of
degradants to secondary decomposition products, and possible reaction of the
succinimides with other nucleophiles, such as free hydroxyl groups on HPMC sugar
moieties

34

Succinimide Racemization in Lyophiles. In addition to the formation of aspartyl
and isoaspartyl peptides, aspartate racemization occurs along the deamidation pathway as
evident by the formation of D-and L- hydrolysis products." In their now classic 1987
study, Geiger and Clarke were able to attribute two-thirds of the total racemization
observed in solution during deamidation of an asparagine-containing hexapeptide to the
succinimide intermediate.'' The remainder they attributed to possible direct abstraction
of the proton in aspartate peptides or to other racemization prone reactive intermediates.
The conversion of naturally occurring L-amino acids to D-amino acids has been reported
at neutral pH with aspartates having a higher propensity for racemization.^^ However,
racemization of aspartic and isoaspartic acids cannot account for the observations of
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Geiger and Clarke because the interconversion rates of aspartates are much slower - on
the order of years in solutions when extrapolated to lower temperatures.^^ Li et. al
observed that Gly-Gln-L-Asn-Glu-Gly transiently formed Gly-Gln-D-Asn-Glu-Gly and
vice versa during the process of deamidation in aqueous solution at pH 10 and 70 °C,
which they attributed to racemization at the tetrahedral intermediate stage.^^
The extent of peptide and protein racemization in the solid-state and the factors
that may affect it have not been systematically explored, to our knowledge. In the
present work, the model depicted in Figure 5-1 assuming racemization only at the
succinimide was able to account for the kinetics of formation of all D-and L-degradation
products observed. Alternative rhodels were considered, such as racemization prior to the
formation of the succinimide, but no improvement in fits could be demonstrated.
However, these results do not eliminate the possibility for racemization at other points
along the deamidation pathway.^^ The calculated rate constants for succinimide
interconversion of ~ 0.2 hr ' in formulation B at 27°C and 40% RH are comparable to the
pseudo first-order rate constants for other reaction pathways involving succinimide
(Table 5-2). Consequently, the concentration of the D-succinimide in formulations
containing the L-succinimide as the starting reactant rose to significant concentrations in
relation to other degradants during the first half-life of succinimide disappearance (Fig.
4C) and the same was true for the L-succinimide when the starting reactant was the Dsuccinimide. Geiger and Clarke reported a first-order rate constant for racermzation in
aqueous solutions at pH 7.4 and 37°C that was 16-fold less than that for hydrolysis of the
succinimide. *' Under the formulation and storage conditions reflected in Table 5-2,
succinimide racemization kinetics proceeded more rapidly than hydrolysis and'exceeded
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the rate constants for racemization reported by Geiger and Clarke by approximately one
order-of-magnitude, even though the overall rate of deamidation of Gly-Phe-L-Asn-Gly
in the present study was approximately an order-of-magnitude slower than that for the
hexapeptide examined by Geiger and Clarke. Several factors, including the reduced water
content in lyophiles as well as formulation composition, peptide structure, temperature
and pH differences may contribute to these disparities. Nevertheless, these results
highlight the potential significance of racemization in amorphous lyophiles of Asncontaining peptides or proteins.
Conclusion

A mechanism-based kinetic model that assigns a central role to the succinimide
intermediate has been employed to quantitatively account for the formation of hydrolysis
and covalent amide-linked degradants resulting from the deamidation of a model
tetrapeptide in the presence of excess Gly-Val in lyophilized formulations. Terminal
degradant profiles were the same when the starting reactant was either Gly-Phe-L-AsnGly or its L-succinimide intermediate further indicating that hydrolysis, racemization,
and covalent amide-linked adduct formation all proceed via the succinirhide intermediate.
Nucleophilic attack occurred preferentially at the a-carbonyl of the succinirhide
intermediate at ratios of ~2:1 when the nucleophile was either water or the N-terminus of
Gly-Val. The bimolecular reaction between the succinimide intermediate and the free
amine of another peptide reported herein suggests a likely mechanism for the formation
of amide-linked non-reducible aggregates in solid-state formulations of proteins, and
peptides.
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Future studies will examine in a more systematic fashion the kinetics of formation
of hydrolysis and covalent adducts in similar formulations as a function of such variables
as water content and excipient dilution.
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Table 5-1. Summary of the calculated rate constants when Eqs. 1-11 were used
to fit the data for lyophiles of Gly-Phe-L-Asn-Gly in formulation A stored at
75% RH and 40 °C. Numbers in parentheses represent 95% confidence
interval.

Parameter
ki

Reaction Step
I

k2

IIl ^ IIIl

k3

IId ^ IIId

k4

IIl ^ IVl

k5

IId ^ IVd

k6

IIl ^Vl

k?

IId ^Vd

kg

IIl -^VIl

k9

IId ^VId

kio

IIl ^ IId

kii

IId ^ IIl
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Calculated Rate
Constant (hr ')
0.106
(0.079-0.133)
1.43
(1.05-1.81)
2.72
(1.81-3.62)
0.64
(0.021-1.25)
1.04
(0.16-1.91)
0.0205
(0.0142-0.0268)
0.0185
(0.0123-0.0247)
0.0208
(0.0143-0.0272)
0.0367m
(0.0235-0.0499,
1.69
(0.26-3.11)
1.26
(-4.1-6.6)

Table 5-2. Comparison of the rate constants for the formation of the four
adducts in lyophiles containing a 30-fold excess of Gly-Val at 40% RH and 27
°C based on the simultaneous fitting of data with and without Gly-Phe-L-AsnGly. Numbers in parentheses represent 95% confidence intervals.
Calculated Rate Constant (hr‘‘)
w/ Gly-Phe-Asn-Gly
Imide Data Alone
Data
3.3x10'^
(2.3x10'^-4.2x10'^)
—
0.082
0.095
(0.047-0.118)
(0.065-0.13)

Parameter

Reaction Step

ki

I ->IIl

k6

IIl ^Vl

k?

IId ^Vd

0.10
(0.060-0.14)

0.093
(0.049-0.137)

ks

VIl

0.15
(0.11-0.19)

0.14
(0.084-0.20)

kg

IId ^ VId

0.27
(0.18-0.36)

0.27
(0.17-0.37)

kio

IIl ^ IId

0.21
(0.11-0.31)

0.20
(0.090-0.30)

ki 1

IId ^ IIl

0.20
(0.12-0.27)

0.15
(0.074-0.23)

kx

IIl/IId Unknown
Degradants

0.21
(0.10-0.32)

0.17
(0.022-0.33)
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Gly-Phe-L-Asp-Gly
f>VJ

Gly-Phe-L-»soAsp-Gly
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u

Gly-Val

G fy-P hH L-Asp )-G ly-Val

Gly-Phe-<D-Asp)-G!y-Val
|VI„I

Figure 5-1. Mechanism-based model for the degradation of Gly-Phe-L-AsnGly [1] to form Gly-Phe-L-Asu-Gly [IIl] which then racemizes to Gly-Phe-D- !
Asu-Gly [IId]- Both succinimide intermediates can then react with water to
form aspartates [111] and [IV], with Gly-Val to form amide-linked adducts [V] ..
and [VI], or possibly with other excipients in the formulation.
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Figure 5-2. HPLC chromatogram showing the formation of four hydrolysis
products (IIIl, IIId, IVl, IVd), two succinimide intermediates (IIl and IId) and
four covalent amide-linked adducts (Vl, Vq, VIl, VId) when lyophiles of I in
formulation A were stored at 75% RH and 40 °C for two hours. Exact
structures of each peak are depicted in Figure 5-1. Changes in the baseline
due to the step gradient were removed and baselines adjusted.
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Figure 5-3. A) Degradation of I (*); B) Formation of IIIl (A), IIIq (A), IVl
(■), IVd (□) ; C) Formation of Vl (♦), Vd (0), VIl (•), VId (o); D) IIl (X) and
IId (+) concentrations over time.
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so

Figure 5-4. Results from the simultaneous fitting of kinetic data when Reactants 1, IIl, and IId are the starting compounds.
A) 1 degradation; B) Adduct and succinimide formation when I is the starting compound; C) Degradation and formation of
IIl

and IId; D) Adduct formation when IIl is the starting compound; E) Adduct formation when IId is the starting

compound.
Key □,

Vl - Vd - o, VIl - A, VId - A ; D) IIl as starting reactant- •; IId as starting reactant - ■,
IIl from I - (-t-), and gray line is predicted concentration of IId when I is the starting peptide.
I-

IIl

from IIdo,

IId

from

Ifr
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CHAPTER 6 - EFFECTS OF WATER AND POLYMER CONTENT ON COVALENT
AMIDE-LINKED ADDUCT FORMATION IN AMORPHOUS LYOPHILES

Introduction
Peptides and proteins are inherently unstable in solution and are therefore
generally formulated as lyophilized solids to maximize their stability.

Amorphous

lyophiles stored below the Tg of the system exist as glasses in which local molecular
reorientations (i.e., local mobility or P-relaxation) dominate while long-range molecular
motions (i.e., global mobility or a-relaxation) are retarded. In recent years, the important
role of molecular motions in inducing instability even at temperatures well below Tg has
become increasingly appreciated.'"^

In turn, this has led to numerous attempts to relate

decreases in stability that accompany increases in temperature and relative humidity to
various measures of molecular mobility such as the Tg itself or relaxation times
C T

Q

determined using such methods as DSC, ' isothermal calorimetry, thermally stimulated
depolarization current spectroscopy,’

dielectric spectroscopy,'®'" thermomechanical

analysis,'" or NMR.'^ Empirical equations that were originally developed to account for
the temperature dependence of structural relaxation in amorphous systems including the
Williams-Landel-Ferry (WLF) equation,''* '^ the Adam-Gibbs-Vogel equation,'^ and the
Kohlrausch-Williams-Watts (KWW) equation'® '® are now frequently utilized in the
pharmaceutical literature to relate chemical degradation to temperature.
Yet, despite these trends, a number of cases cited in the literature haye shown a
lack of correlation between reactivity and Tg^®'^' or other measures of molecular
mobility.^^

One possible explanation is that different types of mobility may be
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responsible for different types of reactions.^^ For example, chemical reactions requiring
translational diffusion of large molecules may be more closely coupled with measures of
global mobility or long-range structural relaxation while intramolecular reactions may be
sensitive only to local reorientations.
Often ignored in attempts to establish the degree of coupling between the kinetics
of a chemical reaction in amorphous solids and a particular relaxation parameter is the
fact that most reactions of pharmaceutical interest involve multiple reaction steps. For
example, most of the important degradation pathways for proteins and peptides including
deamidation, isomerization, and racemization,^'* covalent aggregate formation involving
disulfide, '
reaction^"*

amide

' or lysinoalanine cross links,

oxidation, '

all occur through one or more reactive intermediates.

and the Maillard
Deamidation of

asparagine residues in proteins and peptides occurs via a succinimide intermediate, in
both aqueous solutions^"^’^^ and amorphous lyophiles.^^'^^ Recently, we demonsrated that
the decomposition of a model asparagine-containing peptide in amorphous lyophiles
containing an excess of a second peptide (Gly-Val) produced at least ten degradants,
including products fi-om hydrolysis, isomerization, and racemization reactions as well as
four amide-linked covalent adducts.^^ Application of a mechanism-based rhodel to fit
the kinetic data established that the rate-determining step in the reaction was the
formation of a reactive succinimide and that the formation of all subsequent degradation
products proceeded through the succinimide.^^
Mechanistic models that take into account the detailed reaction chemistry, when
known, may be useful tools in understanding how changes in formulation and storage
conditions might impact amorphous product stability and the degradants generated. It is
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likely that such models may provide more clarity in understanding the role of structural
relaxation in chemical stability by allowing one to explore the degree of coupling of each
reaction step to various types of relaxation parameters.

In this study, formulations

containing the model peptide, Gly-Phe-L-Asn-Gly in the presence of an excess of a 2"'*
peptide (Gly-Val) were chosen as a model systems to explore the effects of relative
humidity and varying percentages of a polymeric excipient (HPMC) on both the rate of
succinimide formation and the competition between two nucleophilic components in the
formulation (water and the N-terminus of Gly-Val) for the reactive intermediate. Bulking
agents such as sugars^* or polymers^^”^*^ are commonly used in protein and peptide
lyophilized formulations to minimize aggregation or recrystallization.

HPMC was

chosen for this study due to its ability to prevent recrystallization of active ingredients,'*'
its relatively high glass transition temperature,

and because the majority of its hydroxyl

groups have been alkylated thus minimizing the number of potential nucleophilic sites on
the excipient.

The results illustrate the value of a mechanism-based model for

understanding the effects of formulation variables and storage conditions on both the
overall rate of degradation and the degradants produced.

Materials and Methods
Reagents
The starting reactant, Gly-Phe-L-Asn-Gly, and corresponding hydrolysis products were
synthesized by GenScript (Piscataway, NJ) as trifluoroacetate salts with'purities greater
than 95% as determined by HPLC. These compounds were further characterized as
previously described.

^>7

Standards of succinimide intermediates (Gly-Phe-D-AsurGly and

Gly-Phe-L-Asu-Gly) and covalent adducts used for HPLC quantitation are described
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elsewhere.^^

A sample of Hypromellose (HPMC, Methocel E5), having an average

substitution of 29% methyl and 10% propyl groups, was donated by Dow Chemical
(Midland, MI) and used as received. Gly-Val was purchased from Bachem (Torrance,
CA) as the zwitterion (purity 99.0% by TLC). HPLC grade acetonitrile was purchased
from Fisher Scientific (Springfield, NJ).

Sodium bicarbonate (ACS grade) was

purchased from EM Science (Gibbstown, NJ) and succinic acid was purchased from
Aldrich (St. Louis, MO). Anhydrous dimethylsulfoxide (DMSO) used in determining
water content was purchased from Acros Organics (Pittsburgh, PA). Deionized water
was used throughout the experiments.
Preparation of Lyophiles
Preparation and characterization of lyophiles from a 0.5% HPMC solution were
previously described in detail. Similarly, solutions of HPMC at higher concentrations
(1.0%, 1.5%, 2.0%, 3.0% (w/v)) were prepared by adding the appropriate arhoiint of
polymer to buffered solutions (pH adjusted to 9.5 with dilute sodium hydroxide)
containing sodium bicarbonate (9.3 mM) and Gly-Val (1.5 mM). Gly-Phe-Asn-Gly was
then added to buffer/polymer solution to make a 1 mM solution. The'peptide’solution
was mixed and 100 pL aliquots were transferred into glass autosampler vials. Vials.were
V

then placed on a pre-chilled lyophilization shelf (-45 °C) to freeze the samples. Once the
samples were frozen (approximately 5-8 minutes), the lyophilization cycle was initiated.
The lyophilization cycle consisted of primary drying at -40°C for 1420 min followed by
an increase in shelf temperature at a rate of 0.2 °C /min to 40°C. Secondary drying at
40°C was completed after 120 min. The pressure was held constant at 100 mtorr
throughout the run.
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Lyophiles for water determination were prepared by transferring 2 mL aliquots
into 20-mL scintillation vials followed by lyophilization using the same cycle as above.
These lyophiles were then dried further in a vacuum oven at 50 °C for four days or until
the weight remained constant, then analyzed for water content as described below.
Kinetic Studies
All kinetic studies were performed at 40 °C. Lyophiles prepared from a 0.5% w/v
solution of HPMC were exposed to various relative humidities by storing the lyophiles
over saturated salt solutions of sodium chloride (75% RH), sodium nitrate (60% RH),
potassium carbonate (40% RH), and magnesium chloride (33% RH)."*^

Lyophiles

containing higher percentages of HPMC were all stored at the same relative humidity
(40% RH).
Initially, lyophiles were pre-equilibrated at ambient temperature and at the same
relative humidity to be employed in kinetic studies for as little as 15 minutes (75% and
60% RH) or as long as 12 hours (40% and 33% RH). This pre-equilibration step was
deemed necessary to ensure that water content became constant prior to initiating kinetic
studies at 40 °C. After the pre-equilibration step, samples were placed in a dessicator at
the same relative humidity and 40 °C and the time (Tzero) was recorded. Samples were
removed at specific time points, diluted with deionized water along with a few micro liters
of 1 N HCl to adjust pH to approximately 4.1 to quench the reaction and provide a similar
pH value as the mobile phase. Samples were then analyzed immediately or placed in a
freezer (-20 °C) until the time of analysis.
The reactant and degradant concentrations were monitored versus time using a
stability indicating HPLC method during a time frame in which < 25% of the starting
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reactant degraded. Mass balance remained at >95% throughout this time frame.
Concentrations of the individual succinimide intermediates, hydrolysis products and
covalent adducts obtained from peak areas and response factors generated from standards
were pooled and labeled as “succinimides,” “aspartates,” and “adducts.” These pooled
concentrations versus time were then analyzed simultaneously using a mechanism-based
kinetic model. Figure 6-1 illustrates the assumed mechanism for the formation of the
succinimide intermediate from the starting asparagine containing peptide followed by its
reaction with water or Gly-Val to form aspartates or amide-linked covalent adducts, .
respectively. Differential equations (Equations 1-4) were derived based on Figure 6-1 to
fit the concentration vs. time using non-linear regression software (Scientist, Micromath
Scientific Software, St. Louis, MO).
i,\ciy.phe^Asn^a,A ^

(1)

o’f
d[Aspartates]
dt
d[Adducts]
dt

_

j^^^cctnirnide]

= kadcluctsl.^^^(^^''T-^''^^d.e]

(3)
(4)

Lyophile Characterization
Water Content:
Post-lyophilization samples were prepared for analysis of water eoiitent by
suspending the entire cake in anhydrous DMSO (~1 mL).

The water content was

measured by injecting the suspension into the cell of a Karl-Fischer apparatus. Carbonate
buffers contribute a molar amount of water to the measured water content.'*^

The

contribution of carbonate buffer was subtracted from the measured water content to

175

obtain initial water contents for each formulation.

A brief validation study was

performed to confirm that carbonate contributes a molar equivalent when analyzed by
Karl-Fischer. Lyophiles containing varying weight ratios of sodium bicarbonate to GlyVal (0:1, 1:1, 2:1 and 3:1) were prepared and analyzed as stated above. Once adjusting
for the molar equivalent of water contributed by the carbonate buffer, the water contents
for each of the lyophiles were equivalent. The water contents for lyophiles stored at
various relative humidities were determined by monitoring their change in weight which
was attributed to water uptake. These results were then added to the initial sample water
contents to obtain the values reported.
Reconstituted solution pH:

Lyophiles were reconstituted with 100 pL of water and the

pH was measured at the beginning and end of the kinetic experiments. An averaged
valued is reported as the experimental value. Measurements were performed using a
Beckman pHI 40 pH Meter (Brea, CA) with a MI-40 combination micro-pH probe
(Microelectrodes, Inc., Bedford, NH).
Polarized Light Microscopy. Samples of each formulation were analyzed by polarized
light microscopy at the beginning and end of the kinetic studies. Cakes were suspended
in silicone oil, placed on a glass slide and then covered with a glass coverslip. Samples
were then examined for crystallinity using a polarizing microscope„(01ympus,BX51)
equipped with a 522 nm filter.
Scanning Electron Microscopy: Lyophiles of various HPMC content were submitted to
SECAT, Inc. for analysis by scanning electron microscopy and energy dispersive
spectrometry (SEM/EDS). Analysis was performed using Scanning Electron Microscopy
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(SEM - JEOL JSM-5900LV) with Backscatter mode under low vacuum. EDS was used
for chemical composition quantitative analysis.

Results
Lyophile Characterization
Appearance and pH. Lyophiles of each formulation post-lyophilization were white and
retained the height of the original fill volume. Lyophiles stored at 75% RH were partially
collapsed (approximately 50% of their original height) after the initial equilibration step
at ambient temperature. No further collapse was observed when the_se samples were
transferred to chambers at the same relative humidity at 40 °C. Lyophiles stored at
relative humidities below 75% showed no evidence of collapse. The absence of any
detectable birefi-ingence when lyophiles were viewed under a polarizing iracroscope
indicated that none of the formulation components crystallized to an extent ‘that could be
visualized by this method. The pH values of reconstituted formulations before and after
the kinetic studies were not significantly different.
Results from SEM/EDS were inconclusive and showed no evidence of phase
separation. The appearance of the cake at low HPMC content was very fibrous compared
to the cakes at the highest HPMC content which appeared much more solid (Figure 6-2).
The results from the elemental spectroscopy showed no significant different, in the
elemental composition of selected areas. If regions of peptides and buffers were more
concentrated in specific areas, elemental analysis would show higher concentrations of
sodium or nitrogen associated with the carbonate buffer or Gly-Val peptide, respectively.
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Water Content and Composition at Varying Relative Humidity. A summary of the water
content in lyophiles varying in the amounts of HPMC incorporated into the formulations
is shown in Table 6-1. Percentages of HPMC and the other formulation components
listed in Table 6-1 were calculated based on the water content determined after
equilibration at 40% RH. The water content immediately after lyophilization ranged
fi-om 2.4% in lyophiles containing 43.1% HPMC to 6.1% for lyophiles containing 69.1%
HPMC.

After vacuum drying at 50°C, the water content of each formulation was

reduced and became more consistent with values between 2-3% w/w. After storage of
lyophiles varying in % HPMC at 40% RH and 40 °C, their water contents ranged from 810% (w/w) and did not differ significantly with the % HPMC. Previously, we reported
the water content for lyophiles prepared from solutions containing 0.5% HPMC that were
equilibrated at 40% RH and 40°C to be significantly higher than the value in Table 6-1
(first column).

Most of the discrepancy (~5%) stems from the fact that no carbonate

correction was applied previously. Also, because one of the aims of the present study
was to examine the effect of water content, larger sample sizes were analyzed in the
present Karl-Fischer analyses and other changes in sampling procedure were
implemented in order to reduce possible moisture changes during sample manipulation.
The present results for water content are more believed to be more reliable.
As stated before, a validation experiment was performed to confirm previous
reports of carbonate contributing a molar equivalent of water when measured by KarlFischer*^^, a brief validation study was performed. Lyophiles containing various amounts
of carbonate buffer to the peptide Gly-Val were prepared and analyzed gravimetrically.
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Once adjusting for the molar equivalent of water contributed by the carbonate buffer, the
water eontent for each of the lyophilized cakes were essentially equivalent (Figure 6-3).
While water concentrations did not change significantly with an increase in %
HPMC, an increase in the amount of HPMC did lead to a corresponding reduction in the
solid-state Gly-Val concentration.

The solid-state concentrations of Gly-Val (in

mmol/mL) were estimated assuming a solid density of 1.3 g/mL. These concentrations
were later used to calculate second-order rate constants for covalent amide-linked adduct
formation to test the assumption in the model (Figure 6-1) that this reaction is
bimolecular.
Water contents in lyophiles containing a constant amount of HPMC (43.1% (w/w)
at 40% RH) increased linearly with increasing relative humidity (Figure 6-4). Also
shown are literature values for water content in films of HPMC alone'*^ as a function of
relative humidity. The higher values found for lyophiles described in these experiments
indicate that the peptides and carbonate buffer contribute substantially to the overall
moisture uptake. To confirm that the absorption of water in HPMC films is similar to
HPMC lyophiles, the water content of a lyophilized sample of the HPMC employed in
this study was determined at 40% RH as indicated by the triangle in Figure 6-4. The
similarity in this value to that previously reported in the literature confirms that the other
formulation components contribute significantly to the water affinity in the present
formulations.

Reactant and Degradant Profdes
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The identification and characterization of each the succinimide intermediates and
subsequent degradants, including the hydrolysis products and covalent amide-linked
adducts, have been previously described elsewhere.^^ The starting reactant, Gly-Phe-LAsn-Gly, first undergoes deamidation to form the reactive L-succinimide intermediate.
The L-succinimide intermediate partially racemizes in the amorphous solid as well as in
solution to form a D-succinimide intermediate.

Both succinimide isomers are then

susceptible to nucleophilic attack at both the a- and P-carbonyls. In the case where water
is the nucleophile, isoaspartate (attack at the a-carbonyl) and aspartate (attack at the.pcarbonyl) residues replace the original asparagine residue. Likewise, the primary amine
group at the N-terminus of Gly-Val can react with either carbonyl in both the

D-

and

L-

succinimide intermediates to form two different types of branched peptides (four
different amide-linked adducts). In summary, a total of ten degradants can be generated
from the deamidation of the starting reactant Gly-Phe-L-Asn-Gly including the
succinimide intermediates,

D-

D-

and L-

and L-diastereomers of isoaspartate and aspartate

containing peptides, and four covalent, amide-linked Gly-Val adducts.
Under all the experimental conditions explored in this* manuscript;, both aspartyl
and isoaspartyl peptides and covalent Gly-Val adducts were observed.

We have

previously examined the effectiveness of a kinetic model wherein all of the observed
degradants proceed through a succinimide intermediate.^^ Using the Gly-Phe^L-Asn-Gly
and its succinimide intermediate as the starting reactant and sirriultaneously fitting
concentration profiles over time, it was confirmed that all degradants were produced
through the succinimide intermediate. However, given the focus of the present
manuscript on effects of formulation and storage conditions on the overall reaction rate
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and the partitioning of the succinimide intermediate to form either hydrolysis products or
covalent, amide-linked adducts, individual degradant concentrations were pooled together
into larger classes including “imides,” “aspartates,” and “adducts.” The advantage of
grouping the degradants into larger categories is that more reliable rate constants could be
generated from the higher concentrations of analytes produced. Shown in Figure 6-5 is a
representative example of the data generated during the degradation of Gly-Phe-L-AsnGly lyophiles along with the fits obtained using Eqs. 1-4.

Consistent with previous

observations, the reaction scheme in Figure 6-1 and Eqs. 1-4 provided good simultaneous
fits of concentration versus time data for reactant disappearance, product formation, and
succinimide intermediate concentrations which were typically present at low,
approximately steady-state concentrations over the time course of these studies.
Reaction Kinetics with Varying HPMC Content
Shown in Figure 6-6A-C are the concentration versus time profiles for the starting
reactant Gly-Phe-L-Asn-Gly (A) and the aspartates (B) and covalent Gly-Val adducts (C)
in lyophiles containing various weight percentages of HPMC.

The overlays of the

fraction Gly-Phe- L-Asn-Gly remaining over time at various HPMC weight percentages
were nearly superimposable (Figure 6-6A), suggesting that increasing the amount of
HPMC polymer diluent in the formulations had a negligible impact on the overall
degradation rate. Similarly, no significant effect of HPMC content was discernible in
Figure 6-6B, where the concentrations of aspartates over time at various HPMC weight
percentages are displayed.

The most significant impact of HPMC content can be

observed in Figure 6-4C where the fraction of covalent amide-linked adduct formation
was clearly highest in the lyophiles with the lowest % HPMC. Decreasing rates of
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formation were observed as % HPMC was increased from 43% to 64%, above which
there was a diminishing effect of further increases in HPMC content.
Pseudo first-order rate constants for the various reaction steps depicted in Figure
6-1 and in Eqs. 1-4, generated from simultaneous fits to the data in Figure 6-4, are listed
in Table 6-2. The rate constants for the rate-determining step in the deamidation, of the
starting reactant Gly-Phe-L-Asn-Gly (i.e., succinimide formation) did not change
significantly as the weight percentage of HPMC increased judging from the overlap, of
the 95% confidence limits. Similarly, the rate constants for aspartate formation showed
no trend with increasing HPMC content. Only for covalent adduct formation were there
significant differences in the pseudo-first order rate constants. The decreaseTn covalent
amide-linked adduct formation with increases in HPMC excipient concentratiori resulted
in dramatic changes in the ratios of hydrolysis products to covalent adducts, as also
evident in Table 6-2.
The rate constants and error bars for the 95% confidence limits shown in Table 62 are plotted against the weight percentage of HPMC in Figures 6-7A-C. Visually, there
appears to be a correlation between the rate constant for deamidation and HPMC content
in Figure 6-7A and a correlation coefficient from a linear fit of 0.88 was obtained, but
based on the 95% confidence interval for the slope this correlation was not significant.
The individual rate constants for aspartate formation in Figure 6-7B are clearly scattered
around the average value confirming the lack of correlation between aspartate formation
and HPMC content.

The plot for rates of formation of covalent adducts: decreased

significantly with increasing amounts of HPMC (Figure 6-7C).

Qualitatively, this

behavior is consistent with the expected bimolecular nature of this reaction step coupled
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with the dilution of Gly-Val accompanying increases in HPMC content (Table 6-1).
Assuming that the reaction between Gly-Val and the succinimide intermediate is a second
order reaction dependent on the concentration of Gly-Val, as governed by Equation 5,
d[Adducts] ^ kadductsVGlyVal][Succinimide]

(5)

and that the succinimide intermediate is at steady-state, Equation 5 can be reduced to
Equation 6.
[ciyM

(6)

To further evaluate the dilution effects on the overall rate of adduct formation, a
plot of the calculated second order rate constant versus the effective concentration of Gly
Val in the lyophile was generated (Figure 6-8). The calculated rate constants for k’adducts
varied from 0.286 to 0.484 M''hr'', but fluctuated around the average value with no
significant differences as determined by the overlap of their 95% confidence intervals,
consistent with Eq. 6.
Reaction Kinetics with Varying Water Content
The qualitative effects of water content on the degradation of Gly-Phe-Asn-Gly
and degradant formation can be seen in Figure 6-9A. At 33% RH, over 4000 hours were
needed to obtain approximately 10% degradation of the starting reactant compared to
75% RH where only one hour was needed to achieve the same amount of degradation.
The first-order rate constant for the deamidation of Gly-Phe-L-Asn-Gly trends;'upwards
from 5.8-10.2% water content and then plateaus from 10.2-13.6% water content (Figure
6-10). No change was detected in the rate of deamidation from 10.2% to 13.6% water
content indicating that the plasticization effects of water had reached a maximum.
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Dramatic increases in the rates of degradant formation can be seen in Figure 6-9B
and 6-9C as water is increased. Similar to the degradation of Gly-Phe- L-Asn-Gly, the
required time to generate the same amount of degradants at 33% RH compared to 75%
RH was 2000 times longer.

Figure 6-11 shows a semi-logarithmic plot of the rate

constants for formation for aspartate and adduct degradants at various water, contents.
Aspartate formation exhibited a similar trend as the formation of the succinimide
intermediate. Increases in the rate of aspartate formation were observed from 5.8 to
10.2% water content, plateauing at 13.6%.

Unlike the other reaction steps, adduct

formation exhibited a bell-shaped profile. The rate increased from 5.8% to 8.1% water
content and then decreased from 10.2% to 13.6%. The first order rate constants for the
degradation of the starting reactant and the formation of hydrolysis and adduct.degradants
are summarized in Table 6-3.

Discussion
Under basic conditions in both aqueous solutions and amorphous solids the rate
limiting step in the deamidation of asparaginyl containing proteins and peptides is the
formation of a reactive succinimide intermediate.^'*’^^'^^ Generally, the succinimide then
undergoes reaction with water at either its a- or P-carbonyl to form isoaspartyl and
aspartyl containing degradants.

While this intermediate has been shown to be

susceptible to attack by other nucleophiles in aqueous solutions, such as amrhOnia and
substituted amine nucleophiles, these reactions seldom compete effectively with water
which is typically present at overwhelmingly higher concentrations.

Only at high

nucleophile concentrations such as in concentrated ammonia buffers or when a
nucleophilic substituent on the same molecule is situated in close proximity to the
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succinimide making possible an intramolecular reaction do such alternative pathways
appear to be significant in aqueous solutions. However, in nonaqueous solvents or in
amorphous lyophiles containing a reduced water content the situation appears to be more
complicated, as both the number and complexity of degradants produced from
asparaginyl deamidation increase substantially. Severs and Froland recently attempted to
stabilize a 31 -amino acid polypeptide drug candidate containing two asparaginyl residues
that was susceptibe to deamidation in aqueous solutions by formulating it in anhydrous
DMSO.'*^

To their surprise, the degradation rate did not decrease and multiple

degradation products, including a variety of amide-linked dimers and multimers were
found. More recently, studies by Desfougeres et al. revealed that lysozyme dimerization
was significant in freeze-dried powders stored in the dry state at 80 °C and correlated
with the concentration of succinimides. They proposed that dimerization could occur by
the attack of a basic group of an amino acid side chain (e.g., lysine) on a neighboring
protein molecule harboring a succinimide."*^
We have recently established using a model system and a mechanism-based
kinetic model

that covalent, amide-linked adduct formation in amorphous lyophiles

could be attributed entirely to reactions involving a succinimide intermediate.

In this

manuscript, we explored the influence of formulation and relative humidity on the
partitioning of the succinimide intermediate to produce either hydrolysis products or
covalent amide-linked adducts.
Equations 1-4 based on the reaction mechanism outlined in Figure 6-1 were
successfully utilized to simultaneously fit the concentration versus time data for reactant
disappearance and the formation of both Gly-Val adducts and hydrolysis products
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(Figures 6-6 & 6-9) as well as the succinimide concentrations that were typically present
at a low steady-state level as illustrated by the example in Figure 6-3. By applying a
mechanism-based model, rate constants for each type of reaction step could be generated
for every formulation and storage condition explored. These values are listed in Table 62 for formulations varying in HPMC content and stored at 40 °C/40% RH and in Table 63 for lyophiles prepared from 0.5% w/w HPMC stored at 40 °C and at varying relative
humidities.
Dilution Effect by HPMC on Degradation of Gly-Phe-L-Asn-Gly and Degradant
Formation
The two-step deamidation process illustrated in Figure 6-1 involving rate
determining succinimide formation followed by nucleophilic attack by either water or
Gly-Val to yield aspartyFiso-aspartyl degradants or covalent, amide-linked adducts,
respectively, provides an opportunity to explore the effects of both formulation and
storage variables on these diverse reaction types.

The first step involves the

intramolecular attack of an asparaginyl nitrogen in the peptide backbone on the carbonyl
of the asparagine side-chain amide resulting in the formation of a 5-membered
succinimide accompanied by ammonia release.

This reaction would be expected to

exhibit first-order kinetics with respect to the concentration of the starting peptide and
therefore should be largely unaffected by the dilution accompanying increases in HPMC
content in the formulation. Other consequences of increasing the HPMC content in the
amorphous lyophiles that might affect the rate of deamidation could include possible
alterations in water uptake at the same relative humidity or alterations in local mobility.
Water molecules may participate in the reaction coordinate for succinimide formation by
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altering the relative stability of the transition state in relation to the ground state through
hydrogen bonding.

Changes in loeal mobility accompanying increases in HPMC

content might also influence succinimide formation, a reaction that has been shown to be
highly dependent on segmental flexibility.'*^'^^
The effect of % HPMC content on succinimide formation, the overall rate
determining step in deamidation under the conditions of this study, is shown in Figure 67A. Although a negative slope was found for the rate constant for deamidation versus %
HPMC, the overlap in 95% confidence limits in the data suggests that there is no
statistically significant influence of HPMC content on this step.

Also, the 95%

confidence interval for the slope of the linear regression line included zero.
As shown in Table 6-1, increasing the amount of HPMC in amorphous lyophiles
had no significant influence on the overall water content. Consistent with these results,
Konno and Taylor observed almost no increase in water uptake with HPMC content
when lyophiles containing various amounts of HPMC (25-85% w/w) were exposed to
75% RH.'"

Comparison of the equilibrium water content of the peptide containing

lyophiles in this study with that for amorphous HPMC alone (Figure 6-4) indicates that
peptide and buffer salts accounted for approximately half of the water uptake (i.e., 4%) at
40% RH. Providing that the formulation components are molecularly dispersed, the
nearly eonstant overall water content with increases in the HPMC content would be
expeeted to have a negligible effect on the deamidation rates, consistent with the lack of a
significant trend as shown in Figure 6-7A.
Although succinimide hydrolysis resulting in the formation of aspartyl and
isoaspartyl peptides is a bimolecular reaction, in aqueous solutions the large excess of
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water leads to pseudo-first order reaction kinetics.

Given the nearly constant water

content in lyophiles as a function of % HPMC as reported in Table 6-1, pseudo-first order
kinetics would also be expected in these solid-state reactions. This was indeed the case,
as illustrated by the nearly constant value for the hydrolysis rate constant as reported in
Figure 6-7B.
Previously, Konno and Taylor demonstrated that increasing the HPMC content in
amorphous felodipine resulted in gradual increases in Tg, consistent with an"
antiplasticizing effect of HPMC.'*' Attempts to obtain reliable values for Tg in the'
amorphous lyophiles of interest in this study were unsuccessful. However, the improved
physical stability of these lyophiles in comparison to formulations of the same peptide
components without HPMC (results not shown) and- the absence of any evidence of
physical collapse or crystallization of components when lyophiles were stored at 40 °C
and 40% RJH are indicative of an inhibitory'effect of HPMC on global (i.e., matrix)
mobility. The absence of effects of increasing HPMC content on either the dearriidation
rate or the rate constant for succinimide hydrolysis could indicate either that changes in
local mobility for relaxation processes that influence the reaction kinetics were srnall over
the range of HPMC percentages explored or that neither of these reactions, aresignificantly coupled to local mobility. The latter possibility is unlikely in.view of the ,
effects of increasing water content on these reactions, which contrast markedly with the
HPMC results {vide infra).
Covalent adduct formation involves the bimoleeular reaction of the succinimide
with Gly-Val, a reaction that should be inhibited by the dilution effect resulting from
increasing the amount of HPMC if the reactants are molecularly dispersed in these
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lyophile formulations. Increasing excipient content has been shown to be effective in
reducing aggregation of proteins in amorphous sugars

and nucleation and

recrystallization in polymers.The plot for the rates of formation of covalent adducts
decreased significantly with increasing amounts of HPMC (Figure 6-7C), qualitatively
conforming to the expected behavior given the bimolecular nature of this reaction step
coupled with the dilution of Gly-Val (Table 6-1). To further evaluate the dilution effects,
Figure 6-8 was generated to determine whether or not the reduction in covalent adduct
formation could be quantitatively ascribed to changes in the Gly-Val concentrations when
the model in Figure 6-1 was assumed. The calculated rate constants for kadducts fluctuated
around the average value with no apparent trend and no significant differences as
determined by the overlap of their 95% confidence intervals.
Water Sensitivity — Dependence on the Reaction Step
As noted by others, water can play a myriad of roles in influencing chemical
reactivity in amorphous solids.

It can function as a direct reactant, as in

hydrolysis reactions, as a catalyst via solvation (e.g., hydrogen bonding) effects that may
stabilize a transition state in relation to its ground state, as a plasticizer to increase local
or global mobility, or as a solvent to solubilize reactants or alter local microenvironment
pH or dielectric constant.

Less appreciated but fairly certain in some cases is the

likelihood that the nature of water’s role will be dependent on the reaction type. For
example, in the present study, the role of water as a direct reactant (i.e., nucleophile)
applies only to succinimide hydrolysis. The plasticization effects of water may be more
critical for the bimolecular steps governing the fate of the succinimide intermediate than
for the intramolecular rate-determining reaction involved in its formation, given the need
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for translational mobility in the former while only orientational mobility would appear to
be necessary for the latter. Clearly ascribing the effect of water on amorphous reactivity
to any one of the above possibilities may prove difficult.
Increases in relative humidity from 33% to 75% RH resulted in linear increases in
water content ranging from approximately 6% to 13% in amorphous lyophiles (Figure 64). These increases in water content resulted in dramatic increases in the deamidation
rate (i.e., succinimide formation) as displayed in Figure 6-10. A change in water content
from 5.8% to 10.2% produced a striking increase in deamidation rate of nearly 4 ordersof-magnitude.

While we are unaware of other examples of such large increases in

reactivity with a <5% increase in water content, others have reported that peptide
deamidation rates in amorphous polymers can be highly sensitive to moisture content.
Increasing water content from 10.2% to 13.6% (w/w) failed to increase the rate of
succinimide formation further. Plateaus in the water induced enhancement in chemical
reactivity are common in the literature, and often indicate a reduction in the Tg of the
system to the temperature of the experiment.

In the present study, partial collapse

of the lyophiles was observed at 75% RH suggesting that a reduction in the system Tg to
a temperature close to 40°C did occur at this relative humidity.
Shown in Figure 6-11, an increase in water content from 5.8% to 8.1% produced
increases in both succinimide hydrolysis and covalent adduct formation of 3 or more
orders-of-magnitude. For the hydrolysis reaction this increase far exceeds that expected
from the change in the solid-state water concentration, indicating that plasticization,
transition-state solvation, or other solvent effects must play an important role. While the
rate constant for hydrolysis appears to reach a plateau at water contents above 8.1%,
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similar to the behavior of the succinimide formation step, the profile for the formation of
covalent Gly-Val adducts is more complex.

First, despite the fact that succinimide

hydrolysis might be expected to undergo greater acceleration than covalent adduct
formation from increases in water content in the low water content region since water is a
direct reactant in the case of hydrolysis, the opposite occurred. At lower water contents
between 5.8% and 8.1% the rate of amide-linked adduct formation increased more
dramatically than the rate of hydrolysis, increasing by approximately 100-fold compared
to a 24-fold increase in aspartate formation in this region.

Strickley and Anderson

observed a similar phenomenon in their studies of insulin degradation in lyophiles
prepared from solutions at pH 2-5.

Within this region, insulin degradation occurs via a

cyclic anhydride intermediate formed at the A21 terminal asparagine residue.

This

intermediate can then undergo competing hydrolysis or covalent insulin dimer formation.
They found that as water content increased the fraction of dimer formation in relation to
hydrolysis increased. To account for this counterintuitive finding, they invoked free
volume theory as originally developed by Cohen and Turnbull,

wherein the diffusion

coefficient depends exponentially on the mean free volume available in the matrix and
the permeant size. Smaller molecules, such as water, have significant mobility compared
to larger peptide or protein molecules in rigid structures such as glasses. While larger
diffusants are severely restricted in their translational mobility in glasses at low water
content they undergo disproportionate increases in molecular mobility relative to a small
molecule like water in systems containing an added plasticizer.
Unlike the other two reaction pathways, the formation of covalent adducts
exhibits a bell-shaped profile versus water content.
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The rate of adduct formation

increased from 5.8% to 8.1% water content, with a flattening in the rate from 8.1% to
10.2%, followed by a decrease of approximately 10-fold from 10.2% to 13.6%. Bellshape profiles in plots of degradation rate versus water content have been reported quite
frequently,

and have been rationalized in the context of water’s multiple roles in

influencing reaction kinetics.For example, plasticization effects leading to increased
reactant mobility with increasing water eontent may be overshadowed by the dilution
accompanying additional increases in water content.
Alternatively, increasing amounts of water in the amorphous lyophiles may
induee or promote phase separation of one or more of the formulation components,
leading to a reduction in the rate of eovalent adduct formation. Increasing water content
in polymers leads to water clustering due to self-association of water,^''^^ producing
heterogeneity in water distribution. In HPMC at high moisture contents (>6%), water
diffusivity increases are correlated with moisture-induced swelling.''^

These

plasticization effects may promote redistribution of other small molecules in the
formulation, particularly ionized species such as Gly-Val, which have a high affinity for
water, as suggested by Figure 6-4.
Previous researchers have described phase separation in binary mixtures of
HPMC with another polymer^'* or peptide.^^ Hussain et al. employed multiple methods
such as scanning electron microscopy, differential seanning calorimetry, and atomic force
microscopy to detect phase separation between HPMC and cyclosporin A, noting that the
degree of phase separation increased with the peptide concentration.^^

These

observations suggest that phase separation in the present systems, particularly at high
moisture contents, cannot be ruled out.
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Conclusion
This study examined the effects of changes in percentage of a polymeric excipient
(HPMC) and water content on the degradants formed from a model asparaginyl peptide
(Gly-Phe-L-Asn-Gly) in amorphous solids also containing an excess of Gly-Val and
carbonate buffer and stored at 40°C. Deamidation of Gly-Phe-L-Asn-Gly in amorphous
solids resulted in the formation of hydrolysis products (aspartates and isoaspartates) and
covalent amide-linked adducts. In all formulations and storage conditions, the formation
kinetics of aspartyl hydrolysis products and covalent adducts could be described by a
mechanism-based model that assigned a central role to the succinimide intermediate.
Increasing the percentage of HPMC (i.e., reactant dilution) did not significantly affect the
overall degradation rate but did favor the formation of hydrolysis products over covalent
amide-linked adducts, consistent with the bimolecular nature of covalent adduct
formation. Increases in water content as relative humidity was varied from 33-75% RH
produced orders-of-magnitude increases in the rate constants for succinimide formation
and hydrolysis with both becoming nearly constant at high water contents. A bell-shaped
profile for the dependence of the rate of covalent adduct formation on water content was
observed, a result that may be indicative of phase separation at higher relative humidities.
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HPMC in Solution
Gly-Phe-Asn-Gly
Gly-Val
Carbonate
Sodium
HPMC
TFA
Water Content after Drying
Water Content @ 40% RH

0.50%
w/w
3.18%
10.8%
23.4%
10.1%
43.1%
0.977%
2.40%
8.43%

1.00%
M
~

0.806
~
—

“
~

—

w/w
2.96%
7.52%
16.3%
7.06%
57.4%
0.517%
2.38%
8.36%

1.50%
M

~
0.562
~
—
—
~

—

w/w
2.75%
5.61%
12.1%
5.13%
64.8%
0.511%
3.23%
9.37%

2.00%
M
—

0.419
~
~
~
—

—

w/w
2.24%
4.56%
9.86%
4.18%
69.2%
0.386%
3.14%
9.75%

nJ 00%
M
~

0.340
—
—
—
—

-

w/w
1.63%
3.30%
7.14%
3.04%
76.1%
0.302%
3.07%
8.65%

M
—

0.246
—
—
—
—

—
On

Table 6-1. Weight percentages of the individual components in amorphous lyophiles prepared from solutions
varying in the amount of HPMC. Also included is the measured water content of lyophiles after drying in a
vacuum oven at 50°C and after equilibration at 40% RH.

HPMC Content (w/w)
Succinimide Formation
Aspartate Formation
Adduct Formation
Ratio Aspartates/Adducts

43%
0.0104
(0.008-0.013)
1.35
(0.95-1.76)
0.36
(0.26-0.47)
3.8

57%
0.0069
(0.0031-0.011)
0.83
(0.31-1.3)
0.161
(0.077-0.25)
5.1

65%
0.0074
(0.0051-0.0097)
1.10
(0.69:1J2)
0.129
(0.092-0.166)
8.5

69%
0.0064
(0.0042-0.0085)
1.24
(0.66-T82)
0.119'
(0.074-0.165)
10.4

76%
0.0062
(0.0028-0.0096)
1.15
(0.34-1.%)
0.119
(0.057-0.18)
9.7
ON

Table 6-2. Pseudo-first order rate constants described in Equations 1-4 using data generated from lyophiles
containing various percentages of HPMC stored at 40 °C/40% RH. 95% confidence intervals are reported in
parentheses.

Table 6-3. Summary of the rate constants for deamidation and degradant
formation at various water contents used to generate Figures 6-10 and 6-11.
Relative Humidity
Succinimide Formation

Aspartate Formation

Adduct Formation
Water Content
Ratio Aspartates/Adducts

33%

40%

60%

75%

1.69x10'^
(0.28xl0'^-3.10xl0‘^)

0.0104
(0.008-0.0130)

0.136
(0.029-0.243)

0.0973
(0.0803-0.114)

1.91x10'^

1.35

(0.35xl0'^-3.47xl0'^)

(0.95-1.76)

4.51
(0.74-8.28)

2.35
(1.97-2.73)

1.46x10"*
(0.23xl0"*-2.69xl0"*)

0.360
(0.255-0.472)

0.512
(0.225-0.798)

0.0441
(0.0333^0.0548)

5.80%

8.10%

10.2%

13.1

3.75

8.81
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■

,i3.6% .

:
"

53.3

Figure 6-1. Reaction mechanism reflected in the kinetic model (Eqs. 1 -4) used
to generate rate constants for the formation of the succinimide intermediate
from Gly-Phe-L-Asn-Gly, and the formation of aspartates or amide-linked
covalent adducts from the reaction of the succinimide with water or Gly-Val,
respectively.
Aspartates

Gly-Phe-Asn-Gly

Adducts
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Figure 6-2. SEM pictures of lyophiles containing weight percentages of 76.1% HPMC (A), 57.4% HPMC (B),
and 43.1% HPMC (C) taken at 200x magnification under low vacuum.

OO

o^

Figure 6-3. Water content as determined by Karl-Fischer for lyophiles
containing various weight ratios of carbonate buffer to Gly-Val. The reported
water content is adjusted for the presence of carbonate buffer which contributes
a molar equivalent of water. Error bars represent standard deviation.
8.00%

£ 5.00%
5C 4.00%
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3tol

Figure 6-4. Increase in water content for the lyophiles containing constant
HPMC (43.1% (w/w)) and buffers when stored at different relative humidities
(0, error bars represent standard deviations (n=3)) and water content for pure
HPMC films'*^ (□). The water content for a pure HPMC lyophile stored at 40%
RH generated in the present study is also shown (A).
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Figure 6-5. Semilogarithmic plots of concentration versus time for the
degradation of Gly-Phe-Asn-Gly (■) to the succinimide intermediates (•) and
the formation of hydrolysis products (A) and covalent adducts (X) in
lyophilies containing 76% HPMC stored at 40 °C and 40%RH.
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Figure 6-6. Concentration versus time profiles for the starting reactant GlyPhe-L-Asn-Gly (A) and the formation of aspartates (B) and covalent Gly-Val
adducts (C) in lyophiles containing various weight percentages of HPMC (43%
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Figure 6-8. Plot of the calculated second-order rate constants for adduct
formation as Gly-Val concentration is varied. The dashed line represents the
overall average and error bars represent the standard deviation.
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Figure 6-9. Concentration versus time profiles for the starting reactant GlyPhe-Asn-Gly (A) and the aspartates (B) and covalent adducts (C) in lyophiles
stored at 40 °C and either 33% RH (inset, X), 40% RH (A), 60% RH (□), and
75% RH (0).
1.0
0.9
I/)
0.8
<I
0.7
I

13
c
I

0

□

1

0.6

o. 0.5
1

o

c

o
t3

(D

X X X

08

0^
1I

0.4
0.3
0.2
0.1

*

06

0 2

o

0
1000

2000

3000

4000

5000

Time (hr)

00
15

10

20

Time (hr)
0 20

0.40

(1)
%
+-»
(0

0.35 H
0.30 -•

*5 S’
.1c s

0.25 -

™ <u
to
+.»

0.15

k.

(1]

Q.

0.20

0.10
0.05

□
□

-

s€
Ba
B3
l-ii
= a

S3.
s

'

B

0.15 0.10 0.05

•

_x_

0 00
0

1000 2000 3000 4000 5000

Time (hr)

□^
□
o
o
o
:o^

0.00
15

10

20

Time (hr)
0.10

^ 0 OOS -]

X

2 s 0.006

■D
"O
«£
c
■s
o
(U>
o
u

0.08

g I 0 ooo ^
g 0 002

(0

0.000 5l<-

0.06 -

1000 2000 3000 4000 5000

Time (hr)

0.04

cP

c

o
*t>

X

.9

□
□

0.02

0.00
0

10

Time (hr)

205

15

20

Figure 6-10. Semi-logarithmic plot of deamidation rate constant in amorphous
solids as water content is increased. Error bars represent 95% confidence
intervals.
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Figure 6-11. Semi-logarithmic plot showing the effects of water content on the
rate constants for aspartate (0) and adduct (□) formation. Error bars represent
95% confidence intervals.
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CHAPTER 7 - SUMMARY AND CONCLUSIONS
Deamidation of asparagine residues via a succinimide intermediate in aqueous
solutions and amorphous solids is a commonly observed pathway of degradation for
therapeutic proteins and peptides. The reactive succinimide intermediate undergoes
hydrolysis at either the a- or P-carbonyl resulting in the formation of isoaspartyl- and
aspartyl-containing peptides, respectively. The number of research articles suggesting a
correlation between the presence of a reactive succinimide intermediate and covalent
aggregation in proteins is increasing. The research presented in this thesis demonstrated
quantitatively that the succinimide intermediate plays a central role not only in the
formation of hydrolysis and racemization products but also in the generation of alternate
degradants formed by its reaction with other nucleophiles. These reactions may be
particularly important in amorphous solids
In Chapter 3, it was demonstrated that the succinimide intermediate formed from
Phe-L-Asn-Gly in aqueous solutions can react with ammonia at sufficiently high
concentrations leading to L- and D-isoasparaginyl-containing peptides along with partial
racemization of the starting peptide. Also, an intramolecular cyclization involving the Nterminus and the a-carbonyl of the succinimide intermediate resulted in the formation of
a diketopiperazine. The competition between water, ammonia, and the N-terminus for
reaction with the succinimide intermediate was demonstrated quantitatively by
application of a mechanism-based kinetic model. Lower pH values favored
diketopiperazine formation while basic solutions favored hydrolysis (i.e., aspartate and
isoaspartate formation).

The detection of alternate degradant formation involving the

succinimide intermediate in aqueous solutions provided the basis for exploring the
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formation of covalent adducts between neighboring peptides in amorphous solids
containing substantially reduced water concentrations.
In Chapter 4, deamidation of a model peptide, Gly-Phe-L-Asn-Gly, in lyophiles
containing HPMC, carbonate buffer and an excess of Gly-Val resulted in the formation of
two types of degradants - hydrolysis products and covalent adducts. Nucleophilic attack
by water resulted in hydrolysis products while Gly-Val attack produced covalent adducts.
Similar to the solution reactions, nucleophilic attack at the a- or (3-carbonyl on the
succinimide resulted in two types of degradants - normal and isopeptides. The
succinimide intermediate also underwent racemization, resulting in the formation of
racemic mixtures of each type of degradant. Therefore, ten total degradants were
observed including two succinimide intermediates, four hydrolysis products, and four
covalent adducts. The structure of each covalent adduct peak was confirmed using a
combination of kinetic experiments monitored by HPLC and mass spectrometry. The
stereochemistry of each covalent adduct was confirmed by monitoring the decomposition
of the L- or D-succinimides in lyophiles containing HPMC, carbonate buffer, and excess
Gly-Val at 27 °C and 75% relative humidity . Two major covalent adducts forming;fi-pm the L-succinimide were the result of Gly-Val attack at the a- and P-carbonyls with rid
change in stereochemistry. Two minor covalent adducts were the result of Gly-Val attack
on the same carbonyls after succinimide racemization. Similarly, degradation of the Dsuccinimide resulted in four covalent Gly-Val adducts, with the D-adducts predominating
over the L-forms. Fractions corresponding to the HPLC peaks for each of the covalent
adducts were collected, concentrated, and analyzed by mass spectroscopy. The MS/MS
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fragmentation patterns of the covalent adducts combined with the HPLC data allowed
tentative structural assignments for each of the degradants.
Once the identity of each degradant was established, experiments in Chapter 5
were designed to quantitatively examine the involvement of the succinimide intermediate
in hydrolysis, racemization, and covalent, amide-linked adduct formation in amorphous
lyophiles. The degradation of the model peptide, Gly-Phe-L-Asn-Gly, and its L- or Dsuccinimide intermediates were examined in lyophiles containing HPMC and a varying
amount of excess Gly-Val. Disappearance of the starting reactants and formation ofup to
10 degradants were monitored when lyophiles were exposed to either 27 °C/40%' RH pr
40 °C/75 RH. Terminal degradant profiles were the same when the starting reactant was
either Gly-Phe- T-Asn-Gly or its succinimide intermediate. Nucleophilic attack occurred
preferentially at the a-carbonyl of the succinimide intermediate at ratios of ~2:1 for both
water and the N-terminus of Gly-Val as the attacking nucleophiles. A mechanism-based
kinetic model analysis indicated that hydrolysis, racemization, and covalent amide-linked
j^

adduct formation all proceed via the succinimide intermediate. The results from-these
experiments provided a firm understanding of the reaction pathways and allowed for a
systematic evaluation of the effects of formulation variables on the reaction rates.' The experiments in Chapter 6 explore the effects of changes in percentage of
HPMC and water content on the rate of succinimide formation and degradant forrnation
in amorphous solids containing excess Gly-Val and carbonate buffer. An increase in the
weight percentage of excipients showed no significant effect on the rate of succinimide
formation or the formation of hydrolysis products (aspartates). The effects of polymer
content were only seen when examining the bimolecular reaction between Gly-Val and
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the succinimide intermediate. Increasing the amount of polymer excipient effectively
reduced the concentration of Gly-Val, a reactive nucleophile, and resulted in a reduction
of the pseudo-first order rate constant for adduct formation. The calculated second-order
rate constant showed no significant difference, consistent with dilution effects of a
bimolecular reaction when nucleophile concentration is varied. A similar result was
observed when Gly-Val was diluted by the addition of carbonate buffer. A four-fold
reduction in the solid-state concentration of Gly-Val by diluting lyophiles containing a
constant weight percentage of HPMC with carbonate buffer resulted in a four-fold
reduction in the rate of adduct formation and a consistent second-order rate constant. ■
The absorption of water showed a linear dependence on relative humidity from
33% to 75%. This linear dependence in water uptake did not directly correlate with the
rates of deamidation and degradant formation. An increase in water content from 5.8% to
10.2% increased the observed reaction rates, including the formation of the succinimide
intermediate, hydrolysis products and covalent adducts, by orders of magnitude.. The
dramatic effect of water content on the reaction rate is consistent with a plasticizatipii
effect of water on reactivity. A plateau in the rate constant for succinimide and aspartate
formation when water content increased from 10.2% to 13.6% indicates that theplasticization effects have reached a maximum. Unlike the other two reaction pathways,
the combined rate constant for covalent adduct formation exhibited a bell-shaped profile
as a function of water content. The rate constant increased fi'om 5.8% to 8.1% water
content and then decreased at the higher water contents.

The bell-shaped curve is

indicative of the multiple roles water can have on reaction kinetics. The bell-shaped
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profiles for the dependence of the rates of covalent adduct formation on water content
may reflect phase separation at higher relative humidities.
The work presented here employed a mechanism-based approach to quantitatively
demonstrate that the formation of covalent amide-linked adducts in amorphous
formulations of proteins and peptides (e.g., insulin, human growth hormone) may
proceed through the succinimide intermediate generated during asparagine deamidation.
This reaction pathway may also be involved in the formation of insoluble aggregates
observed in biological diseases such as cataract formation, Alzheimer’s disease, and
Parkinson’s disease. In addition to verifying the reaction pathway for aggregate
formation, the research presented in this thesis highlights the potential value of
mechanism-based kinetic models to understand reactions in amorphous solids.

Copyright © Michael P. DeHart 2011
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